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Abstract 
Atherosclerotic plaques are predominantly localised to bends and branches of arteries, 
where low shear stress causes altered gene expression in endothelial cells, leading to 
enhanced proliferation, apoptosis, inflammation and lesion development. A central 
regulator of these events is NF-κB signalling, comprising a family of transcription factors 
which can be subdivided into two pathways – canonical and non-canonical. While the 
canonical pathway is known to promote atherogenesis, investigation of the role of its 
negative regulator Cezanne (OTUD7B), has not been undertaken. Cezanne also inhibits 
the non-canonical NF-κB pathway, which has not been studied in the context of ECs 
exposed to shear stress. The hypothesis that Cezanne expression was regulated by shear 
stress and consequently modify NF-κB activity and lesion development was tested. In 
addition, the expression and role of non-canonical NF-κB was investigated in endothelial 
cells exposed to shear stress, and the contribution of Cezanne to this pathway also tested. 
Immunofluorescence staining for Cezanne in the murine aortic arch revealed elevated 
expression at an atheroprone site. Exposure of human cells to shear stress in two 
complimentary flow systems in vitro showed enhanced expression under low shear 
stress. Following silencing of Cezanne, NF-κB phosphorylation was found to be 
enhanced, but no effect was detected on NF-κB target genes, or on non-canonical NF-κB.  
Otud7b–/– mice were also found to have no difference in NF-κB target gene expression or 
proliferation as measured by immunofluorescence staining; moreover, lesion size in 
Otud7b–/–Ldlr–/– animals was unaltered. 
The expression of non-canonical NF-κB subunits p100/p52 and RelB were also found be 
enhanced by low shear stress, in RNA isolated from porcine aortas as well as in vitro. 
Silencing and immunofluorescence staining revealed that the pathway promoted 
proliferation specifically at sites of low shear stress in vitro, via repression of p21. 
Analysis of proliferation in the aortic arches of Nfkb2–/– recapitulated this finding, with 
decreased proliferation at the inner curvature of the aortic arch, measured by Ki-67 
positivity. 
The conclusions were that Cezanne expression was elevated by low shear stress, and is 
responsible for inhibition of NF-κB phosphorylation, but does not affect target gene 
expression or the development of atherosclerosis. The non-canonical NF-κB pathway is 
also elevated by low shear stress. Cezanne did not alter its activity, which was to promote 
proliferation by inhibiting the expression of p21. This reveals a novel mechanism for the 
control of low shear stress proliferation, as well as identifying the role of non-canonical 
NF-κB in endothelial cells.  
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1. Introduction 
Atherosclerosis is a chronic disease of the vascular system which can lead to angina 
pectoris, myocardial infarction or stroke, together responsible for over 400,000 hospital 
episodes in the UK each year (British Heart Foundation, 2016), and in 2015 accounted 
for 27% of all deaths (Townsend et al., 2015). It is not a modern disease, having been 
identified in ancient Egyptian remains (Zimmerman, 1993) and documented for 
hundreds of years. Leonardo da Vinci, who performed various autopsies on blood vessels 
of the young and old in the early sixteenth century, remarked that in the vessels of the 
old “the coat thickens so much that they close themselves up and stop the movement of 
the blood” (Boon, 2009). Indeed, this is a simplified definition of the pathology of 
atherosclerosis. The arterial thickening described by da Vinci is in fact development of 
fatty lesions on the inner wall of arteries. 
These atherosclerotic plaques are a complex arrangement of various cell types, 
extracellular matrix and lipids, the development of which takes place over the lifetime of 
an individual. Plaque development is outlined in Figure 1.1. They begin as early “fatty-
streak” type lesions which have been detected even in foetal aortas (Napoli et al., 2005). 
Endothelial cells (ECs) which line the lumen of blood vessels secrete chemokines such as 
monocyte chemoattractant protein 1 (MCP-1) when they are activated, which attract 
circulating leukocytes to the endothelium. These cells then attach to the vessel wall, aided 
by the presence of adhesion molecules like vascular cell adhesion molecule 1 (VCAM-1) 
and endothelial selectin (E-selectin). Subsequently, monocytes transmigrate through the 
endothelium into the subendothelial space, in part driven by enhanced endothelial 
junctional permeability at disease sites (Jaipersad et al., 2013; Libby, 2002).  
Within the intima, monocytes differentiate into macrophages as a result of macrophage 
colony stimulating factor (M-CSF) and other molecules, and begin to take up low density 
lipoprotein (LDL) (Weber and Noels, 2011). The permeable endothelium allows 
transport of circulating LDL into the intima, where it can become oxidised (ox-LDL) 
through exposure to transition metal ions or via the oxidative actions of enzymes 
expressed by ECs, vascular smooth muscle cells (VSMCs) or macrophages (Yoshida and 
Kisugi, 2010). Scavenger receptors such as CD36 and scavenger receptor A on the surface 
of macrophages are responsible for the majority of ox-LDL uptake. Within the cell, acyl-
coenzyme A:cholesterol acyltransferase 1 (ACAT1) activity results in the esterification of 
LDL cholesterol, which subsequently is stored in cytoplasmic lipid droplets (Yu et al., 
2013). These lipid-laden macrophages are referred to as foam cells due to the appearance 
of the lipid droplets within the cytoplasm. 
Figure 1.1: The mechanism of atherogenesis. Monocytes circulating in the blood weakly
adhere to activated endothelial cells through the action of selectins including E-selectin.
The weak adhesion causes the monocyte to ‘roll’ along the endothelial surface, driven by
chemokines like IL-8 and MCP-1 until interaction with the adhesion molecules VCAM-1 or
ICAM-1 cause firm adhesion. Adherent monocytes then invade the endothelium,
interacting with junctional proteins, and differentiate into macrophages. These
macrophages take up LDL which has been oxidised in the intima, causing a build-up of
lipid bodies within their cytoplasm. These lipid-laden ‘foam cells’ are responsible for
early fatty-streak lesions, and their continued growth and apoptosis lead to the
formation of plaques.
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Further inflammatory and growth-factor signalling from ECs, foam cells and other 
invading leukocytes like T cells and neutrophils (Döring et al., 2015) causes infiltration 
of more monocytes and proliferation of foam cells. In addition, circulating progenitor 
cells can infiltrate the subendothelial space and differentiate into VSMCs which further 
proliferate, leading to intimal thickening (Sata et al., 2002). VSMCs from the arterial wall 
can also play a role in pathogenesis; these cells become phenotypically altered, changing 
from a contractile to synthetic phenotype, and migrating into the intima, where they too 
begin to proliferate and lay down collagen to create a fibrous cap (Bennett et al., 2016; 
Lopes et al., 2013). Cytokine release and oxidative stress within the intima leads to 
apoptosis of foam cells, which deposit their lipid contents into the extracellular matrix 
while also further enhancing inflammatory signalling (Seimon and Tabas, 2009). 
Over a period of years, this process continues and the lesion grows in size until it begins 
to occlude the blood vessel. When a lesion partially blocks a vessel, it gives rise to 
conditions such as angina pectoris or peripheral arterial disease, whereby impaired 
oxygen availability as a result of poor circulation causes pain in the affected area. In some 
cases, this is a stable condition; a higher degree of lesion fibrosis is associated with stable 
angina pectoris which has a low cardiovascular event rate (Bando et al., 2015). 
In contrast, a thin fibrous cap can lead to plaque rupture (Stone et al., 2011). In part 
driven by the action of matrix metalloproteinases (MMPs) which degrade the cap 
(Agewall, 2006), plaque rupture results in the core of the plaque being exposed to the 
bloodstream. The presence of thrombogenic stimuli within the core generates thrombus 
formation on the surface of the plaque, which can serve to completely occlude blood flow 
if arterial narrowing is already severe (Libby, 2002). These cases can result in myocardial 
infarction if in a coronary artery, stroke if in an artery supplying the brain or ischaemia 
of the affected limb or organ if in another artery. The prognosis for these conditions is 
worse; myocardial infarction and stroke can be fatal as a result of loss of oxygen to these 
critical organs, and survival rates are largely dependent on the length of time before a 
patient can be treated (Martin et al., 2014). Due to the rate of disease incidence 
associated with atherosclerosis, it represents a significant burden to the health service 
and therefore research into preventative medicine is critical; understanding how the 
disease develops may aid in finding a method to reduce its prevalence. 
There are several medical and environmental risk factors which play large roles in the 
development of atherosclerosis. Blood cholesterol and cigarette smoking are two of the 
most important risk factors; elevated cholesterol increases the amount of LDL available 
for uptake by foam cells, while cigarette smoking increases reactive oxygen species (ROS) 
concentrations in the blood which can oxidise this LDL and promote inflammation 
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(Csordas and Bernhard, 2013). Obesity, poor diet and physical inactivity also play roles 
in increasing an individual’s risk of developing the disease (Dod et al., 2010; Hjermann 
et al., 1981; Yusuf et al., 2004). However, while these factors are systemic in nature, 
applying throughout the vasculature, the development of atherosclerotic lesions is focal, 
occurring predominantly at bends and branches within the arteries. 
Lining the inner wall of the blood vessels, ECs provide an interface between the 
circulating blood and the tissues of the vessel wall. These cells are responsible for a 
variety of physical and biochemical functions which act in concert to maintain vascular 
health. These functions, reviewed by Michiels (2003) include acting as a barrier between 
blood components and VSMCs; contributing to vasodilation through nitric oxide (NO) 
signalling to VSMCs; the development of new blood vessels through angiogenesis; and 
regulation of inflammation. Quiescent ECs maintain the health of the vasculature, 
however at sites prone to atherosclerosis, disease development is promoted through the 
dysregulation of EC physiology. The resulting changes include morphological 
differences, with ECs adopting rounded, cobble-stone shapes rather than aligning with 
the direction of the arterial blood flow (Reidy and Langille, 1980). At atheroprone sites, 
ECs also exhibit elevated turnover (Davies et al., 1986), rates of proliferation (Akimoto 
et al., 2000) and apoptosis (Choy et al., 2001). Furthermore there is increased 
inflammatory signalling activity through the mitogen activated protein kinase (MAPK) 
and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathways 
(Warboys et al., 2011), the latter of which will be focused on in more detail in this report. 
A great deal of research has been carried out to determine the particular factors at the 
bends and branch points of the vascular system leading to this observed endothelial 
dysfunction and thus atherosclerosis. 
1.1 Vessel haemodynamics contribute to plaque localisation and 
progression 
The environment in which a plaque develops is not only governed by biochemical 
processes which occur within and between cells, but also through physical forces which 
shape the cellular response. Blood flowing through the vasculature exerts several forces 
on the cells, including hydrostatic pressure, cyclic stretch across the cardiac cycle and 
shear stress. Caro et al. (1969) proposed that the focal nature of atherosclerosis results 
from these mechanical properties of blood flow. Contrary to literature at the time which 
assumed that sites prone to atherosclerosis would be subject to mechanical damage from 
rapid flow, Caro identified that atherosclerosis was preferentially located at sites where 
the wall shear stress of blood against the endothelium is locally decreased. This was 
confirmed using glass-blown models of the human aorta and correlation to regions of 
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atherosclerosis in human tissue samples (Caro et al., 1971). Shear stress is the frictional 
force exerted on a surface by the movement of another substance across it, in the case of 
haemodynamics it is exerted on ECs by the movement of blood. It is a function of blood 
velocity, blood viscosity and vessel diameter, defined by the equation: 
!"##	%ℎ'"(	%)('%% = 4,-.(/  
Where µ is viscosity, Q is flow rate and r is vessel radius (Cunningham and Gotlieb, 
2005). Since Caro’s initial publications, more sophisticated computational fluid 
dynamics (CFD) models have been generated which can more precisely map and 
characterise the forces generated by blood flow at these regions in different species 
(Chatzizisis et al., 2011; Feintuch et al., 2007; Lantz et al., 2012; Samady et al., 2011; 
Serbanovic-Canic et al., 2016). 
Although the specific haemodynamics can be an order of magnitude apart in different 
species, sites of lesion development tend to have similar features. In these models, blood 
flow at regions prone to atherosclerosis is complex, characterised by flow recirculation, 
oscillation, lower velocity and shear stress while regions protected from atherosclerosis 
are more ordered, possessing higher velocity and shear stress with a unidirectional flow 
(Figure 1.2). 
Elegant in vivo studies have solidified the causative link of low shear stress in the 
development of atherosclerosis by utilising murine models of atherosclerosis along with 
techniques to alter shear stress within the vasculature (Figure 1.3). Implantation of a 
flow-restricting cuff is one method of carrying this out, whereby a cast with fixed internal 
geometry is placed around a carotid artery, altering the shape of the vessel to create 
regions of low shear stress, high shear stress and oscillating shear stress. The 
development of atherosclerosis was found to be induced specifically at the low and 
oscillating shear stress regions, and not in high shear stress or in the contralateral artery 
with no cuff (Cheng et al., 2006). A similar result was found with a different method of 
inducing low shear stress. Nam et al. (2009) found that partial ligation of one carotid 
artery resulted in low, oscillating shear stress in that vessel, with an increase in shear in 
the other. Again, analysis of lesion development showed a localisation to the low shear 
stress region. This difference in lesion development determined by the biomechanical 
forces exerted on ECs reveals the crucial role that these cells play in altering vessel 
susceptibility to disease. 
Figure 1.2: Simplified shear stress dynamics of the aortic arch. Blood flowing through
the vasculature is not uniform, illustrated by this diagrammatic representation of an
aortic arch. At branch points, shear stress is high (red arrow) on the downstream wall of
the branch, while on the upstream wall the shear stress is lower (blue arrow) and the
flow pattern is more complex, including oscillations. Similarly at bends in the vessels, the
outer wall of the bend experiences unidirectional flow with high shear, while shear stress
at the inner wall is lower and recirculation zones are present.
© Mary Ann Liebert, Inc. Reproduced with permission.
Figure 1.3: Methods to alter shear stress in vivo. This illustration shows two methods
which have been successfully used to alter the natural shear stress experienced by ECs in
the murine vasculature. (a) The right carotid artery after placement of a constrictive cuff.
Shear stress is relatively low upstream, but the gradual narrowing of the cast interior
causes an increase. Upstream of the cast, regions of oscillatory shear stress form. (b)
Partial carotid ligation of the left carotid artery induces oscillatory flow. Ligation of three
of the four branching arteries (external carotid artery, internal carotid artery and
occipital artery) of the left carotid artery causes reciprocal flow of low shear stress in that
artery, while increasing the shear stress in the right carotid artery.
© Mary Ann Liebert, Inc. Reproduced with permission.
15 
 
 
1.1.1 Exposure to different shear stress patterns regulates EC gene expression 
and phenotype 
Differences in shear stress can potentially lead to EC dysfunction via two mechanisms. 
The first is that due to a decrease in flow velocity and an increase of recirculation at sites 
of low shear stress, there is an increase in the transport of blood molecules into the 
endothelium (Tarbell, 2003). There are various data which support this hypothesis, 
suggesting that not only biologically inert molecules like albumin (Staughton et al., 
2001), but also LDL may show an increased rate of transport into the subendothelial 
space (Wada and Karino, 2002). Additionally, at atheroprone sites, a low oxygen 
environment is generated (Santilli et al., 1995), explained by an increase in oxygen 
uptake and consumption but a decrease in oxygen replacement due to flow stagnation. 
This can activate hypoxic signalling (Akhtar et al., 2015), and lead to a further increase 
in LDL uptake through inducing apoptosis, creating gaps in the endothelium at so-called 
leaky junctions (Weinbaum et al., 1985), as well as generation of ROS which can activate 
ECs (Heo et al., 2011).  
The second mechanism by which shear stress can regulate EC dysfunction is via direct 
sensing of the mechanical force, transducing this into biochemical signals. Evidence 
which points specifically to mechanosensing as a mechanism of physiological changes in 
ECs comes primarily from in vitro studies, where it is possible to introduce artificial flow 
conditions to cultured cells. In these systems, unidirectional flow has been shown to 
suppress inflammatory activation (Chiu et al., 2005; Partridge et al., 2007; Surapisitchat 
et al., 2001), proliferation (Akimoto et al., 2000) and apoptosis (Dimmeler et al., 1996), 
observations which are also supported in vivo at sites protected from atherosclerosis. 
The phenotypic changes observed in ECs as a result of differences in shear stress arise 
from significant shifts in gene expression profiles. Several unbiased screens have been 
carried out to date, investigating differences in EC gene expression between samples 
exposed to different shear stress patterns (Dunn et al., 2014; Ni et al., 2010; Passerini et 
al., 2004; Serbanovic-Canic et al., 2016). Combined, these studies show that cells 
exposed to high and low shear stress display differential expression of hundreds of genes, 
in pathways including inflammation, proliferation, apoptosis and development. 
Modification of gene expression may result from altered molecular transport, 
mechanosensing, or perhaps a combination of both. Oxidised LDL – and other 
circulating molecules such as interleukin-1β (IL-1β) and cluster of differentiation 40 
ligand (CD40L) – can stimulate expression of inflammatory target genes such as VCAM-
1 and E-selectin (Collins et al., 1995; Cominacini et al., 2000; Henn et al., 1998). 
However, expression of these molecules can also be altered by shear stress alone, with 
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ECs exposed to low shear stress in vitro displaying similar phenotypes to those at disease 
prone sites in vivo (Dardik et al., 2005). This may be mediated by the function of 
mechanosensory complexes such as the platelet endothelial cell adhesion molecule 
(PECAM)-1, vascular endothelial cell cadherin (VE-cadherin) and vascular endothelial 
growth factor receptor 2 (VEGFR2) complex (Tzima et al., 2005). This complex is able to 
transduce mechanical signals of blood flow to invoke physiological changes under 
laminar flow. Cells deficient in either VE-cadherin or PECAM-1 were found to not align 
under flow as wild-type cells do, furthermore as well as impaired EC alignment in the 
aorta, PECAM-1–/– mice showed reduced inflammatory activity at atheroprone sites. 
Regulation of the expression of such a large number of genes is possible through 
modification of the expression or activity of transcription factors or transcriptional 
coactivators such as Krüppel-like factor 2 (KLF2), histone deacetylases (HDACs) or NF-
κB (Hajra et al., 2000; Lee et al., 2012), which can act alone or together to promote or 
repress the expression of many genes. Of particular interest in this thesis is the shear 
stress modulation of NF-κB signalling, pathway members of which have been implicated 
in playing a key role in regulating EC inflammation, apoptosis and proliferation (Van der 
Heiden et al., 2010). Understanding how this pathway functions to regulate these key 
markers of endothelial dysfunction may give insight into the development of 
atherosclerosis. 
1.2 NF-κB signalling 
The NF-κB family is a group of transcription factors which regulate many cellular 
processes, including immune cell activation, differentiation, cell growth and survival, 
and tissue inflammation. There are five subunits which make up the family, illustrated 
in Figure 1.4: RelA, RelB, c-Rel, p50 and p52 (Hayden and Ghosh, 2008). These combine 
by homo- or heterodimerisation to form active transcription factors. NF-κB subunits are 
characterised by the presence of a well conserved Rel homology domain (RHD; 
(Vallabhapurapu and Karin, 2009). This domain folds into two distinct subdomains 
(Figure 1.5) with a short linker region between. The carboxy-terminal subdomain is 
responsible for the dimerisation of NF-κB subunits while the amino-terminal subdomain 
wraps around a DNA helix, bringing the linker region into contact with the major groove 
of DNA and thus permitting transcription factor activity through the transactivation 
domain (TAD) found only on RelA, RelB and c-Rel (Müller and Harrison, 1995). The p50 
and p52 subunits require activation by proteasomal processing from their respective 
precursors p105 and p100. The mature proteins may still bind DNA but can only serve to 
inhibit transcription without interaction with a cofactor activator (Beinke and Ley, 
2004). 
 Figure 4. Domain structures of the NF-κB family subunits. The five subunits of the NF-κB 
family show varying amounts of similarity to each other. All five possess the Rel homology 
domain (RHD) responsible for DNA binding activity. Only RelA, RelB and c-Rel possess the C 
terminal transactivation domain (TAD) that confers the ability to activate transcription of a target 
gene. The remaining two — p52 and p50 — are processed from larger precursors by 
proteasomal processing, with the cleave site shown as an arrow in each. The precursors can act 
as inhibitors of NF-κB activation through their ankyrin repeats; the mature forms require 
heterodimerisation with another subunit to activate gene transcription.
Figure 1.4: Domain structures of the five NF-κB family subunits. The five subunits of the
NF-κB family show varying amounts of similarity to each other. All five possess the Rel
homology domain (RHD) responsible for DNA binding activity. Only RelA, RelB and c-Rel
possess the C terminal transactivation domain (TAD) that confers the ability to activate
transcription of target genes. The remaining subunits – p52 and p50 – are processed
from larger precursors by proteasomal processing, with the cleave site shown as an
arrow in each. The precursors can act as inhibitors of NF-κB activation through their
ankyrin repeats; the mature forms require heterodimerisation with another subunit to
activate gene transcription.
 Figure 5. Structure of NF-κB bound to DNA. The structure of the p50/RelA dimer bound to 
DNA reveals the distinct subdomain structure of the RHD. The C terminal mediates dimerisation 
through β-sheet interactions, while the link between the N and C termini is responsible for binding 
DNA in the major groove. $
Structure downloaded from PDB, solved by Chen et al., 1998.
Figure 1.5: Structure of NF-κB bound to DNA. The structure of the p50/RelA dimer
bound to DNA reveals the distinct subdomain structure of the RHD. The C terminal
mediates dimerisation through β-sheet interactions, while the link between the N and C
termini is responsible for binding DNA in the major groove.
Structure downloaded from the Protein Data Bank, solved by Chen et al., 1998.
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NF-κB activation can be initiated by a diverse range of stimuli (discussed further below), 
and the pathway exhibits stimulus-dependent and cell-type-dependent regulation of 
gene expression (reviewed by Sen and Smale, 2009). In part this may be due to cofactors 
such as cyclic adenosine monophosphate response element binding protein (CREB) 
binding protein (CBP)/p300 and ubiquitously expressed transcript protein (UXT) 
(Vanden Berghe et al., 1999; Sun et al., 2007), which can bind to NF-κB and enhance its 
transcriptional activity. In addition, post-translational modification of NF-κB subunits 
can alter their activity and consensus sequence (Perkins, 2006). Phosphorylation at the 
serine 276 residue of RelA by protein kinase A regulates binding to the transcriptional 
coactivators CBP and p300, a change which results in an induction of NF-κB activity 
(Zhong et al., 1998), while phosphorylation at serine 536 may alter turnover from 
promoter regions and target gene specificity (Bohuslav et al., 2004; Lawrence et al., 
2005; Moles et al., 2013; Sasaki et al., 2005).  
Perhaps the most important mechanism by which NF-κB signalling is regulated is in the 
combination of subunits which make up the active dimer. The consensus sequence of 
members of the NF-κB family is usually written as a variant of 5’ GGGRNNYYCC 3’, 
where ‘R’ represents a purine, ‘Y’ a pyrimidine and ‘N’ any nucleotide (Natoli et al., 
2005). However, due to the heterogeneity of the total population of NF-κB dimers this is 
only an approximation. There are 15 possible homo- or heterodimeric combinations, 12 
of which have been confirmed in vivo (Hoffmann et al., 2006). Certain dimers are more 
common; RelA and c-Rel preferentially dimerise with p50 – indeed the most abundant 
NF-κB dimer is RelA/p50 – but RelB instead shows preference for p52 dimerisation 
(Vallabhapurapu and Karin, 2009). These two groups of dimers have almost entirely 
different mechanisms of upstream activation and are responsible for the activation of 
distinct genes, although the mechanism for this is not yet fully understood. Thus, NF-κB 
activation is separated into two pathways; the canonical and non-canonical pathways. 
1.3 Activation of NF-κB signalling 
NF-κB activity relies on its ability to bind DNA (Figure 1.5). In unstimulated cells, NF-
κB dimers are retained in the cytoplasm through blocking of the nuclear localisation 
sequence (NLS) - found at the C-terminal end of the RHD - by inhibitory molecules of 
the family of inhibitor of κB (IκB) of which there are three typical molecules: IκBα, IκBβ 
and IκBε. Multiple ankyrin repeats present on IκB molecules are responsible for binding 
to the NLS of one or both of the subunits of the NF-κB dimer. This results in either a flux 
of NF-κB across the nuclear membrane through the action of a free NLS (Jacobs and 
Harrison, 1998) and opposing nuclear export sequence (NES) on the C terminus of IκBα 
or –ε (Arenzana-Seisdedos et al., 1997; Lee and Hannink, 2002), or constitutive 
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cytoplasmic localisation of the NF-κB:IκBβ complex through blocking of both NLSs 
(Malek et al., 2001). IκBα can additionally provide a dampening mechanism of negative 
feedback; its expression is induced by NF-κB and it is subsequently able to transport 
cytoplasmic dimers back to the cytoplasm, creating oscillations of nuclear NF-κB as a 
hallmark of the response (Nelson et al., 2004). In addition to the typical IκBs, 
unprocessed p100 and p105 can act as inhibitors through the ankyrin repeat domain 
present in place of the TAD (Basak et al., 2007; Beinke and Ley, 2004). In all cases, 
inactive NF-κB is primarily localised to the cytoplasm; however, the mechanism of 
cytoplasmic release differs between the canonical and non-canonical pathways. 
1.3.1 Canonical NF-κB 
The canonical NF-κB pathway (Figure 1.6) is responsible for activation of p50, RelA and 
c-Rel dimers. Its main characteristic is proteasomal degradation of IκB as a means to 
release NF-κB from its cytoplasmic retention and allow translocation to the nucleus. 
Various receptors are responsible for the initial stimulus to activate the canonical NF-κB 
pathway. TNFR (tumour necrosis factor α (TNFα) receptor), TLRs (Toll-like receptors) 
and IL-1R (interleukin-1 receptor) have all been discovered to be involved, among others 
(de Winther et al., 2005). Each receptor differs slightly in its mechanism of activation 
but these feed into the same pathway downstream. Different pathways can be categorised 
broadly by the signal adaptors which perpetuate the activation of each receptor. 
Signalling through TNFα to TNFR first recruits the adaptor protein TNFR-associated 
death domain protein (TRADD), which binds to TNFR (Hsu et al., 1995), then secondly 
TNFR-associated factor 2 (TRAF2) (Hsu et al., 1996a), and finally receptor-interacting 
serine/threonine-protein kinase 1 (RIP1) (Hsu et al., 1996b). TLRs and IL-1R function in 
an analogous manner, utilising the adaptors MyD88 (myeloid differentiation primary-
response protein-88), TOLLIP (Toll interacting protein) and IRAK (IL-1R-associated 
kinase) family proteins in place of TRADD. These proteins activate another TRAF family 
protein, TRAF6.  
Both RIP1 and TRAF6 are then involved in a complex polyubiquitin signalling network, 
which unites the different upstream signals into a single pathway. RIP1 becomes 
ubiquitinated by lysine-63 (K63) or -11 (K11)-linked ubiquitin chains (Dynek et al., 2010; 
Lee et al., 2004). As TRAF2 possess E3 ubiquitin ligase activity, which is the enzymatic 
reaction responsible for the addition of the first ubiquitin molecule to a specific site of 
the target protein, it was thought that it was directly responsible for catalysing 
ubiquitination of RIP1. In fact, two more proteins known as cellular inhibitors of 
apoptosis 1 and 2 (cIAP1 and -2) also associate with TRAF2 to carry out E3 ubiquitin 
ligase function as a complex (Bertrand et al., 2008; Vince et al., 2009). TRAF6 may 
Figure 1.6: The canonical pathway of NF-κB activation. Activation of the membrane
receptor (TNFR illustrated, see text for differences with other receptors) causes lysine-
63-linked polyubiquitination of RIP1, mediated by the TRAF2/cIAP1/cIAP2 complex. The
kinase TAK1 associates with this polyubiquitin chain via the adaptor TAB2, as does its
target – NF-κB essential modifier (NEMO). In this conformation, TAK1 is able to
phosphorylate IκB kinase β (IKKβ), which forms the IKK complex together with IKKα and
NEMO. Activated IKK phosphorylates the inhibitor of κB (IκB), which recruits a ubiquitin
ligase complex to mark it for proteasomal degradation by lysine-48-linked
polyubiquitination. This releases NF-κB from its sequestration in the cytoplasm, allowing
it to enter the nuclear and activate transcription.
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become autopolyubiquitinated with K63-linked ubiquitin chains when activated 
(Lamothe et al., 2007) and as such would be analogous to the TRAF2-mediated 
ubiquitination of RIP1, although this is unclear at present, as TRAF6 autoubiquitination-
independent activation has been reported (Walsh et al., 2008).  
The polyubiquitin chains extend and act as a scaffold, linking to the NF-κB essential 
modulator (NEMO) (Ea et al., 2006), part of the IκB kinase (IKK) complex, also 
comprising IKKα and IKKβ (Krappmann et al., 2000). Linear ubiquitin chains (linked 
by methionine 1) have also been found to link NEMO to the TNFR complex 
independently of RIP1, and this is required for efficient progression of signalling (Haas 
et al., 2009). The presence of the polyubiquitin scaffold between the receptor and IKK 
complex allows recruitment of the mitogen-activated protein kinase kinase kinase 
(MAP3K) molecule TAK1 (transforming growth factor-β-activated kinase-1) via the 
adaptor molecule TAK1 binding protein 2 (TAB2) (Chen et al., 2006). By binding to the 
polyubiquitin scaffold, TAK1 is brought into proximity of its target, IKKβ. TAK1 
phosphorylates serines 177 and 181 of IKKβ, thus activating the IKK complex (Delhase et 
al., 1999). The IKK complex possesses serine/threonine protein kinase activity through 
the combined activity of IKKα and -β (Zandi et al., 1997) and is responsible for 
phosphorylating IκB proteins at conserved serine residues in the DSGXXS motif 
(Hayden and Ghosh, 2008). This phosphorylation creates a binding site for β-transducin 
repeat containing protein (βTrCP). βTrCP is a variable ‘F-box’ component of the larger 
SCF (Skp1-Cullin-1/Cdc53-F-box protein) E3 ubiquitin ligase complex (reviewed by 
Cardozo and Pagano, 2004). SCFβTrCP ubiquitinates two lysine residues upstream of the 
phosphorylation site with K48-linked ubiquitin to mark it for proteasomal degradation 
(Perkins, 2006), thus freeing the NF-κB dimer to enter the nucleus and carry out its 
transcription factor activity. 
The function of the canonical NF-κB pathway is primarily in the regulation of 
inflammatory signalling. Activation of NF-κB signalling is crucial in the cellular response 
to injury and infection; affected sites produce inflammatory molecules – such as ILs and 
MCP-1 – and adhesion molecules as a result of active NF-κB which attract leukocytes to 
the area to resolve the infection or initiate tissue repair (Caamaño and Hunter, 2002; 
Wang et al., 2013b). Additional canonical NF-κB functions include regulation of cell 
survival via the upregulation of anti-apoptotic and antioxidative genes like B-cell 
lymphoma 2 (BCL2) and superoxide dismutase 2 (SOD2), which can have a profound 
role in promoting tumour survival (Baldwin, 2012). 
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1.3.2 Non-canonical NF-κB 
The non-canonical pathway (Figure 1.7) is responsible predominantly for activation of 
p52/RelB dimers. In contrast to the canonical pathway, the non-canonical does not rely 
on degradation of IκB to promote NF-κB activation, but instead relies on the processing 
of p100 into p52 (Sun and Ley, 2008). The unprocessed p100 is able to dimerise with 
and stabilise RelB through multiple domain interactions, including the dimerisation 
domain and C terminal ankyrin repeat domain (Fusco et al., 2009). The p100/RelB 
complex is transcriptionally inactive due to predominant localisation to the cytoplasm. 
In a similar fashion to NF-κB/IκBα, a NES present on the N-terminus of p100 combats 
the NLS of RelB thus causing a shuttling of the complex across the nuclear membrane, 
with a bias towards export (Solan et al., 2002). 
The NF-κB-inducing kinase (NIK) is responsible for activating p100 processing. This 
serine/threonine MAP3K is necessary for non-canonical NF-κB activity (Xiao et al., 
2001), and is able to specifically phosphorylate IKKα independent of the trimeric IKK 
complex in canonical activation (Ling et al., 1998). Serines 866 and 870 on the C 
terminus of p100 form a phosphorylation site for IKKα which bears similarity to the IκBα 
site responsible for ubiquitin-mediated degradation. Sure enough, phosphorylation of 
these serines on p100 allows recruitment of SCFβTrCP to this site (Fong and Sun, 2002). 
Bound to p100, SCFβTrCP is then able to catalyse polyubiquitination at lysine 855 (K855) 
approximately 10 residues upstream of the binding site (Amir et al., 2004), marking p100 
for proteolytic processing into p52. 
Processing of p100 to p52 is a tightly regulated process; in the absence of activation, p100 
is much more abundant than p52, and even overexpressed p100 has extremely low rates 
of processing to p52 in comparison to p105 to p50 processing which is constitutive (Sun, 
2011). Downregulation is achieved by a multi-component degradative pathway upstream 
of NIK. Cellular abundance of NIK is maintained at low levels in spite of its constitutive 
expression, through continued proteasomal degradation. Another ubiquitin ligase 
complex, consisting of TRAF2 and -3, and cIAP1 and -2 constitutively interacts with NIK 
to mark it for proteasomal degradation. TRAF3 binds to the N-terminal binding motif 
ISIIAQA on NIK (Liao et al., 2004) and to TRAF2, acting as a bridge between NIK and 
cIAP1/2 (Zarnegar et al., 2008b); while cIAPs possess E3 ubiquitin ligase activity 
through a RING domain (Yang et al., 2000) and conjugate ubiquitin onto NIK to mark it 
for proteasomal degradation and thus maintain a low NIK concentration (Skaug et al., 
2009). Zarnegar et al. illustrated the importance of this control of NIK accumulation with 
an elegant rescue experiment in mice. Traf3–/– mice were found to die within weeks of 
birth due to elevated NIK leading to overactive p100 processing and constitutive non-
Figure 1.7: The non-canonical pathway of NF-κB activation. This pathway relies on
proteasomal processing of p100 to p52 for its activation. Upon stimulation by one of the
ligands named in the figure, NIK activates this process by phosphorylating IKKα
independent of IKKβ, which in turn phosphorylates p100, complexed with RelB. This
phosphorylation recruits a ubiquitin ligase, conjugating lysine-48-linked polyubiquitin to
mark p100 for processing. Prior to stimulation (red box) this process is halted by
constitutive degradation of NIK by TRAF3 ubiquitin ligase activity. Stimulation causes a
shift so the TRAF2/cIAP1/cIAP2 complex marks TRAF3 for degradation instead, allowing
NIK accumulation and thus NF-κB activation.
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canonical NF-κB activity. Mice with NIK deletions (Map3k14–/–) were rescued from this 
phenotype. 
Activation of the non-canonical pathway proceeds through a variety of TNFR family 
receptors, including lymphotoxin-β (LT-β) receptor (LTβR), B-cell-activating factor 
(BAFF) receptor (BAFFR), CD40, and receptor activator of NF-κB (RANK), which all 
contain TRAF binding motifs (Sun, 2011). Upon activation of these receptors by their 
corresponding ligands, the TRAF2/3/cIAP complex relocalises to the cytoplasmic 
domain of the receptor (Matsuzawa et al., 2008). This causes a functional change in cIAP 
activity, which instead initiates K48-linked polyubiquitination of TRAF3 and subsequent 
degradation (Vallabhapurapu et al., 2008). In the absence of TRAF3, the TRAF2/cIAP 
ubiquitin ligase complex is unable to associate with NIK and thus it is no longer 
constitutively degraded; translation of NIK continues and cellular abundance increases 
until it is able to activate p100 processing and thus generate active RelB/p52 dimers. 
Non-canonical NF-κB signalling is of utmost importance in the regulation and 
development of B cells and lymphoid organs. Loss of IKKα or NIK results in a deficiency 
in B cell maturation (Hahn et al., 2016; Jellusova et al., 2013), and mice deficient in LTβR 
or NIK display a complete absence of lymph nodes (Fütterer et al., 1998; Yamada et al., 
2000). Stimulation of non-canonical NF-κB signalling by ligation of LTβR is required for 
the development of lymph nodes and lymphangiogenesis (Bénézech et al., 2013; Onder 
et al., 2013; Vondenhoff et al., 2009). Like the canonical NF-κB pathway, the non-
canonical pathway can also be oncogenic. In B cell cancers, aberrant nuclear localisation 
enhances proliferation, inhibits senescence and represses apoptosis (De Donatis et al., 
2015; Park et al., 2006; Vallabhapurapu et al., 2015). Less is known about the target 
genes of non-canonical compared to canonical NF-κB, however several studies have 
found proliferative genes such as cyclin D1 (CCND1), p21 (CDKN1A) and regulated in 
development and DNA-damage response 1 (REDD1) are transcriptional targets of p52 
(Ramachandiran et al., 2015; Rocha et al., 2003; Schumm et al., 2006), indicating that 
regulation of proliferation is a key function of this pathway. 
1.4 NF-κB activity regulates the development of atherosclerosis 
NF-κB activity is important for regulating vascular health and has been implicated in 
regulating the development of atherosclerosis, as mice deficient in EC NF-κB display a 
marked reduction in lesion size (Gareus et al., 2008). Activated NF-κB has been detected 
in VSMCs, macrophages and ECs of advanced human atherosclerotic lesions in 
comparison to little or no activation in other regions of the aorta (Brand et al., 1996). 
Several processes involved in atherogenesis are regulated by NF-κB signalling (de 
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Winther et al., 2005). Activation of NF-κB in ECs results in the secretion of pro-
inflammatory cytokines and the expression of adhesion molecules (Collins et al., 1995; 
Kaplanski et al., 1993), which collaborate to enhance monocyte infiltration, as well as 
furthering the inflammatory response in macrophages or VSMCs already present in 
lesions. Further progression, by monocyte differentiation into macrophages and tissue 
invasion can also be regulated by NF-κB; expression of the differentiation regulator M-
CSF in monocytes has been found to be dependent on NF-κB signalling through TNFα 
(Kogan et al., 2012). Furthermore, expression of MMP9 is induced by NF-κB activity, 
and is required to degrade the extracellular matrix (ECM) of the blood vessels to provide 
optimal macrophage invasion of the tissue (Bond et al., 1998). Indeed, MMP9 deficient 
mice crossed with mice prone to atherosclerosis showed a reduced level of plaque 
development throughout the aorta (Luttun et al., 2004).  
There is some evidence to suggest that non-canonical NF-κB signalling could be involved 
in the development of atherosclerosis too. Mice deficient in CD40L are protected from 
lesion development (Lutgens et al., 1999), potentially implicating downstream non-
canonical NF-κB regulation. However, no direct link between non-canonical NF-κB 
signalling and cardiovascular health has been described. 
The activity of NF-κB in ECs at sites prone to atherosclerosis may be as a consequence of 
stimulation by cytokines such as TNFα and IL-1β (Libby, 2002), or by oxidised LDL (ox-
LDL) (Cominacini et al., 2000; Parhami et al., 1993). However, the shear stress 
experienced by ECs within the vasculature plays an important role in regulating the NF-
κB response. 
1.5 Endothelial NF-κB is regulated by blood flow patterns. 
Corresponding to the observed pattern of atherosclerosis localisation with respect to 
blood flow patterns within the vasculature, endothelial NF-κB activity is also 
differentially localised to these particular regions. Examinations of tissue samples from 
regions of low shear stress in otherwise healthy mice (Hajra et al., 2000) and pigs 
(Passerini et al., 2004) have shown increased NF-κB abundance without a corresponding 
increase in activity, indicating cells here enter a ‘primed’ state where inflammatory 
signalling molecules can induce a rapid inflammatory response. Novel regions of low 
shear created in the vasculature of mice with constrictive cuffs have been shown to 
induce NF-κB expression too (Cuhlmann et al., 2011), supporting the idea that blood flow 
can control its activation. 
There are many in vitro data which support these observations. Human ECs grown in 
culture and subjected to high shear stress (as found in atheroprotective regions in vivo) 
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show a consistent dampening of NF-κB activity and reduced expression of the NF-κB 
target genes E-selectin, VCAM-1 and IL-8, as well as an induction of anti-inflammatory 
pathways (Partridge et al., 2007). In addition, these cells showed a dampened response 
to TNFα induced NF-κB activity. Other studies have shown that cultured cells exposed 
to oscillatory flow display an increase in inflammatory signalling correlating to that seen 
at atheroprone regions in vivo (Chappell et al., 1998). 
Recent experiments have gone further into characterising NF-κB expression in 
atheroprone haemodynamic conditions, attempting to identify more specifically which 
aspects of this flow pattern cause an induction of the transcription factor and finding that 
NF-κB expression is very sensitive to flow dynamics and direction. Feaver et al. (2013) 
mapped the compound flow pattern experienced at an atheroprone region of the human 
carotid artery bifurcation into a wave. Calculating the wave equation from this pattern, 
they split it into its constitutive frequencies and introduced these frequencies to an 
atheroprotective waveform, finding that certain frequencies were able to specifically 
induce NF-κB expression. Additionally, Wang et al. (2013a) showed that changing the 
angle at which the direction of flow intersects the direction of EC alignment can cause an 
change in NF-κB expression, with perpendicular flow inducing a maximal response in 
comparison to the minimal response seen with parallel flow. Similar experiments have 
been carried out in vivo, utilising a constrictive cuff placed around the murine carotid 
artery. The geometry of the cuff generates low shear stress upstream, a gradient of 
increasing shear stress within the cuff and low oscillating shear stress downstream 
(Cheng et al., 2005). RelA expression was found to be at its minimum in ECs exposed to 
high shear stress, with greater expression under low shear stress, and further elevation 
with the addition of oscillations (Cuhlmann et al., 2011). 
The PECAM-1-containing mechanosensor complex has been shown be involved in the 
NF-κB response to flow. Tzima et al. (2005) showed that low shear stress in vitro was no 
longer able to activate NF-κB in PECAM-1 deficient cells. PECAM-1 may act by inducing 
MAPK pathway members (Wang and Sheibani, 2006) such as p38 and c-Jun N-terminal 
kinase (JNK). Proteins in the NF-κB activation pathways are upstream activators of the 
MAP kinase pathway; TAK2 and NIK are both MAP3K and as such phosphorylation of 
these can activate the MAPK pathway. The MAPK and NF-κB pathways have been found 
to be closely linked at sites of low shear stress. RelA expression has been found to be 
dependent on JNK activity in murine models (Cuhlmann et al., 2011). Furthermore, 
inhibition of MAPK signalling by MAPK phosphatase-1 (MKP-1) or suppression of 
upstream activators produces anti-inflammatory effects with a correlated decrease in 
VCAM-1 expression (Zakkar et al., 2008, 2009). 
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Given the known risk of hypercholesterolaemia on inducing atherosclerosis (Wilson et 
al., 1998), as well as the effect of ox-LDL on NF-κB activation (Cominacini et al., 2000), 
evidence supporting the accumulation and increased transport of LDL into the 
endothelium at atheroprone regions cannot be ignored as a regulator of atherogenesis. 
Nevertheless, sensing of shear stress patterns by mechanosensors seems to be ultimately 
responsible for the priming of cells to begin atherogenesis by inducing expression of NF-
κB in response to flow conditions independently from concentrations of LDL. High blood 
levels of LDL or other inflammatory signalling molecules may accelerate the process of 
atherogenesis by further stimulating NF-κB. 
1.6 The role of ubiquitin in NF-κB regulation 
Ubiquitination is of utmost importance to the regulation of NF-κB activation by both 
canonical and non-canonical pathways. Ubiquitin is a 76 residue, highly stable, 8.5 kDa 
protein which is well conserved from insects to humans (Vijay-Kumar et al., 1987). Post-
translational addition of ubiquitin to proteins is an important step in the regulation of 
many cellular pathways. Ubiquitin modification tends to occur at lysine residues and can 
take different forms, with the addition of one ubiquitin molecule (monoubiquitination), 
or linear or branched linked chains (polyubiquitination). In NF-κB activation, 
polyubiquitination is key; the function conferred by this modification depends on the 
conformation of the ubiquitin chain. Polyubiquitin chains can be formed between lysines 
or the N terminal methionine (M1) of one molecule and the C terminus of the next 
(Komander and Rape, 2012). There are seven lysines available for polymerisation (Figure 
1.8), and chains utilising each of them have been detected in vivo (Peng et al., 2003). 
Polyubiquitination occurs via a process involving three classes of enzymes, shown in 
(Figure 1.9). Ubiquitin activating (E1) enzymes prime ubiquitin for polymerisation by 
conjugating a ubiquitin molecule onto an active-site cysteine residue via an adenylate 
intermediate in an ATP-dependent reaction (Schulman and Harper, 2009). Ubiquitin-
conjugating (E2) enzymes then transfer the activated ubiquitin molecule onto their own 
active site cysteine residue (Ye and Rape, 2009). A complex between the target molecule, 
an E2 and a ubiquitin ligase (E3) catalyses the final step in addition, whereby the 
ubiquitin is transferred from the E2 to a lysine residue on the target or pre-existing 
ubiquitin, either via transient binding to the E3 or directly from the E2 (Deshaies and 
Joazeiro, 2009). The E3 component of the complex is responsible for the specificity of 
target binding, while the type of lysine linkage is regulated by the E2 (David et al., 2010). 
K48-linked polyubiquitin is perhaps the best studied, it is responsible for inducing 
proteasomal degradation via the 26S proteasome, which specifically recognises 
ubiquitinated proteins and degrades them (Baumeister et al., 1998). K63-linked 
 Figure 8. The structure of ubiquitin. Ubiquitin is a small molecule, adopting a compact 
structure through a single α-helix and β-sheet. It is able to form polymers through binding of its C 
terminal glycine (magenta) to any of the lysines indicated in red or the N terminal methionine. 
Shown in bold are those residues which have been shown to be involved in linkages in vivo. 
Binding to different sites causes a change in how open the polyubiquitin chain is.$
Structure downloaded from PDB, solved by Vijay-Kumar et al. (1987).
Figure 1.8: The structure of ubiquitin. Ubiquitin is a small molecule, adopting a compact
structure through a single α-helix and β-sheet. It is able to form polymers through
binding of its C terminal glycin (magenta) to any of the lysines indicated i red, or the N
term al methionine. Shown in bold are those residues which have been shown to be
involved in linkages in vivo. Binding to different sites causes a change in how open the
polyubiquitin chain is.
Structure downloaded from the Protein Data Bank, solved by Vijay-Kumar et al., 1987.
Figure 9. The mechanism of polyubiquitination. Ubiquitin monomers become activated by E1 
ubiquitin-activating enzymes in an active process requiring ATP. E2 ubiquitin-conjugating 
enzymes then bind the activated ubiquitin via a cysteine residue, and determine the conformation 
of the polyubiquitin chain by its lysine-linkage. E3 ubiquitin-ligase enzymes are responsible for 
targeting the ubiquitination to the correct site; there are many types, which bind to specific sites 
on target molecules as well as to the E2, creating a bridge for the transfer of the ubiquitin to a 
lysine on the target molecule or to lengthen a preexisting chain.
Figure 1.9: Th mechanism of polyub quitination. Ubiquitin monomers become
activated by E1 ubiquitin-activ ting enzymes in an active process re uiring ATP. E2
ubiquitin-conjugating enzymes then bind the activated ubiquitin via a cysteine residue,
and determine the conformation of the polyubiquitin chain by its lysine-linkage. E3
ubiquitin-ligase enzymes are responsible for targeting the ubiquitin to the correct site;
there are many types, which bind to specific s tes on target molecules as well as to the
E2, creating a bridge for the transfer of the ubiquitin to a lysine on the target molecule or
to lengthen a preexisting chain.
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polyubiquitin is involved in non-degradative signalling and is widespread in NF-κB 
activation, as discussed above. Other forms are less well studied, but K11- and M1-linked 
polyubiquitination are reported to be involved in NF-κB signalling too. K11 chains may 
promote IKK activation (Dynek et al., 2010) while overexpression of the linear ubiquitin 
chain assembly complex — responsible for M1-linked chain conjugation — has been 
shown to induce NF-κB (Tokunaga, 2013). 
Constitutive ubiquitination of NF-κB results in pathological dysfunction of NF-κB 
signalling. Negative feedback mechanisms regulated by several deubiquitinating 
enzymes (DUBs) are thus in place to remove polyubiquitin and maintain homeostasis. 
There are five families of DUBs, ubiquitin C-terminal hydrolases (UCHs), ubiquitin-
specific proteases (USPs), Josephins, JAB1/MPN/MOV34 metalloenzymes (JAMMs) 
and ovarian tumour proteases (OTUs), characterised by their functional domains. UCHs, 
USPs, Josephins and OTUs are cysteine proteases, while JAMMs are zinc 
metalloproteases (Komander et al., 2009).  
Three DUBs have been shown to be of particular importance in NF-κB signalling. The 
USP cylindromatosis tumour suppressor (CYLD) is able to interact with NEMO and 
degrade K63 polyubiquitin from TRAF2 and TRAF6, thereby inhibiting IKK activation 
(Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003). CYLD 
deficiency results in the hereditary disease familial cylindromatosis (Biggs et al., 1995), 
involving enhanced NF-κB activation as part of its pathogenesis (Zhang and Stirling, 
2006). The OTU domain-containing DUB A20 is another inhibitor of NF-κB activity, 
which forms a negative feedback mechanism due to its induction by NF-κB itself (Evans 
et al., 2004; Wertz et al., 2004). In humans, single-nucleotide polymorphisms of A20 
have been associated with inflammatory diseases including atherosclerosis in diabetic 
patients (Boonyasrisawat et al., 2007). The catalytically active OTU domain cleaves K63 
polyubiquitin from TRAF6 or RIP1 with cysteine protease activity (Komander and 
Barford, 2008), causing inhibition of IKK activation. Interestingly, A20 also possesses 
E3 ligase activity through seven zinc finger domains, which polyubiquitinate the 
deubiquitinated TRAF6 or RIP1 with K48-linked polyubiquitin, inducing their 
proteasomal degradation and thus further suppressing NF-κB (Wertz et al., 2004). Lastly 
is the OTU domain 7B (OTUD7B) protein, also known as zinc finger A20 domain-
containing protein 1 (ZA20D1) or Cezanne (cellular zinc-finger anti-NF-κB). This DUB 
was identified due to its similarity to A20, and is similarly able to inhibit NF-κB 
activation (Evans et al., 2001) of both the canonical (Enesa et al., 2008a) and non-
canonical (Hu et al., 2013) pathways. 
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1.7 Cezanne may be important in regulating the development of 
atherosclerosis 
Cezanne is an 843 residue protein encoded by the OTUD7B gene found at the 1q21.2 
locus. It possesses cysteine protease DUB activity through a three residue conserved 
active site (Cys209, His373 and Asp206) in its OTU domain, and also contains a C 
terminal zinc finger domain which may be involved in regulating this activity (Evans et 
al., 2003). The active site cysteine is sensitive to oxidisation, and hydrogen peroxide has 
been shown to inhibit Cezanne activity through this mechanism (Enesa et al., 2008b). 
Cezanne can inhibit canonical NF-κB activation in vitro through deubiquitination of 
K63-linked polyubiquitinated RIP1 (Enesa et al., 2008a) and TRAF6 (Luong et al., 2013), 
with ECs treated with siRNA and knockout mice both showing elevated expression of 
target genes such as intracellular adhesion molecule-1 (ICAM-1) and IL-8. Furthermore, 
in mouse embryonic fibroblasts (MEFs) and B cells, Cezanne has been shown to inhibit 
non-canonical NF-κB. Otud7b–/– cells show a decrease in TRAF3 expression when 
stimulated with non-canonical pathway activators alongside an increase in K48 
polyubiquitination, indicating Cezanne is able to stabilise TRAF3 and thus induce NIK 
degradation (Hu et al., 2013). Cezanne has been shown to preferentially hydrolyse 
polyubiquitin in vitro, either as K11 chains (Bremm et al., 2010) or as branched chains 
with K63 or K48 (Evans et al., 2003). There is evidence suggesting that K11 
polyubiquitination of RIP1 is important in regulating NF-κB activation (Dynek et al., 
2010), however whether this occurs in conjunction with K63 polyubiquitin is not known. 
Distinct K11 polyubiquitination of RIP1 could indicate that Cezanne plays a novel but as 
yet uncharacterised role in NF-κB inhibition over and above the previously described 
roles. 
The ability of Cezanne to inhibit both the canonical and non-canonical NF-κB pathways 
is of great interest. Stimulation of the canonical pathway with TNFα has been shown to 
increase p100 expression four-fold, leading to cytoplasmic retention of canonical dimers 
through the inhibitory activity of p100 (Basak et al., 2007). Non-canonical signalling 
through NIK is thus able to also promote activation of these dimers through p100 
degradation (Zarnegar et al., 2008a). Cezanne could be an enzyme involved in control of 
this balance by inhibiting one or both pathways to stop excessive stimulation. Hu et al. 
(2013) demonstrated that Cezanne deficiency in mice resulted in an increase of nuclear 
RelB and p52 in MEFs and B cells upon non-canonical stimulation, however whether or 
not regulation of the non-canonical NF-κB pathway is relevant in atherosclerosis is not 
clear. Interestingly, Cezanne has been shown to negatively regulate NF-κB activation in 
cancer cells, induced by retinoic acid, a known activator of the developmental homeobox 
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genes (Kanki et al., 2013), which may indicate a further role for Cezanne in linking 
developmental and inflammatory pathways. 
Cezanne has also been shown to increase the stability of hypoxia inducible factor 1α and 
2α (HIF-1α, 2α) by separate mechanisms (Bremm et al., 2014; Moniz et al., 2015). It has 
been shown to remove K11-linked polyubiquitin chains from HIF-1α to rescue it from 
degradation, while HIF-2α expression is increased by Cezanne stabilising E2F1, which is 
a transcription factor upstream of HIF-2α. 
Cezanne’s regulation by different flow patterns is key in the understanding of its 
physiological function. Using ECs isolated from atheroprone and atheroprotected 
regions from porcine aortic arches, a microarray identified Cezanne upregulation in the 
atheroprotected area (Passerini et al., 2004). Endothelial Cezanne expression in vitro 
has been found to be induced by TNFα stimulation, exposure to high shear stress relative 
to static cells (Enesa et al., 2008a) and hypoxia (Luong et al., 2013). All of these have 
been found to be differentially regulated between atheroprone and protected sites of the 
vasculature. As such, the mechanism for Cezanne’s regulation by flow is not understood, 
and given the multifunctional role of Cezanne in inhibition of both pathways of NF-κB 
activation it warrants further investigation to determine whether Cezanne is responsible 
for changes in endothelial gene expression observed between regions of low and high 
shear stress. 
1.8 Summary 
Atherosclerosis is a chronic disease of the vasculature whereby fatty plaques occlude 
arterial blood flow and in severe cases leads to myocardial infarction or stroke, which can 
be fatal. The development of atherosclerosis is a complex series of events which occur 
over many years, involving monocyte infiltration into the arterial wall and uptake of 
circulating lipids. Localisation of lesion development is regulated by blood flow; the 
frictional force (shear stress) at bends and branches within the vasculature is locally 
decreased and exhibits oscillations. Endothelial cells which line the lumen can sense 
these differences in shear stress and display a large shift in gene expression, from a 
quiescent phenotype to an activated one, displaying enhanced apoptosis, proliferation 
and inflammation.  
A central regulator of these changes is the transcription factor NF-κB, a dimeric family 
split into two pathways – canonical and non-canonical – that can induce gene expression 
of many molecules which promote lesion development. Canonical NF-κB expression and 
activity in ECs is dynamically regulated by shear stress, elevated by low shear stress both 
in vitro and in vivo and thus contributes in transducing shear stress into biochemical 
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signals which promote atherosclerosis. Low shear stress has also been observed to 
increase non-canonical NF-κB expression in a microarray study, but has not been 
investigated further. Its activity in ECs and potential role in atherosclerosis is unknown. 
The deubiquitinase Cezanne is a negative regulator of both canonical and non-canonical 
NF-κB through removal of ubiquitin chains from upstream signalling pathways. Cezanne 
expression has also been found to be regulated by factors altered between atheroprone 
and protected areas, including shear stress, inflammatory cytokine stimulation and 
hypoxia, however its regulation by physiological flow conditions has not been studied. 
Given its ability to inhibit both pathways of NF-κB as well as promote hypoxic signalling, 
understanding how the expression and function of Cezanne is controlled in the context 
of atherosclerosis may help understand how these pathways are regulated, and 
potentially aid in controlling them to limit lesion development. 
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1.9 Hypotheses 
1. Cezanne expression is differentially regulated in ECs in areas prone to or protected 
from atherosclerosis, due to differences in shear stress in combination with 
inflammatory signalling or hypoxia. 
2. Cezanne functions to inhibit NF-κB and promote hypoxic signalling, and thus protect 
arteries from the development of atherosclerosis. 
3. The non-canonical NF-κB pathway is regulated by shear stress, and functions to 
control EC proliferation. 
1.10 Aims of this study 
The preceding hypotheses will be tested as follows: 
1. Utilising in vivo and in vitro models of shear stress to investigate Cezanne expression 
under different shear patterns, combined with the addition of inflammatory 
cytokines or culture under hypoxic conditions. 
2a. Employing siRNA to deplete cells of Cezanne expression in conjunction with the 
application of shear stress in vitro and investigating the effect on canonical NF-κB, 
non-canonical NF-κB and HIF stability. 
2b. Investigating the development of atherosclerosis in a novel Otud7b–/–Ldlr–/– mouse 
model. 
3a. Utilising in vivo and in vitro models of shear stress to investigate flow effects on non-
canonical NF-κB expression and activity. 
3b. Using siRNA to deplete cells of non-canonical NF-κB subunits and test the effect on 
proliferation and inflammation. 
3c. Testing proliferation in the aortic arches of Nfkb2–/– mice.  
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2. Materials and Methods 
2.1 Isolation of human umbilical vein endothelial cells (HUVECs) 
Human umbilical cords were obtained anonymously from the Royal Hallamshire 
Hospital with ethical approval (Sheffield REC 10/H1308/25). At the time of birth, 
umbilical cords were placed into pots containing collection media (Eagle’s minimum 
essential medium (EMEM; Life Technologies) with 1% 100X penicillin/streptomycin 
(Life Technologies), 1% 250 µg/ml amphotericin B (Fisher Scientific), 2% 1 M HEPES 
(Lonza) and 0.9 mg/ml sodium bicarbonate (Sigma). Cords were stored at 4 °C until 
further use. 
A 75 cm2 growth area flask (T75; Corning) was prepared for each cord by incubating for 
30 minutes at 37 °C with 5 ml of 1% (w/v) gelatin from bovine skin (Sigma) in phosphate 
buffered saline (PBS; Oxoid) coating the growth surface. Each cord was cleaned and the 
vein cannulated with a 14G cannula and flushed with 20 ml of incomplete M199 medium 
(Appendix 7.1). The free end was then clamped and the vein inflated with sterile filtered 
1 mg/ml collagenase A from Clostridium histolyticum (Sigma) in incomplete M199. The 
cord was incubated with the collagenase for 20 minutes before flushing into a 50 ml tube 
with a further 20 ml of incomplete M199. The resulting cell suspension was centrifuged 
for 5 minutes at 1200 rpm, the supernatant discarded and the cell pellet resuspended in 
complete M199 (Appendix 7.2), then transferred to gelatin-coated T75 flasks and 
incubated at 37 °C with 5% CO2. After 24 hours, the media was refreshed. 
2.2 Passaging HUVECs 
Confluency was assessed regularly and cells passaged upon reaching confluence. The 
growth media was aspirated and replaced with 5 ml sterile PBS; gentle rocking washed 
the cells before the PBS was discarded. Another wash was carried out and then 1 ml of 
0.25% trypsin-EDTA (Life Technologies) added to the cells, ensuring full coverage. The 
HUVECs were incubated with the trypsin for 2-5 minutes, until cells were visibly 
dislodged. The trypsin was neutralised by the addition of complete M199. The resulting 
cell suspension was centrifuged at 1200 rpm for 5 minutes in a bench top centrifuge, the 
supernatant discarded and the cell pellet resuspended in fresh media and split into 3 new 
gelatin-coated T75 flasks. 
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2.3 Gene knockdown using Lipofectamine RNAiMAX 
HUVECs were seeded onto gelatinised six well plates the day before transfection, at a 
density of 2 × 105 cells per well in 2 ml complete M199. A 1.25 µl volume of each 20 µM 
stock of siRNA to be used (Appendix 7.3) was diluted to a final volume of 150 µl in Opti-
MEM® I Reduced Serum Media (Life Technologies). In separate tubes, 7.5 µl 
Lipofectamine® RNAiMAX was diluted to a final volume of 150 µl in Opti-MEM®. After 
gentle mixing, the siRNA dilutions were combined with the Lipofectamine® dilutions, 
mixed and incubated for 20 minutes at room temperature to allow complex formation. 
Pre-warmed antibiotic-free complete M199 was added to the tubes to a final volume of 
1000 µl and this media used to replace that of the plated HUVECs, resulting in a final 
siRNA concentration of 25 nM. The cells were incubated with this mixture for 5 hours 
before being washed and replaced with 3 ml complete M199. 
2.4 Gene knockdown using the Neon™ electroporation system 
Flasks of confluent HUVECs were washed twice with PBS, then incubated with 1 ml 
trypsin at 37 °C for 2-5 minutes to dislodge the cells. Trypsin activity was then neutralised 
with 4 ml per flask of complete M199 lacking antibiotics and amphotericin B, with 
aggravation to resuspend the cells. The cell suspension was centrifuged at 1200 rpm for 
5 minutes before removing the supernatant and washing twice with Ca2+/Mg2+ free PBS 
(Life Technologies). Depending on the number of cells being transfected, two different 
protocols were followed. 
2.4.1 Small transfection (10 µl) 
For one to five wells per condition, 2.5 × 106 cells were resuspended in 66 µl of 
resuspension buffer (R buffer, Life Technologies). This suspension was then divided into 
0.6 ml tubes along with a 50 µM siRNA solution to a total volume of 12 µl and siRNA 
concentration of 5-10 µM. The Neon™ pipette with 10 µl tip was used to take up the 
suspension and the pipette and tip placed into the electroporation apparatus (Neon™ 
Transfection System model MPK5000; Life Technologies) so the tip containing the cells 
was dipped into a tube containing 3 ml E buffer. Electroporation was carried out using a 
single pulse for 30 ms at a voltage of 1350 V. The pipette was then removed and cells 
dispensed directly into 2 ml of pre-warmed M199 without antibiotics or amphotericin B 
in a gelatinised six-well plate (Greiner bio-one). This process was repeated for each well, 
the plate gently rocked to disperse the cells and the plate left in the incubator for at least 
four hours to allow the cells to adhere. The media was then removed and replaced with 
3 ml complete media and the cells used for further experiments. 
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2.4.2 Large transfection (100 µl) 
For six wells per transfection, 2.5 × 106 cells were resuspended in a total of 120 µl of R 
buffer containing 50 µM siRNA solution at a concentration of 3-6 µM. A 100 µl tip was 
fitted to the Neon™ pipette and the suspension taken up. Electroporation was carried 
out using a single pulse for 40 ms at 1200 V. The pipette was removed and the cells 
dispensed into 9 ml pre-warmed M199 without antibiotics or amphotericin B. This was 
thoroughly mixed and then 1.5 ml added to each well of a gelatinised six-well plate 
containing 0.5 ml of the same media. The cells were left to adhere in the incubator for at 
least four hours before the media being replaced with 3 ml complete media and the cells 
used for further experiments. 
2.5 Culturing HUVECs under shear stress 
Flasks of confluent HUVECs at passage 3 were washed twice with PBS, then incubated 
with 1 ml trypsin for 2-5 minutes. The trypsin was neutralised with 4 ml complete M199 
with aggravation to resuspend cells. The suspension was centrifuged at 1200 rpm for 5 
minutes and the cell pellets resuspended in fresh media. A haemocytometer was used to 
count cells. 
2.5.1 Using the orbital shaker apparatus 
Six-well cell culture plates were coated with 1 ml 1% (w/v) gelatin in PBS for 30 minutes 
at 37 °C, then were seeded with 2-5 × 105 cells per well in 2 ml of complete M199 and 
placed in the incubator for at least 4 hours until the cells had adhered. The media was 
changed and 3 ml fresh media added. The plates were placed onto an orbital shaker 
(model PSU-10i; Grant-Bio) set at 210 rpm in a 37 °C incubator with 5% CO2. CFD models 
have previously calculated that the centre and periphery of each well experience different 
time-averaged wall shear stress magnitudes, with the centre experiencing complex 
multidirectional flow with a shear stress of 5 dyn/cm2, and the periphery a pulsatile 
unidirectional flow with shear stress of 13 dyn/cm2 (Warboys et al., 2014). 
2.5.2 Using the ibidi parallel plate flow apparatus 
Each µ-Slide I0.4 Luer (ibidi) was coated with 150 µl 1% gelatin for 30 minutes. After this, 
2.5 × 105 cells in 150 µl of complete M199 were carefully seeded onto the slide, adding 
the suspension to the inlet and removing gelatin from the outlet to pull the cells into the 
chamber by capillary action. The cells were allowed to adhere for one hour then the slides 
washed twice with fresh media. Media reservoirs were sterilised by spraying with 70% 
ethanol (Sigma) and left to fully air dry in a laminar flow cabinet. The reservoirs were 
then inserted into a fluidic unit (v1.1; ibidi) and connected to 15 cm tubing (ibidi) before 
being loaded with 13.6 ml complete M199 media, ensuring there were no air bubbles. 
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Filters were placed on top of the media reservoirs and connected to the air tubing. Using 
a clamp to prevent leakage, the central connector on the tubing was removed and the free 
ends connected to each end of the slide. The clamp was then removed and the tubing 
connected to the appropriate channels on the fluidic unit. Lastly, the fluidic unit was 
placed into an incubator at 37 °C with 5% CO2 and the air tubing and data cables 
connected to the main pump (ibiPump 2; ibidi). The air inlet was placed into the 
incubator and attached to a flask containing silica beads in order to remove moisture 
before entering the pump. On the software the shear stress values were selected, using 
one of two different profiles. The unidirectional high shear stress profile was the same 
for the master and all slaves, increasing from 4 dyn/cm2 to 13 dyn/cm2 over ten minutes. 
The low shear stress profile was 4 dyn/cm2 unidirectional for the master unit and 4 
dyn/cm2 oscillating every 0.5 seconds for the slaves. 
2.6 Exposing HUVECs to shear stress and hypoxia. 
HUVECs were exposed to hypoxia using the GenBOX apparatus (bioMérieux). This 
utilises an oxygen scavenging pouch to alter the atmospheric composition of a sealed 
container. HUVECs were seeded onto six-well plates and exposed to shear stress with the 
orbital shaker system as normal for 48 hours. Then, plates were placed into the GenBOX 
and secured in place with tape. The provided indicator was placed into the container to 
ensure the appropriate environment was created. The GenBOX was then placed onto the 
orbital shaker for 24 hours. Samples were collected from these cells as quickly as possible 
to minimise time spent in a normoxic environment. 
2.7 RNA isolation from HUVECs 
At least three wells (orbital shaker) or a single slide (ibidi) were required for sufficient 
RNA for further analysis.  
2.7.1 Sample collection from the orbital shaker 
Plates were removed from the orbital shaker after 72 hours and placed directly onto ice. 
Media was removed by aspiration and the cells washed twice with 0.5 ml cold PBS. A 
further 0.5 ml cold PBS was added to each well and cells from the periphery scraped with 
the plunger from a 1 ml syringe. The cell suspension was recovered and pooled from 
replicate wells. Each well was washed a further two times with cold PBS and the scraping 
process repeated for the centre of the well. Cell suspensions were centrifuged in a 
refrigerated centrifuge at 12000 rpm for 1 minute. The supernatants were removed and 
cell pellets resuspended in 350 µl lysis buffer (RLT buffer; Qiagen) containing 1% (v/v) 
β-mercaptoethanol (Sigma). 
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2.7.2 Sample collection from ibidi slides 
Slides were removed from the flow apparatus and placed directly onto ice. Media was 
removed from one inlet, then cold PBS was passed through twice and the chamber left as 
dry as possible. 150 µl RLT buffer was then added to the slide and left for 20 minutes on 
ice, rocking periodically, before removing to a fresh tube. 
2.7.3 QIAGEN RNEasy spin column 
Each sample was passed through a 21G needle (BD Bioscience) five times to homogenise 
the lysate before being diluted in an equal volume of 70% ethanol and mixed well. This 
was added to an RNEasy spin column (QIAGEN), the lid closed gently and centrifuged 
for 15 s at 10000g in a microcentrifuge. The flow-through was discarded and 350 µl 
Buffer RW1 (QIAGEN) added to the spin column which was then centrifuged for 15 s at 
10000g and the flow-through discarded. 10 µl DNase I stock solution (QIAGEN) was 
added to 70 µl Buffer RDD (QIAGEN) for each sample and this added directly to the 
membrane of each spin column and incubated at room temperature for 15 minutes. Next, 
350 µl RW1 was added to the column and centrifuged for 15 s at 10000g and the flow-
through discarded. 500 µl Buffer RPE (QIAGEN) was added to each column and 
centrifuged for 15 s at 10000g, then the flow-through discarded, a further 500 µl Buffer 
RPE added to the column and centrifuged for another 2 min at 10000g. The spin column 
was removed from the collection tube and placed into a fresh tube and centrifuged at full 
speed for a further minute to dry the membrane. Lastly, the column was placed into a 
final 1.5 ml collection tube, 30 µl RNase free water (QIAGEN) was added directly to the 
membrane and centrifuged for 1 min at 10000g to elute the RNA. 
2.7.4 Measuring RNA concentration and complementary DNA (cDNA) 
synthesis 
RNA concentrations were measured using a Nanodrop 1000 spectrophotometer. Blank 
measurements were obtained using a water sample, then absorbances measured for each 
sample. Quality control was carried out by ensuring each sample had a 260/230 and 
260/280 ratio between 1.9 and 2.1. Reverse transcription was carried out using 200 ng 
RNA. The total reaction consisted of 76% sample (diluted to a total mass of 200 ng with 
RNase free water), 20% 5X iScript Supermix (BioRad) and 4% iScript reverse 
transcriptase (BioRad). Samples were placed into a thermal cycler which heated the 
samples to 25 °C for 5 minutes, 42 °C for 30 minutes then 85 °C for 5 minutes. The cDNA 
was then placed on ice and diluted to 0.4 ng/µl with RNase free water. 
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2.8 Quantitative real-time PCR 
For each gene to be analysed, a master mix was first created, combining SYBR Green 
Supermix (BioRad) with 0.5 µM forward primer and 0.5 µM reverse primer (Appendix 
7.4), loading each reaction in triplicate. A 384-well plate was loaded first with the master 
mix, then with 1.76 ng cDNA per reaction to a total reaction volume of 10 µl. A plastic 
seal was placed on top of the plate, and the plate centrifuged at 1000 rpm for 1 minute to 
ensure the liquid was collected at the bottom of each well. The plate was then loaded into 
a BioRad CFX384 qPCR machine and the thermal profile set to 95 °C for 30 s to start, 
then 40 cycles of 95 °C for 5 s, 60 °C for 30 s, taking a fluorescence reading after each 
cycle. Finally, a melt curve was generated by raising the temperature from 60 to 95 °C in 
0.5 °C increments, taking a reading at each stage. Data was exported as CT values and 
analysed using the 2-ΔΔCT method, normalising to the housekeeping gene HPRT. 
2.9 Western blotting 
2.9.1 Cell lysis 
For cells grown on six-well plates, two static wells or six orbited wells were used to obtain 
enough material for further analysis. Plates were removed from the incubator and placed 
immediately onto ice. Each well was washed twice with cold PBS then cells from the 
periphery and centre were scraped separately into 500 µl cold PBS, with two PBS washes 
between each isolation. The resulting cell suspensions were then centrifuged at 10000 
rpm for 5 minutes at 4 °C in order to pellet the cells. To lyse the cells, 50 µl of RIPA buffer 
(Sigma) containing 1% 100× Halt™ protease inhibitor cocktail (Thermo Scientific) and 
1% 100× phosphatase inhibitor cocktail (Cell Signaling) was used to resuspend the pellet 
and incubated on ice for 20 minutes with periodic vortexing. 
For cells grown using the ibidi® system, slides were removed from the incubator and 
placed immediately onto ice. Media was removed from the chamber using an aspirator, 
and each slide washed twice with cold PBS, ensuring complete removal of the PBS once 
completed. Next, 150 µl of RIPA buffer containing protease and phosphatase inhibitors 
was added directly to the chamber and the slides incubated on ice for 20 minutes with 
rocking. After lysis was complete, the samples were centrifuged at 12000 rpm for 15 
minutes at 4 °C and the supernatants transferred to fresh tubes for further use. 
2.9.2 Protein quantification and normalisation 
Before loading onto a Western blot, the protein content of each sample was quantified 
and normalised to ensure equal loading. A bicinchoninic acid (BCA) assay kit (Thermo 
Scientific) was used for this according to the manufacturer’s instructions. Albumin 
standards were made by diluting the stock (2000 µg/ml) in RIPA buffer containing 
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protease and phosphatase inhibitors. In a 96 well plate, 10 µl of each standard and 2 µl 
of each sample to be tested were loaded in triplicate and 200 µl working solution ( 50:1 
ratio of Reagent A to Reagent B) was added to the wells. The plate was incubated at 37 
°C for 30 minutes to allow the reaction to progress. The plates were then taken out of the 
incubator and incubated at room temperature for 5 minutes before the absorbance at 562 
nm was measured for each well. Concentrations of each sample were calculated using the 
standard curve, and normalisation of the samples achieved by diluting to the 
concentration of the least concentrated sample. 
Each sample was prepared for loading by adding dithiothreitol (DTT; Sigma) to a 
concentration of 92 mM and 25% 4× Loading Dye (Life Technologies). The tubes were 
vortexed briefly to mix and incubated at 100 °C for 10 minutes followed by 5 minutes on 
ice. 
2.9.3 SDS-PAGE and transfer to PVDF 
Samples were loaded into pre-cast 3-8% or 4-12% Bis-Tris gradient gels (Novex®, Life 
Technologies) depending on the molecular weight of the protein of interest, along with a 
protein ladder to identify band sizes (Spectra™ Multicolor Broad Range Protein Ladder; 
Thermo Scientific). Electrophoresis was carried out according to the manufacturer’s 
instruction; gel tanks (XCell SureLock™; Thermo Scientific) were filled with 1X MES-
SDS running buffer (Life Technologies) and run at 200 V for 35 minutes to allow the 
samples to migrate through the gel. Next, the samples were transferred to polyvinylidene 
fluoride (PVDF) membrane (Immobilon-P, Millipore). Gels were removed from the 
apparatus and assembled into a transfer stack pre-soaked in 1X transfer buffer (Life 
Technologies) containing 10% (v/v) methanol (VWR chemicals) and 0.1% NuPAGE® 
Antioxidant (Life Technologies), this stack was loaded into the transfer apparatus and 
run at 35 V for 65 minutes. After completion of the transfer, the PVDF membrane 
containing the separated proteins was removed and used for further immunoblotting. 
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2.9.4 Immunoblotting 
Membranes were blocked in 5% skimmed milk powder (Premier Foods Group) in Tris 
buffered saline (TBS) containing 0.1% (v/v) Tween-20 (Sigma) (TBST) for 1 hour, then 
incubated with the appropriate primary antibody (Appendix 7.5) in a 100 ml tube with 
rotation overnight at 4 °C. For initial experiments, full membranes were used for each 
antibody. For repeat experiments, when detecting multiple targets from the same 
membrane, the membrane was carefully cut using the protein ladder as a marker before 
incubation with antibody. 
Following primary antibody incubation, the membranes were washed 3 times for 5 
minutes each in TBST at room temperature then incubated with the appropriate 
secondary antibody for 1 hour at room temperature with rotation. Membranes were 
washed again as previously then placed protein side up onto a sheet of cling film and 
incubated with 1.5 ml enhanced chemiluminescent solution (ECL Select™ Western 
blotting detection reagent; GE Healthcare) for 5 minutes. 
Images were collected using a LI-COR C-DiGit® Blot Scanner (Model 3600; LI-COR) on 
the high sensitivity setting and quantification analysis carried out using the tools 
provided in the Image Studio Digits software (LI-COR). 
2.10 Immunofluorescence staining of HUVECs 
The day before beginning the protocol, 34 mm2 round cover clips were cleaned with 70% 
ethanol, left to dry in a laminar flow cabinet then autoclaved to ensure sterility. Three 
drops of di-N-butylphthalate polystyrene xylene (DPX; VWR) were added to each well of 
a six-well plate and a cover slip placed into the well using forceps. The lid was placed 
onto the plate and the DPX left to dry overnight. The following day, HUVECs were seeded 
into the six-well plates according to the particular protocol for the experiment to be 
carried out. 
Following the experiment, plates were placed directly onto ice. The media was removed 
from each well and the cells washed three times with ice-cold PBS. The cells were then 
fixed with 4% formaldehyde at room temperature without rocking for 12 minutes, then 
washed a further three times with 1 ml ice-cold PBS. Cells were then permeabilised with 
700 µl 0.1% Triton-X100 (Sigma) in PBS at room temperature for 15 minutes with 
rocking, then blocked with 500 µl 20% goat serum (Sigma) in PBS for one hour at room 
temperature. The primary antibodies to be used for staining were diluted to the 
appropriate concentration (Appendix 7.5) in 5% goat serum in PBS and a 120 µl drop 
placed onto a sheet of parafilm (Bemis) in a humid staining tray. Using curved forceps, 
the cover slips were then gently lifted from the wells and placed face-down onto the 
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droplet of antibody solution. The lid was then placed on the staining tray and it was 
incubated overnight at 4 °C. 
Following incubation with the primary antibody, cover slips were placed face-up into a 
fresh six-well plate and washed three times with 1 ml PBS. Secondary antibody was then 
diluted in 5% goat serum in PBS and a 120 µl drop placed onto a new sheet of parafilm. 
Coverslips were placed face-down onto the secondary antibody and incubated for 1 hour 
at room temperature protected from light, then washed as before. Cover slips were kept 
in the wells for the next step; 2 µg/ml 4,6-Diamidino-2-phenylindole (DAPI) (Life 
Technologies) in PBS was added to each well and rocked for 15 minutes at room 
temperature protected from light. Cover slips were washed a final time then removed 
from the wells and placed face-down onto a drop of ProLong® Gold mounting medium 
(Life Technologies) on a glass slide. Nail varnish (Clinique) was placed around the edge 
of the cover slip and allowed to dry protected from light before imaging. 
2.11 Isolation of RNA from the porcine aortic arch. 
Porcine hearts and attached major vessels were obtained from a local abattoir (N Bramall 
& Sons) shortly following the death of the animal. Tissue was placed immediately into 
cold transport medium consisting of Dulbecco’s modified Eagle’s medium (DMEM; Life 
Technologies) containing 1% penicillin/streptomycin, 1% amphotericin B and 100 µg/ml 
gentamycin (Sigma) and brought to the laboratory. The aortic arches were dissected and 
cleaned, ensuring they were kept cold throughout. Then using a scalpel, 1 cm2 sections 
were cut from regions of the inner and outer curvatures corresponding to low and high 
shear stress respectively, as calculated by computational fluid dynamics (Serbanovic-
Canic et al., 2016). These sections were then incubated endothelial side down on a 1 ml 
drop of M199 containing 1 mg/ml collagenase for 15 minutes, then the solution was 
collected to a 1.5 ml tube, and the edge of a clean scalpel used to gently scrape remaining 
ECs into the corresponding solution. Cell suspensions were centrifuged for 6 minutes at 
1000 rpm and supernatants carefully removed using a pipette. RNA was then isolated 
from each sample as described in Section 2.7.3. 
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2.12 Genotyping from mouse ear-clips 
Ear-clips were lysed in ear-clip lysis buffer (Appendix 7.6) containing 3% Proteinase K 
(Thermo Scientific). To each sample, 150 µl of this solution was added and incubated at 
55 °C overnight. Following a brief vortex to disrupt the tissue, the clips were heated to 
100 °C for 12 minutes before being placed on ice and diluted with 600 µl nuclease-free 
H2O. A genotyping PCR was then carried out, with reaction volumes outlined in 
Appendix 7.7. The samples were placed in a thermal cycler and run on a thermal profile 
consisting of melting at 95 °C for 30 s, followed by an annealing stage for 30 s at 63 °C 
(Cezanne wild-type reaction), 65 °C (Ldlr reaction) or 67 °C (Cezanne gene-trap 
reaction), then an extension stage at 72 °C for 45 s; this cycled 40 times. Following the 
PCR, 6× DNA loading dye (Thermo Scientific) was added to each sample (diluting by 
1:6). A DNA ladder mixture was made by combining 8.33% 100 bp ladder (New England 
Biolabs) with 16.67% 6× DNA loading dye in water. A 1.5% agarose gel was cast by 
dissolving agarose (Bioline) in Tris-acetate EDTA (TAE) buffer (diluted from 50× stock, 
Geneflow) by heating in a microwave until completely dissolved. After allowing to cool 
slightly, 0.05% ethidium bromide (Sigma) was added and mixed well. The agarose 
solution was poured into a gel tray with the ends covered with tape and a comb inserted 
and left to set for approximately 30 min. The gel was then placed into an electrophoresis 
tank and covered with TAE buffer; the ladder and DNA samples were loaded onto the gel 
then the apparatus connected to a power supply. Electrophoresis was carried out at 100 
V for 25 min, then the gel removed and placed in a transilluminator attached to a PC 
running GeneSnap software (SynGene). Images were acquired and printed then 
genotypes evaluated. 
2.13 Mouse strains and breeding strategy 
2.13.1 Otud7b–/– 
Mice were obtained from the Toronto Centre for Phenogenomics (Toronto, Canada) 
heterozygous for an allele of Cezanne containing an insertion of a NorCOMM (North 
American Conditional Mouse Mutagenesis) cassette (Figure 2.1), Otud7btm1(NCOM)Cmhd on 
a C57BL/6N background. This causes a deletion of 5397 bp, removing exons 4-7. For 
brevity, this allele will be referred to as a knockout allele. Otud7b+/+ and Otud7b–/– mice 
were generated as littermates by breeding the heterozygotes. Figure 2.1b and c show the 
genotyping results from the progeny of a heterozygous cross. 
 	
Figure 2.1: Genotyping mice for Otud7b and Ldlr alleles. (a) A schematic showing the
structure of the wild-type and gene trapped knockout Cezanne alleles. A LacZ cassette
inserted in place of exons 4-7 disrupts expression of functional protein. Green arrows
indicate the approximate position of primers used in the genotyping reactions. (b) The
offspring of a cross between Otud7b heterozygotes were genotyped. Genomic DNA was
isolated from ear clip tissue and amplified by PCR in two reactions using primers specific
to the wild-type and gene-trap alleles respectively. Reaction products were run on an
agarose gel with ethidium bromide and bands imaged using a UV transilluminator.
Genotypes are noted in a table. (c) Cezanne knockouts were bred with Ldlr knockouts.
Wild-type and knockout alleles of each gene were assessed using PCR and subsequent
electrophoresis. Results are summarised in the table
1 2 3 8 9 10 11 12 13
LacZ Neo pA
LacZ Neo pA
1 2 3 4 5 6 7 8 9 10 11 12 13
ATG
ATG
a
b
Wild-type Otud7b
Gene trap Otud7b
c
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2.13.2 Ldlr–/– 
Homozygous Ldlrtm1her mice were obtained from the Jackson Laboratory and bred on 
site, maintained as a homozygous colony. The Ldlrtm1her allele contains a neomycin 
resistance cassette insert into exon 4 of the Ldlr gene, resulting in a truncation within 
the ligand binding domain, and loss of the membrane spanning region (Ishibashi et al., 
1993). 
2.13.3 Otud7b–/–Ldlr–/– 
Otud7b–/– mice were bred with Ldlr–/– mice to obtain Otud7b+/–Ldlr+/– animals. These 
were intercrossed, and Otud7b+/–Ldlr–/– progeny selected for further breeding to fix the 
Ldlr alleles. A further round of intercrossing generated Otud7b–/–Ldlr–/– animals, which 
were incrossed to generate experimental animals. 
2.13.4 Nfkb2–/– 
Nfkb2–/– mice were obtained from the laboratory of Prof Mark Pritchard and Dr Carrie 
Duckworth (University of Liverpool), in collaboration with Dr Jorge Camaaño 
(University of Birmingham). The mutant allele contains a phosphoglycerin kinase 
neomycin cassette inserted into exon 4, resulting in a loss of protein expression 
(Caamaño et al., 1998). All animals were housed at the University of Liverpool and tissue 
taken offsite. 
2.14 Intraperitoneal injection of bacterial lipopolysaccharide 
Lipopolysaccharides (LPS) from Escherichia coli 0111:B4 (LPS; Sigma) were dissolved in 
sterile PBS to a concentration of 1 mg/ml. Mice were weighed and injected 
intraperitoneally with a volume of LPS to deliver 4 mg/kg. The animals were continually 
monitored and sacrificed after 6 hours.  
2.15 Administration of a high-fat Western diet 
Animals were fed Western RD diet (Special Diets Services), the composition of which is 
described in Appendix 7.8. Multiple mice were housed in each cage and normal chow 
replaced with the Western diet at 5 g per mouse per day. Mice were monitored daily 
throughout feeding. 
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2.16 Isolation and en face staining of the murine aorta 
Each mouse was sacrificed by intraperitoneal injection of 100 µl pentobarbitone to 
induce anaesthetic overdose; once the pedal reflex was lost, blood was taken by cardiac 
puncture. The ribcage was then opened and the vasculature cleaned by clipping the right 
atrium and perfusion of 10 ml PBS through the left ventricle. Following this, 10 ml of 4% 
formaldehyde was perfused to fix the endothelial cells in situ. The ribcage was then 
removed and placed in 2% formaldehyde for one hour before being placed in PBS and 
stored at 4 °C. The aorta was dissected from the ribcage using fine forceps and a 
dissection microscope and cleaned thoroughly. Each aorta was cut into three sections; 
the aortic arch, and two pieces of the descending aorta, which were cut additionally 
lengthways to open the endothelial surface (Figure 2.2). Aortic sections were placed in 
individual wells of a 96-well plate, then blocked and permeabilised in 100 µl of 20% goat 
serum in 0.5% Triton-X100 PBS at 4 °C overnight. Antibody against the endothelial 
marker PECAM-1, conjugated to Alexa Fluor® 488 (BioLegend) was then diluted in 5% 
bovine serum albumin (BSA; Sigma) in PBS and the sections incubated in 100 µl for 5 
days. Following this, the sections were washed by flushing several times with PBS before 
being incubated at 4 °C overnight with primary antibodies to the gene of interest 
(Appendix 7.5), diluted to 5 µg/ml in 100 µl of 5% BSA in PBS. The sections were washed 
with PBS again and incubated at room temperature for 5 hours with 100 µl secondary 
antibody diluted in 5% BSA in PBS. Next, the sections were washed again before being 
incubated with the nuclear stain TO-PRO-3 (Life Technologies) diluted 1/300 in PBS. 
Finally, the sections were mounted endothelial side down on coverslips in a droplet of 
ProLong® Gold, a slide was placed on top of this and the slides placed under weights 
overnight to flatten the sections. Nail varnish was applied to the edge of the coverslip to 
prevent the slides drying out. 
  
Figure 2.2: Sectioning of the murine aorta. Aortae were perfusion fixed with
formaldehyde and dissected before being cut into sections for further immunostaining.
The descending aorta was cut into two sections which were both used. The aortic arch
was cut following the brachiocephalic artery allowing a single flattened section with both
disturbed and undisturbed flow, shown by pink and yellow shading respectively.
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2.17 Oil Red O staining of the murine aorta. 
To make the Oil Red O staining solution, 1% H2O was added to 99% isopropanol (VWR 
Chemicals), the Oil Red O powder (Sigma) added to the solution until saturation. The 
slurry was then filtered using Whatman filter paper to remove undissolved Oil Red O. 
On the day of staining, this solution was diluted to 60% in H2O. 
Aortas were perfusion fixed, removed from the animals and cleaned as in Section 2.16, 
then opened longitudinally. Each aorta was rinsed in H2O followed by 60% isopropanol 
for 2 minutes each, then immersed in Oil Red O solution for 15 minutes. Following 
staining, aortas were washed in 60% isopropanol, then H2O for a further 2 minutes each. 
To image the stained tissue, molten wax was poured into a petri dish and allowed to 
partially solidify. While the wax was still warm, the aortas were pinned flat using insect 
pins (Fine Science Tools) and immersed in PBS. Aortas were imaged using a dissection 
microscope, including an image of a ruler for software calibration. Analysis was carried 
out using ImageJ; total aortic area and lesion area were outlined and the area calculated 
using the software. 
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3. Regulation of Cezanne expression by shear stress 
3.1 Introduction 
The development of atherosclerotic lesions within the vasculature is not uniform; ECs at 
sites of predilection such as at bends and branch points are activated, leading to 
enhanced inflammation, proliferation and apoptosis. Haemodynamic conditions at these 
sites lead to an alteration in the cellular environment. Notably, the low oscillating shear 
stress exerted on the vessel wall at these regions promotes an induction of NF-κB (Hajra 
et al., 2000) via a JNK-ATF2 (activating transcription factor 2) pathway (Cuhlmann et 
al., 2011). Furthermore, local oxygen tension is reduced at these sites (Santilli et al., 
1995), suggesting that cells here may possess differences in oxygen mediated pathways 
such as hypoxia or ROS signalling. 
The deubiquitinase Cezanne has been linked to the regulation of several pathways 
involved in the pathogenicity of atherosclerosis, but it is unknown whether Cezanne is 
differentially expressed in ECs exposed to physiological levels of shear stress found at 
atheroprotected and atheroprone sites in vivo. Previous research has revealed that the 
application of unidirectional shear stress to HUVECs was able to cause induction of 
Cezanne mRNA expression, as was stimulation of several NF-κB inducing ligands, 
including TNFα (Enesa et al., 2008a), CD40L and LT-β (Hu et al., 2013). Exposure to 
hypoxia has also been found to significantly induce Cezanne expression in human ECs 
from a variety of vascular beds. Moreover, surgically induced kidney ischaemia followed 
by reperfusion was sufficient to induce Cezanne expression in whole kidney samples 
from both rats and mice (Luong et al., 2013). 
Of particular note, a microarray study identified an enrichment in Cezanne expression at 
an atheroprotected site, although expression of Cezanne at the protein level was not 
studied (Passerini et al., 2004). It is important to discover whether cells at these regions 
possess an elevated level of Cezanne expression and the mechanisms governing its 
activation, as Cezanne has been implicated in regulating NF-κB and hypoxic signalling 
and thus may be responsible for focal atherosclerosis.  
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3.2 Hypothesis and aims 
Hypothesis: Cezanne expression is differentially regulated at sites of predisposition to 
atherosclerosis in ECs, due to either differences in shear stress, inflammatory signalling 
or hypoxia. 
Aim 1: Characterise Cezanne expression at sites prone to and protected from 
atherosclerosis in vivo. 
Aim 2: Characterise Cezanne expression in ECs exposed to different shear stress 
patterns. 
Aim 3: Characterise Cezanne expression upon stimulation with NF-κB-activing 
molecules in ECs exposed to different shear stress patterns. 
Aim 4: Characterise Cezanne expression in ECs exposed to hypoxia in addition to 
different shear stress patterns.  
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3.3 Cezanne expression was elevated at regions predisposed to 
atherosclerosis. 
The localisation of atherosclerotic lesions within the murine vasculature has been well 
described (VanderLaan et al., 2004), with a major site of development being at the inner 
curvature of the aortic arch in genetically modified disease models. To determine 
whether Cezanne expression was differentially regulated in ECs at regions prone to or 
protected from the development of atherosclerosis, aortas from 8-week-old mice were 
dissected and Cezanne expression analysed using immunofluorescence staining (Figure 
3.1). Staining of PECAM-1 to mark endothelial junctions showed a marked difference in 
EC morphology between the regions investigated, with cells from the inner curvature of 
the aortic arch displaying the ‘cobblestone’ appearance typical of low shear stress (Davies 
et al., 1986), in comparison to the elongated, aligned conformation seen in cells and 
nuclei from both the outer curvature and descending aorta. Staining of Cezanne revealed 
a cytoplasmic localisation, with heterogeneity in the signal between different cells. Total 
expression was found to be significantly elevated in ECs at the inner curvature of the 
aortic arch compared to the outer curvature. Expression in the descending aorta was 
greater than in the outer curvature of the aortic arch, but this was not statistically 
significant. This suggests that Cezanne expression is upregulated at sites prone to 
atherosclerosis, but the pathway governing this expression change is not clear. 
3.4 Cezanne expression is elevated under low shear stress in vitro. 
Differences in expression between the inner and outer curvatures of the murine aorta 
can be due to a variety of mechanisms. Due to the curving geometry of the aortic arch, 
shear stress exerted by flowing blood is not distributed evenly (Figure 1.2). At the outer 
curvature, shear stress is unidirectional and high magnitude, while at the inner curvature 
it is oscillating and lower magnitude. A range of mechanosensitive molecules and 
structures can sense these differences in shear stress and lead to modulation of EC gene 
expression, causing profound changes to cellular phenotype (reviewed by Chiu and 
Chien, 2011). Cezanne expression at the inner curvature could be directly stimulated as 
a downstream target of one or more mechanosensors, alternatively its expression could 
be regulated by the activity of another signalling pathway – such as HIF or NF-κB 
signalling – that are known to be differentially expressed under different shear stress 
conditions (Akhtar et al., 2015; Hajra et al., 2000).  
To test the effect of different shear stress patterns on the expression of Cezanne, primary 
HUVECs were exposed to physiologically relevant shear stress patterns in vitro using 
two complimentary systems – the ibidi® and orbital shaker systems. Using the ibidi® 
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Figure 3.1: Cezanne expression is elevated under low shear stress in vivo. Aortas from 8
week old wild-type C57BL/6 mice were perfusion fixed, dissected and stained using
antibodies against Cezanne or an isotype control rabbit IgG. In addition, each tissue
section was stained using an antibody against the endothelial cell marker PECAM-1
conjugated to Alexa Fluor 488, and the nuclear marker TO-PRO-3 Iodide. Sections were
mounted en face onto glass coverslips and cells from the inner and outer curvatures of
the aortic arch, as well as the descending aorta were imaged using confocal microscopy.
The mean fluorescence intensity was determined for each region using ImageJ software.
Data are presented as mean ± SD.
n=4; p<0.01; One-way ANOVA with Tukey’s multiple comparisons.
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pump system, HUVECs were exposed to either unidirectional 13 dyn/cm2 (high) or 
oscillating (1 Hz) 4 dyn/cm2 (low) shear stress, conditions which approximate the shear 
stress environment experienced by human aortic ECs (Doriot et al., 2000; Milner et al., 
1998; Samady et al., 2011). While the ibidi® system applies a precise magnitude of shear 
stress to cells within a chamber slide, it applies only a unidirectional flow or bidirectional 
oscillations to cells. In contrast, ECs in vivo are subject to complex shear stress patterns, 
with pulsatility and multidirectionality varying across the endothelial surface. The 
orbital shaker system allows a single population of ECs to be exposed to both high and 
low shear stress within a single well, and cells in the centre are exposed to 
multidirectional shear. It also allows for higher throughput experiments. Following the 
application of shear stress in these systems, the alignment of the ECs was assessed to 
confirm a differential response (Figure 3.2). In both the ibidi® and orbital shaker 
systems, ECs aligned with the direction of flow when exposed to high shear stress, but 
adopted the polygonal “cobblestone” appearance under low shear stress, indicating that 
the cells were behaving as in vivo. 
Next, mRNA expression in cells exposed to both low and high shear stress was analysed 
in samples from each of the flow systems. The expression of control genes MCP-1 and 
endothelial nitric oxide synthase (eNOS) were tested, as these are known to be 
upregulated in low and high shear stress conditions respectively, as well as expression of 
Cezanne (Figure 3.3). MCP-1 and eNOS expression was enriched under low and high 
shear stress respectively in both systems. Expression of Cezanne was significantly higher 
in ECs isolated from the low shear stress condition of each of the systems in comparison 
to cells exposed to high shear stress. To test whether this difference in mRNA expression 
coincided with an elevation in protein expression, lysates were also generated from cells 
exposed to both low and high shear stress using each of the flow systems and Cezanne 
expression measured by Western blotting. Cezanne protein was more highly expressed 
under low shear stress compared to high shear stress (Figure 3.4). Interestingly, while 
Cezanne is predicted to have a molecular weight of 100 kDa, two bands were found on 
the Western blots, at 90 and 110 kDa. To determine which band corresponded to 
Cezanne, a second antibody targeting the carboxy terminus of Cezanne was used to probe 
the samples, finding bands at 90 and 110 kDa which matched those seen with the first 
antibody and suggesting that both bands correspond to Cezanne. These results suggest 
that the induction of Cezanne expression observed in vivo at the inner curvature of the 
aortic arch is as a result of low shear stress acting on ECs, rather than due to the effects 
of neighbouring cells or mass transport mechanisms. 
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Figure 3.2: HUVEC alignment is altered when exposed to high or low shear stress in
vitro. (top panels) HUVECs at passage 3 were seeded onto gelatinised ibidi® μ-Slide I0.4
chamber slides and allowed to adhere. The slides were then connected to the pump
systems and exposed to either ±4 dyn/cm2 at 1 Hz (low shear stress) or 13 dyn/cm2 (high
shear stress) for 72 hours. Following the application of flow, images were taken of each
slide using phase contrast microscopy. (bottom panels) HUVECs at passage 3 were
seeded onto gelatinised six-well plates and allowed to adhere. The media was changed
to 3 ml of fresh media and plates placed on an orbital shaker at 210 rpm for 72 hours to
generate a defined shear stress pattern across the well, with low shear stress of
approximately 4 dyn/cm2 in the centre and high shear stress of approximately 13
dyn/cm2 in the periphery. Following exposure to shear stress, cells were washed with
PBS then fixed with 4% formaldehyde and stained for VE-cadherin using
immunofluorescence techniques, DAPI staining was also included as a nuclear marker.
Images were then taken using fluorescence microscopy.
Figure 3.3: Cezanne mRNA expression is elevated under low shear stress in vitro.
HUVECs were exposed to low or high shear stress for 72 hours using the ibidi® (left) and
orbital shaker (right) systems. Following the application of flow, cells were lysed directly
and RNA isolated using a commercially available kit. Next, cDNA was generated and
mRNA expression of control genes MCP-1 and eNOS, as well as Cezanne quantified by
qPCR, normalising to expression of the housekeeping gene HPRT. Fold change was
calculated using the 2-ΔΔCT method. Data are presented as mean ± SD.
n=3; *p<0.05; **p<0.01; ***p<0.005; ****p<0.001; Two-tailed paired t test. Statistical
tests were carried out on ΔCT values.
MCP-1 eNOS Cezanne
0
1
2
3
4
Re
la
tiv
e 
m
RN
A 
ex
pr
es
si
on *
*
**
MCP-1 eNOS Cezanne
0
2
4
6
8
10
Re
la
tiv
e 
m
RN
A 
ex
pr
es
si
on
**
****
Low shear stress
High shear stress
***
ibidi® orbital shaker
Low shear stress High shear stress
0.0
0.5
1.0
1.5
Re
la
tiv
e 
Ce
za
nn
e 
pr
ot
ei
n 
ex
pr
es
si
on
*
110 kDa
110 kDa
90 kDa
90 kDa
110 kDa
90 kDa
Cezanne
(N terminal)
Cezanne
(C terminal)
Cezanne
(Merged)
PDHX
Shear stress low high
Figure 3.4: Cezanne protein expression is elevated under low shear stress in vitro.
HUVECs were exposed to low and high shear stress using the ibidi (a) and orbital shaker
(b) systems for 72 hours. Following the application of flow, cells were lysed separately
from each condition. Protein concentration was determined using a BCA assay, and
samples normalised accordingly. The expression of Cezanne was determined by Western
blotting, normalising to the housekeeper PDHX. For orbital shaker samples, a second C
terminal antibody was used following stripping of the membrane and images of each
overlaid using ImageJ. Densitometry was carried out using ImageJ software, on the
combined intensity of both Cezanne bands. Data are presented as mean ± SD.
n=3 (ibidi) n=10 (orbital shaker); *p<0.05; **p<0.01; ***p<0.005; Two-tailed paired t
test.
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3.5 TNFα does not further induce Cezanne expression under low shear 
stress. 
Previous studies have shown that Cezanne expression in ECs can be induced by the 
addition of inflammatory stimuli such as TNFα and reoxygenation following hypoxia 
(Enesa et al., 2008a; Luong et al., 2013). As Cezanne has also been shown to be a negative 
regulator of the inflammatory NF-κB pathway, this is of relevance to its potential role in 
atherosclerosis as inflammatory signalling is enhanced at atheroprone sites in vivo 
(Cuhlmann et al., 2011; Hajra et al., 2000) due to differences in both haemodynamic 
conditions (Mohan et al., 1997; Nagel et al., 1999; Wang et al., 2013a) and the release of 
proinflammatory cytokines from adherent leukocytes (Libby, 2002). Thus, the presence 
of exogenous cytokines may be a regulatory factor in the expression levels of Cezanne, 
causing its expression to increase during atherogenesis. 
To test whether Cezanne expression is upregulated by inflammatory cytokine exposure 
in ECs exposed to flow, HUVECs were cultured under shear stress using the orbital 
shaker system, then treated with TNFα to activate NF-κB. Immunofluorescence staining 
of the NF-κB subunit RelA was carried out in cells exposed to low shear stress in the 
presence or absence of TNFα. The degree of nuclear localisation of RelA was used to 
control for endothelial responses to TNFα. As expected, the addition of TNFα strongly 
induced nuclear localisation of RelA, verifying that the HUVECs responded to TNFα 
(Figure 3.5a). Furthermore, mRNA expression of the NF-κB target gene and positive 
control MCP-1 was strongly induced by TNFα (Figure 3.5b). By contrast, Cezanne 
transcript expression was not found to be significantly altered by stimulation with TNFα, 
although there was a trend towards an increase particularly in cells from the high shear 
stress site (Figure 3.5c). These data indicate that activation of the TNFR pathway is not 
sufficient to further induce Cezanne expression in cells exposed to low shear stress, thus 
the mechanism underlying elevated Cezanne expression at atheroprone regions in vivo 
may not be as a result of the presence of exogenous TNFα and potentially other cytokines, 
but instead due to low shear stress acting through another pathway. 
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Figure 3.5: Cezanne expression is not regulated by TNFα in cells exposed to shear
stress. HUVECs were exposed to low and high shear stress using the orbital shaker
system for 72 hours. The same populations of cells were exposed to both conditions
depending on their location within the well. TNFα (10 ng/ml) was added to half the wells
for the last 4 hours of shear stress, with the remainder left untreated. (a) Following
treatment, cells were fixed with 4% formaldehyde and stained for the NF-κB subunit RelA
(green) as well as the nuclear marker DAPI (blue). Cells were visualised by wide-field
fluorescence microscopy and images captured using the Leica LAS AF software. (b & c)
After treatment, cells were scraped from each condition. RNA was obtained using a
commercially available kit and cDNA generated. The expression of both MCP-1 (b) and
Cezanne (c) were quantified by qPCR, normalising to the housekeeping gene HPRT. Data
are presented as mean ± SD.
n=3; p<0.05; Two-tailed paired t test. Statistical tests for qPCR results were carried out on
ΔCT values.
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3.6 Non-canonical NF-κB signalling does not regulate Cezanne 
expression in endothelial cells exposed to shear stress. 
There is published evidence that Cezanne expression is under the regulation of the non-
canonical branch of the NF-κB pathway in B cells, with stimulation by CD40L and LT-β 
causing enhanced Cezanne expression (Hu et al., 2013). These cytokines are expressed 
by various cell types present in the blood such as B cells, T cells and platelets (Henn et 
al., 1998; Sun, 2011) and thus could influence the expression of Cezanne in ECs. In order 
to investigate whether Cezanne expression is under the control of this molecular pathway 
in ECs exposed to shear stress, HUVECs were cultured using the orbital shaker system 
to generate shear stress and then stimulated with CD40L to activate the non-canonical 
NF-κB pathway. Confirmation of activity was obtained by Western blotting for 
p100/p52; these blots showed that stimulation consistently induced cleavage of p100 to 
p52, indicated by a reduction in p100 levels and a concomitant increase in p52 (Figure 
3.6). Interestingly, the expression of these proteins was also found to be strongly 
regulated by shear stress (see Chapter 5). The expression of Cezanne was not altered by 
CD40L in cells from either the low or high shear stress regions of the plate. These data 
indicate that the induction of Cezanne expression at atheroprone sites in vivo is not due 
to the presence of ligands which activate the non-canonical NF-κB pathway. 
3.7 Hypoxia does not alter Cezanne expression in endothelial cells 
exposed to shear stress. 
The expression of Cezanne in ECs has previously been reported to be enhanced following 
exposure to hypoxia (Luong et al., 2013), however this was not investigated in cells 
exposed to shear stress. There is evidence to suggest that atheroprone sites have lower 
oxygen availability than protected sites (Santilli et al., 1995), and ECs overlying lesions 
display enhanced expression of HIF-1α (Akhtar et al., 2015), a transcription factor 
central to promoting cellular responses to hypoxia. The expression of Cezanne in ECs 
exposed to shear stress may therefore also be regulated by exposure to hypoxia. To test 
whether changes in Cezanne expression generated by differential shear stress can be 
modified by hypoxic signalling, HUVECs were exposed to shear stress for 72 hours using 
the orbital shaker system and placed into a hypoxic chamber for the last 4 or 24 hours. 
Cells were isolated and the expression of Cezanne was tested by Western blotting (Figure 
3.7). Cezanne expression was elevated by low shear stress, but did not appear to be 
altered by either 4 or 24 hours of hypoxia. These results indicate that the presence of 
hypoxia does not regulate Cezanne expression in ECs exposed to shear stress. 
100 ng/ml CD40L – – + +
Shear stress low high low high
p100
p52
Cezanne
PDHX
Figure 3.6: Cezanne expression is not regulated by CD40L in cells exposed to shear
stress. HUVECs were exposed to low and high shear stress using the orbital shaker
system for 72 hours. The same populations of cells were exposed to both conditions
depending on their location within the well. CD40L (100 ng/ml) was added to a
proportion of the wells for the last 2 hours of shear stress, with the remainder left
untreated. Following the application of flow, cells were scraped from each condition and
lysed. Protein concentration was determined by BCA assay and samples normalised
accordingly. The expression of p100/p52 and Cezanne was quantified by Western
blotting, normalising to the housekeeper PDHX. Densitometry was carried out using
ImageJ software. Data are presented as mean ± SD.
n=3; Two-tailed paired t test. Statistical tests were carried out on raw data.
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Figure 3.7: Cezanne expression is not regulated by hypoxia in cells exposed to shear
stress. HUVECs were exposed to low and high shear stress using the orbital shaker
system for 72 hours. The same populations of cells were exposed to both conditions
depending on their location within the well. For the final 4 or 24 hours of shear stress,
plates were placed into the GENbox apparatus, generating a hypoxic environment, one
plate was left in normoxic conditions as a control. Following treatment, cells were
scraped from each condition and lysed. Protein concentration was assessed by BCA assay
and samples normalised accordingly. Expression of Cezanne was analysed by Western
blotting.
Data is from a single experiment.
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3.8 Conclusions 
Cezanne expression has been found to be induced in vivo at a site of predilection to 
atherosclerosis. The driving factor for this induction is the presence of low shear stress 
at this site, as in vitro studies show elevated Cezanne expression under low shear stress. 
This induction is dominant over stimulation with TNFα, CD40L or hypoxia, as addition 
of these factors conferred no further increase in Cezanne expression in cells exposed to 
low shear stress.  
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3.9 Discussion 
The ovarian tumour deubiquitinase Cezanne has been previously shown to be a negative 
regulator of EC inflammation through inhibition of NF-κB (Enesa et al., 2008a; Evans et 
al., 2001; Luong et al., 2013). In addition, these and other studies have identified factors 
which can induce expression of Cezanne, including shear stress, inflammatory cytokines 
and hypoxia. These conditions are all altered in ECs at sites of atherosclerosis, and as 
NF-κB signalling is known to be critical in the development of lesions (Gareus et al., 
2008), Cezanne may be important in regulating this process. The role of Cezanne has not 
been previously studied in the context of atherosclerosis, but analysis of its contribution 
may shed light on a mechanism by which it can be controlled. 
3.9.1 Cezanne expression was elevated by low shear stress in vivo and in vitro. 
The experiments described demonstrate that Cezanne is consistently more highly 
expressed in ECs which have been exposed to shear stress patterns associated with 
regions of the vasculature which are prone to the development of atherosclerotic lesions. 
This induction of Cezanne expression is seen in vivo in the aortas of wild-type mice. 
Immunofluorescence staining of ECs from the inner and outer curvatures of the aortic 
arch revealed cytoplasmic localisation of Cezanne, as previously reported (Evans et al., 
2001).  Expression was found to be significantly higher in ECs from the inner curvature 
of the aortic arch, in comparison to the outer curvature, with ECs in the descending aorta 
possessing intermediate levels. The inner curvature is documented to be a site prone to 
the development of inflammation and atherosclerosis (VanderLaan et al., 2004) so this 
suggests that Cezanne induction may act as a negative feedback mechanism for NF-κB 
signalling, thereby dampening inflammation. There are several notable differences in the 
cellular environment of cells from the inner and outer curvatures which may result in 
alterations in Cezanne expression – differences in shear stress as a result of the geometry 
of the vessel, enhanced inflammatory signalling, and a decrease in oxygen tensions. To 
test whether haemodynamic forces were responsible for regulation of Cezanne 
expression, shear stress was exposed to ECs in vitro using two complimentary systems. 
These experiments recapitulated the expression changes seen in vivo. In both the ibidi® 
and orbital shaker systems, Cezanne mRNA and protein was more highly expressed 
under low compared to high shear stress. However, the relative differences in expression 
between the two shear stress conditions in each system was notably different. The levels 
of mRNA were over two-fold greater in the low compared to high shear stress in the 
ibidi® system, while in the orbital shaker system there was less than a 1.5-fold difference. 
By contrast, protein expression showed the opposite. Increases of 1.5-fold and 2.5-fold 
were seen in the ibidi® and orbital shaker systems, respectively. The differences between 
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these results may reflect the sensitivity of Cezanne expression to directionality of shear 
stress. The ibidi® system exposes cells to shear stress along a single axis, whereas the 
orbital shaker system is multiaxial and pseudopulsatile. The expression of other shear-
sensitive molecules have been shown to be profoundly regulated by the application of 
shear at different angles relative to cellular alignment (Wang et al., 2013a), and Cezanne 
expression could be governed by a similar mechanism. Alternatively, the separation of 
both shear stress conditions in the ibidi® system may be a causative factor in these 
differences. Molecules such as nitric oxide – produced as a result of eNOS activity – and 
MCP-1 are secreted by cells under high and low shear stress respectively (Figure 3.3a), 
and have opposing functions on EC inflammation (Kuchan and Frangos, 1994; Passerini 
et al., 2004; Shyy et al., 1994). Therefore, ECs in the orbital shaker and ibidi® systems 
are exposed to different secretory milieus which could potentially influence Cezanne 
expression. 
 Further research could focus on identifying whether alterations in expression due to 
shear stress are due to transcription, translation, or post-translational mechanisms. An 
observation which may be of relevance to this was the presence of two bands 
corresponding to Cezanne on Western blots. This could be as a result of alterations in 
splicing, in the addition of post-translational modifications such as ubiquitination, or 
cleavage of the protein. Interestingly, the related protein A20 can be cleaved, causing a 
subsequent reduction in function (Malinverni et al., 2010); potentially Cezanne could be 
regulated by a similar mechanism. Further work utilising actinomycin D or 
cyclohexamide experiments should be carried out on cells exposed to shear stress, in 
order to test whether the alterations in Cezanne expression were as a result of altered 
transcription or translation. 
The expression of Cezanne was previously reported as being induced at an 
atheroprotected site in the porcine aorta, based on a microarray study (Passerini et al., 
2004). Surprisingly, the results described here show the opposite expression pattern, 
however there are several explanations for this disagreement. Firstly, the haemodynamic 
conditions vary between the studies. The regions that were studied in the porcine aortic 
arch by Passerini et al. were directly opposite the brachiocephalic and subclavian 
branches for the atheroprone site, and approximately 2 cm distal for the atheroprotected 
site. We have recently used CFD to precisely model the shear stress within the porcine 
aorta, finding that the atheroprotected site used in the aforementioned work possesses a 
high degree of oscillatory shear stress (Serbanovic-Canic et al., 2016). Given that 
Cezanne expression was found to be induced by oscillating shear stress in the ibidi® 
system, this may be a factor in the heightened expression of Cezanne mRNA observed at 
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this site. The in vivo Cezanne expression data included in this thesis was carried out 
using murine aortas, compared to the porcine vessels used by Passerini et al. The average 
shear stress experienced within the murine vasculature is an order of magnitude higher 
than in pigs (Feintuch et al., 2007; Suo et al., 2007), and the geometry is different due to 
a much smaller size and the presence of three major branching arteries. These differences 
may also contribute to the difference in the pattern of Cezanne expression seen between 
this research and the previous work. Further study of Cezanne expression in the porcine 
aortic arch at a variety of sites with known shear stress levels may shed light on the 
sensitivity of Cezanne expression to small changes in flow magnitude and direction. 
3.9.2 Low shear stress confers an insensitivity to Cezanne induction by 
cytokines or hypoxia. 
While the previous experiments show that low shear stress was able to elevate the 
expression of Cezanne, other studies have shown that its expression can also be enhanced 
by TNFα (Enesa et al., 2008a), CD40L (Hu et al., 2013) and hypoxia (Luong et al., 2013). 
These factors have all been previously associated with atherosclerotic lesions; infiltrating 
leukocytes release TNFα and CD40L, amongst other cytokines (Libby, 2002), while HIF-
1α expression was found to be increased in ECs overlying lesions (Akhtar et al., 2015). 
Cezanne expression at sites of predilection may be driven further by exposure to these 
factors and thus have a significant effect on the inflammatory response of ECs and thus 
on atherosclerosis. 
Thus, Cezanne expression was tested in ECs exposed to shear stress using the orbital 
shaker system in the presence of these cytokines, or hypoxia. Surprisingly, Cezanne 
expression under low shear stress was found to be unaffected by the addition of TNFα, 
CD40L or culturing in hypoxia. The lack of elevated expression following exposure to 
these stimuli is contradictory to the previously published studies, however there are 
several important differences in the methodology which may explain the differences.  
In one paper, Cezanne expression was modestly induced by unidirectional shear stress 
and this was further elevated by treatment with TNFα (Enesa et al., 2008a). However, 
those experiments were comparing expression between static cultures and 12 dyn/cm2 
unidirectional shear stress. In contrast, the results described here compare the 
expression differences between two shear stress conditions. It is plausible that the 
stimulus of low shear stress may be sufficient to provide maximal Cezanne expression, 
thus further stimulation with TNFα has no effect. Indeed, while not statistically 
significant, a trend towards an induction in Cezanne mRNA expression was seen in cells 
exposed to high shear stress and TNFα, consistent with this idea. 
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The discrepancy between induction of Cezanne expression by CD40 ligation in B cells 
and MEFs (Hu et al., 2013) and the data presented here may be simply due to differences 
in cell type. The authors do not describe a mechanism for the induction of Cezanne by 
CD40L stimulation, but suggest that it requires non-canonical NF-κB. While the results 
in this chapter show that there is an appreciable level of p100/p52 expression in ECs, 
they are less than those expressed in B cells (biogps.org) and may not be sufficient for 
Cezanne induction. 
Previously, Cezanne expression was seen to be induced by exposure to hypoxia in static 
ECs in a p38/ATF2 dependent mechanism (Luong et al., 2013). Interestingly, the 
upregulation was sensitive to oxygen concentration. Induction was found to occur at 1% 
O2, but not 2% or 5%. In this chapter, the results showed that hypoxia did not cause an 
induction of Cezanne expression in ECs exposed to shear stress. However, it is plausible 
that oxygen levels were not reduced sufficiently for Cezanne induction. Alternatively, it 
is possible that the p38/ATF2 mechanism described is also sensitive to shear stress. The 
activity of p38 has found to be higher at sites prone to atherosclerosis, due to inhibition 
under high shear stress (Zakkar et al., 2008). Cezanne expression under low shear stress 
may be driven by this signalling pathway and as such, the addition of hypoxia may not 
further enhance p38/ATF2 signalling, resulting in no change in Cezanne expression. 
In order to fully explore the contribution that NF-κB and hypoxic signalling make to the 
expression of Cezanne, it would be necessary to perform detailed experiments with RNA 
silencing or chemical inhibition of the pathways. The results presented in this chapter 
show that additional activation of these pathways do not confer a change in Cezanne 
expression, however it may be possible that exposure to low shear stress causes sufficient 
activation of the pathways to promote Cezanne upregulation. Silencing or inhibition of 
NF-κB or HIF pathways in HUVECs exposed to shear stress followed by assessment of 
Cezanne expression would allow the testing of whether these pathways promote Cezanne 
transcription or translation without excess stimulation. 
3.9.3 Localisation of Cezanne expression may determine its function in 
atherosclerosis. 
Research from several groups has previously implicated Cezanne in the regulation of 
pathways related to atherosclerosis. It has been shown to inhibit canonical and non-
canonical NF-κB signalling, and promote hypoxic signalling (Bremm et al., 2014; Enesa 
et al., 2008a; Hu et al., 2013; Luong et al., 2013). The results in this chapter may give an 
insight into the potential role of Cezanne in carrying out these functions to regulate 
endothelial activation. The induction of Cezanne by low shear stress, thus at sites prone 
to atherosclerosis, suggests that it is able to negatively regulate NF-κB signalling, which 
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is also upregulated under these conditions and is critical to the development of 
atherosclerosis (Gareus et al., 2008). Thus, Cezanne may act as a protective factor by 
limiting the expression of adhesion molecules and cytokines which drive lesion 
development. As stimulation with activating cytokines does not appear to further 
increase its expression under low shear stress this may mean that Cezanne is responsible 
for maintaining homeostasis by inhibiting aberrant NF-κB in vessels which are not 
exposed to an inflammatory stimulus, but will allow a response by cells to signalling 
which may also be caused by injury or infection, thus not compromising the ability of 
ECs to respond when they are required to for survival. 
Cezanne has been shown to increase levels of both HIF-1α (Bremm et al., 2014) and HIF-
2α (Moniz et al., 2015) via independent mechanisms and thus may promote the 
expression of hypoxia target genes which can regulate proliferation and apoptosis 
(Carmeliet et al., 1998). Hypoxic signalling is another pathway of interest in 
atherosclerosis. Nuclear HIF-1α has been found to be present in ECs covering human 
and murine atherosclerotic lesions. In addition, mice with an inducible endothelial 
knockout of Hif1a have been shown to be protected from the development of 
atherosclerosis (Akhtar et al., 2015). Although hypoxia did not increase Cezanne 
expression under low shear stress, it may still function at these sites to maintain an 
enhanced level of HIF expression and lead to lesion progression. 
Understanding the function of Cezanne at sites of low shear stress is crucial to 
understanding its potential role in atherosclerosis. Testing these pathways in cells with 
Cezanne levels depleted will allow the functional consequence of Cezanne’s elevated 
expression in low shear stress to be analysed. 
3.9.4 Summary 
Increased expression of Cezanne at the inner curvature of the murine aortic arch is likely 
due to the curving geometry of this site causing blood flow to exert low magnitude, 
oscillating shear stress on ECs. This is supported by in vitro studies in two systems to 
apply shear stress to cultured ECs, both showing that Cezanne mRNA and protein 
expression was elevated under these conditions. Contrary to previous work, exposure of 
ECs cultured under shear stress to hypoxia or NF-κB activating cytokines did not further 
elevate expression of Cezanne. This may reflect phenotypic differences in ECs exposed to 
shear stress and gives further information about the potential role of Cezanne in 
regulating the development of atherosclerosis. Cezanne may regulate NF-κB or hypoxic 
signalling and thereby alter vascular physiology, but further experiments are required to 
test this hypothesis. 	
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4. Functional studies of Cezanne 
4.1 Introduction 
The findings presented in chapter 3 show that the expression of Cezanne in ECs is 
strongly and consistently regulated by shear stress, with its expression being the highest 
in cells exposed to low shear stress with oscillations in direction. These conditions 
approximate the haemodynamic environment which cells at regions prone to 
atherosclerosis experience in the human vasculature (Doriot et al., 2000; Milner et al., 
1998; Samady et al., 2011), suggesting that Cezanne may be involved in cellular signalling 
events which lead to the initiation or progression of atherosclerotic lesion development. 
There are several mechanisms by which Cezanne could be acting to alter EC phenotype 
at these sites. 
As a deubiquitinase, the previously studied functions of Cezanne are in the removal of 
ubiquitin from several key molecules involved in important cellular pathways which may 
be involved in regulating endothelial activation at sites of low shear stress. Cezanne has 
been implicated in the regulation of canonical NF-κB signalling via disassembly of the 
polyubiquitin chain linking either RIP1 (Enesa et al., 2008a) or TRAF6 (Luong et al., 
2013) to NEMO. Ubiquitin in this context acts as a scaffold to allow recruitment of TAK1 
and TAB2, which initiate a kinase cascade resulting in IκBα degradation and subsequent 
release of NF-κB complexes from the cytoplasm. Cezanne’s deubiquitinase activity 
therefore inhibits release of NF-κB from the cytoplasm and thus dampens canonical NF-
κB signalling. Active NF-κB signalling in ECs is known to be critical for the development 
of early lesions (Gareus et al., 2008), so Cezanne may be playing a role in limiting 
canonical NF-κB signalling at sites of low shear stress, potentially protecting these 
regions from lesion development. 
A role for Cezanne in non-canonical NF-κB signalling has also been described. In a recent 
paper, Hu et al. posit that Cezanne can remove lysine 48-linked polyubiquitin chains 
from TRAF3, thereby stabilising the protein by blocking proteasomal degradation (Hu et 
al., 2013). TRAF3 is responsible for targeting the NIK for degradation and as such, 
enhancement of TRAF3 levels lead to a downregulation of NIK and consequently a 
downregulation of non-canonical NF-κB signalling. While non-canonical NF-κB has not 
been directly implicated in the pathogenesis of atherosclerosis, expression of the 
subunits p52 and RelB is increased at sites of low shear stress (see Chapter 5), as are 
cellular processes which the pathway regulates – such as proliferation (Ishikawa et al., 
1997; Schumm et al., 2006) and apoptosis (Burkitt et al., 2015; Saxon et al., 2016). I 
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therefore hypothesised a potential role for Cezanne may be to limit non-canonical NF-
κB signalling at sites of low shear stress, to reduce cell turnover at these sites. 
Finally, the activity of Cezanne has been implicated in the regulation of hypoxic 
signalling via HIF-1α and HIF-2α. Classically, HIF protein levels are thought to be tightly 
controlled within cells by an oxygen-sensitive upstream mechanism involving the von 
Hippel-Lindau tumour suppressor (VHL) which leads to degradation of HIF under 
normoxic conditions. Loss of Cezanne, however, has been associated with a decrease in 
both HIF-1α and HIF-2α stability, via separate mechanisms independent of proteasomal 
degradation (Bremm et al., 2014; Moniz et al., 2015). In ECs exposed to low shear stress, 
Cezanne may act to maintain a pool of HIF and promote hypoxic signalling, potentially 
leading to aberrant proliferation at these sites. 
The function of Cezanne in ECs at sites of low shear stress is unclear, however the 
pathways that it has been reported to regulate in other cell types or contexts may be 
extremely important in altering EC phenotype to the classical activated state present in 
early atherogenesis. Understanding which pathways Cezanne may regulate in the context 
of atherosclerosis may be key in prevention or treatment of the disease. 
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4.2 Hypothesis and aims 
Hypothesis: Cezanne functions to negatively regulate NF-κB signalling and/or 
positively regulate HIF signalling in ECs exposed to low shear stress.  
Aim 1: Use siRNA technology to deplete Cezanne from ECs exposed to shear stress and 
test the resulting effect on: 
a) Canonical NF-κB signalling (via phosphorylation of RelA and target gene 
analysis), 
b) Non-canonical NF-κB signalling (via processing of p100 to p52), 
c) HIF signalling (via assessing the stability of HIF-1α). 
Aim 2: Use aortic tissue from mice lacking Cezanne and determine the consequential 
effect on: 
a) Endothelial inflammation, 
b) Endothelial proliferation, 
c) Atherosclerotic lesion development. 
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4.3 Optimisation of Cezanne gene silencing 
A powerful tool to probe the function of a gene of interest in a particular biological 
context is to utilise RNA interference technology to deplete levels of endogenous mRNA 
and thus the expressed protein. Analysis of putative target pathways can reveal 
differences between cell populations transfected with specific siRNA compared to the 
non-targeting “scrambled” control siRNA, thus suggesting that the gene of interest is 
involved in the particular cellular event. In order to probe the function of Cezanne in ECs 
exposed to shear stress, siRNA specific to the OTUD7B gene was transfected into 
HUVECs via liposomal delivery (Lipofectamine RNAiMAX) and electroporation to 
determine the optimal method for delivery (Figure 4.1). The percentage knockdown of 
Cezanne mRNA and protein was determined for each delivery method; electroporation 
was found to be effective at reducing Cezanne expression, providing a 77% reduction in 
mRNA expression (Figure 4.1d) and an 87% reduction in protein (Figure 4.1b) in low 
shear stress as analysed by qPCR and Western blotting respectively. In comparison, with 
Lipofectamine, mRNA expression was reduced by only 37% (Figure 4.1c) and protein 
47% (Figure 4.1a). Furthermore, Cezanne expression with the control siRNA was more 
similar to untransfected cells in electroporated samples as compared to those transfected 
with Lipofectamine, indicating that there may be less off-target effects. Electroporation 
was thus chosen as the method of transfection for use in the following experiments.  
4.4 Cezanne limits phosphorylation of NF-κB RelA under low shear 
stress. 
The NF-κB subunit RelA has been previously found to exhibit differential expression 
regulated by  shear stress patterns in vivo, with expression being induced at sites of low 
shear stress (Cuhlmann et al., 2011). A reported function of Cezanne is in the regulation 
of the upstream signalling cascade leading to NF-κB activation (Enesa et al., 2008a) or 
phosphorylation (Luong et al., 2013), so to test whether Cezanne was carrying out this 
function in ECs exposed to low shear stress, siRNA targeting Cezanne was delivered to 
HUVECs by electroporation prior to exposure to shear stress using the orbital shaker 
system. RelA activity was then assessed by Western blotting for phosphorylated RelA (at 
serine 536) as well as total levels (Figure 4.2). Analysis of total RelA expression showed 
an increase in both control and Cezanne knockdown cells under low shear stress in 
comparison to high shear stress, no difference was seen in total RelA levels between 
control and knockdown samples (Figure 4.2 – upper panels). Western blotting with the 
antibody specifically targeting RelA phosphorylated at serine 536 showed that although 
there was a trend towards an increase in expression in low compared to high shear stress, 
this was not statistically significant (Figure 4.2 – lower right panel). There was, however, 
Cezanne siRNA + + – – – –
Scrambled siRNA – – + + – –
Shear stress low high low high low high
a
PDHX
Cezanne
b
c
Cezanne siRNA + + – – – –
Scrambled siRNA – – + + – –
Shear stress low high low high low high
PDHX
Cezanne
Figure 4.1: Electroporation is more effective than liposomal delivery at delivering siRNA
to silence Cezanne expression. At passage 3, HUVECs were transfected with siRNA
targeting Cezanne or scrambled control siRNA with two methods to test the efficiency of
knockdown. (a) HUVECs were seeded onto gelatinised six well plates and allowed to
adhere overnight. Lipofectamine RNAiMAX and siRNA solutions were then prepared in
Opti-MEM media before being combined and added to wells. Five hours later, the
transfection media was replaced with M199 and the plates placed on the orbital shaker
for 72 hours. Cezanne expression was quantified by Western blotting, normalising to the
housekeeper PDHX. (b) HUVECs were trypsinised and washed in PBS before being
resuspended in R buffer containing siRNA. The cells were then electroporated using the
Neon system and plated onto gelatinised six well plates containing warm antibiotic free
M199. After six hours, when the cells were adherent, plates were placed on the orbital
shaker for 72 hours. Cezanne expression was quantified by Western blotting, normalising
to the housekeeper PDHX. In addition, cDNA was generated and mRNA expression of
Cezanne in cells transfected by (c) Lipofectamine RNAiMAX and (d) electroporation
quantified by qPCR, normalising to the housekeeper HPRT.
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Figure 4.2: Depletion of Cezanne results in an increase in RelA phosphorylation in cells
exposed to low shear stress. HUVECs were transfected with siRNA targeting Cezanne or
a scrambled control siRNA using electroporation. The cells were then seeded onto six-
well plates. Once adherent, cells were exposed to shear stress for 72 hours using the
orbital shaker system, then scraped from each condition separately. Samples were lysed,
protein concentration determined using a BCA assay and normalised accordingly. The
expression of Cezanne, total RelA and RelA phosphorylated at serine 536 were analysed
by Western blotting, normalising to the housekeeper PDHX. Densitometry was carried
out using ImageJ.
n=3; p<0.05; Two-way ANOVA.
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a significant increase in phosphorylated RelA in the Cezanne knockdown samples under 
low shear stress in comparison to all other conditions (Figure 4.2 – lower left panel). This 
could suggest that Cezanne functions in ECs exposed to low shear stress to inhibit the 
phosphorylation of RelA, without affecting its overall expression levels. This may be 
indicative of regulation of NF-κB activity and so this was explored further by studying 
NF-κB target genes. 
4.5 Expression of NF-κB target genes is not affected by Cezanne 
knockdown. 
Several target genes of canonical NF-κB signalling are upregulated at sites of low shear 
stress in vivo. Some important examples are adhesion molecules such as ICAM-1, VCAM-
1 and E-selectin, which are involved in the attachment of circulating monocytes to sites 
of low shear stress in early plaque development (Van der Heiden et al., 2010). The RelA 
subunit is the NF-κB subunit which possesses the transactivation domain responsible for 
inducing gene expression in the canonical NF-κB pathway (Huxford and Ghosh, 2009), 
and as Cezanne is capable of regulating its shear stress-dependent phosphorylation this 
may result in an alteration in target gene expression. To investigate whether the role of 
Cezanne dependent inhibition of RelA phosphorylation is to repress the expression of 
NF-κB target genes, HUVECs were transfected with either Cezanne or scrambled siRNA 
and exposed to shear stress in combination with TNFα as a known activator of NF-κB 
activity. Following treatment, cDNA was collected and the relative expression levels of a 
panel of known NF-κB target genes measured by qPCR (Figure 4.3). Many of the genes 
were regulated by shear stress in the untreated samples, with upregulation in low shear 
stress where RelA expression is also elevated. In addition, stimulation with TNFα caused 
the expression of many the genes to be strikingly enhanced, with fold changes in excess 
of one thousand in some cases. Notably, expression of the anti-apoptotic genes Bcl-2 and 
growth arrest and DNA-damage-inducible β (GADD45β) were unaffected by TNFα 
treatment, despite having been previously found to be regulated by this pathway (Catz 
and Johnson, 2001; De Smaele et al., 2001). Silencing of Cezanne, however, conferred 
no effect on the expression level of any of the NF-κB target genes studied, suggesting that 
modulation of RelA phosphorylation by Cezanne does not alter target gene expression in 
this context. 
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Figure 4.3: Depletion of Cezanne does not alter the expression of NF-κB target genes.
HUVECs were transfected with siRNA targeting Cezanne or a scrambled control siRNA
using electroporation. The cells were then seeded onto six-well plates. Once adherent,
cells were exposed to shear stress for 72 hours using the orbital shaker system, then
scraped from each condition separately. RNA was collected from the samples and
converted to cDNA. The expression level of the various genes were tested using qPCR,
normalising to the housekeeping gene HPRT.
n=3; *p<0.05; **p<0.01; ***p<0.005; ****p<0.001; Two-way ANOVA with Tukey’s post
test analysis.
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4.6 Cezanne does not regulate non-canonical NF-κB signalling in 
endothelial cells under shear stress. 
Recent evidence from experiments in B cells has indicated that Cezanne may play a role 
in the regulation of non-canonical NF-κB signalling via deubiquitination of TRAF3 
leading to repression of the pathway (Hu et al., 2013). The canonical and non-canonical 
branches of NF-κB also exhibit a degree of cross-talk (Oeckinghaus et al., 2011) so to test 
whether non-canonical NF-κB signalling was regulated by Cezanne in ECs, siRNA was 
used to deplete Cezanne expression and the processing of p100 to p52 investigated using 
Western blotting (Figure 4.4). HUVECs were transfected with either non-targeting 
control siRNA or siRNA specifically targeting Cezanne using electroporation. 
Transfected cells were then seeded on six-well plates and once adherent placed on the 
orbital shaker for 72 hours of shear stress. Cells were scraped from the high and low shear 
stress regions from each condition and lysed for Western blotting. Samples were probed 
with an antibody which detects both p100 and p52 so cleavage could be assessed. The 
blots show that expression of p100 and p52 was significantly higher under low shear 
stress than high shear stress, however there were no significant differences in either p100 
or p52 levels between control or Cezanne knockdown samples. These results indicate that 
Cezanne is not responsible for regulating non-canonical NF-κB signalling in ECs exposed 
to shear stress. 
4.7 Cezanne does not alter HIF-1α stability or transcriptional activity in 
endothelial cells exposed to shear stress. 
There is some published evidence to suggest that Cezanne may be involved in the 
regulation of hypoxic signalling, utilising a mechanism of HIF-1α deubiquitination which 
increases stability of the hypoxia-driven transcription factor and leads to a prolonged 
transcriptional response (Bremm et al., 2014). In order to test whether Cezanne is 
responsible for regulating HIF-1α expression in ECs exposed to shear stress, Cezanne 
expression was depleted using a specific siRNA with and without the presence of 
dimethyloxaloglycine (DMOG), a potent upstream activator of HIF. Western blotting 
was used to assess the expression of HIF-1α (Figure 4.5). The results show that HIF-1α 
expression is increased under low shear stress conditions both in the absence and 
presence of DMOG, but there is no difference in expression between cells transfected 
with Cezanne siRNA compared to the scrambled siRNA control. In addition, the 
expression of the HIF-1α transcriptional targets enolase 2 (ENO2) and 6-phosphofructo-
2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) were analysed by Western blotting in 
the samples treated with DMOG (Figure 4.6). Consistent with the results for HIF-1α 
stability, depletion of Cezanne did not alter levels of these HIF-1α target genes in low 
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Cezanne siRNA – – – – – – + +
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Figure 4.4: Depletion of Cezanne does not alter processing of p100 to p52. HUVECs were
transfected with siRNA targeting Cezanne or a scrambled control siRNA using
electroporation. The cells were then seeded onto six-well plates. Once adherent, cells
were exposed to shear stress for 72 hours using the orbital shaker system. (a) Cells from
each condition were lysed and protein content normalised. The expression of p100, p52
and Cezanne were determined by Western blotting, normalising to the housekeeper
PDHX. (b) For the final 2 hours of orbiting, 100 ng/ml CD40L was added to the indicated
samples to induce p100 processing to p52. Samples were then lysed and the expression
of p100, p52 and Cezanne determined by Western blotting, normalising to the
housekeeper PDHX.
n=3
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b
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Figure 4.5: Depletion of Cezanne does not alter stability of HIF-1α. HUVECs were
transfected with siRNA targeting Cezanne or a scrambled control siRNA using
electroporation. The cells were then seeded onto six-well plates. Once adherent, cells
were exposed to shear stress for 72 hours using the orbital shaker system. Half of the
wells were stimulated with 0.5 mM DMOG for the final 4 hours of shear stress, while the
other half were unstimulated. Cells from each condition were lysed and protein content
normalised. The expression of HIF-1α was determined by Western blotting, normalising
to the housekeeper calnexin.
n=4. Western blot performed by Dr Shuang Feng.
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Figure 4.6: Depletion of Cezanne does not alter HIF-1α target gene expression in low
shear stress. HUVECs were transfected with siRNA targeting Cezanne or a scrambled
control siRNA using electroporation. The cells were then seeded onto six-well plates.
Once adherent, cells were exposed to shear stress for 72 hours using the orbital shaker
system. The wells were stimulated with 0.5 mM DMOG for the final 4 hours of shear
stress, then cells exposed to low shear stress from each knockdown were lysed and
protein content normalised. The expression of HIF-1α, ENO2 and PFKFB3 were
determined by Western blotting, normalising to the housekeeper calnexin.
n=4. Western blot performed by Dr Shuang Feng.
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shear stress. Taken together, these data suggest that while expression of HIF-1α is 
elevated under the same shear stress conditions as Cezanne, the mechanism for this 
differential expression or subsequent transcriptional activity does not require Cezanne. 
4.8 VCAM-1 expression in the endothelium of Otud7b–/– mice is 
unchanged from wild-type 
There are several reasons that could account for depletion of Cezanne in vitro not 
conferring an effect on the expression of inflammatory target genes, despite the elevation 
in RelA phosphorylation at serine 536. Depletion with siRNA leaves a small pool of 
functional protein which may possess enough activity to mask changes that are 
occurring. Looking in vivo at endothelial cells from Otud7b–/– mice may give more 
information about the true function of Cezanne, avoiding residual expression. In this 
system, ECs are exposed to not only shear stress of different magnitudes but also an array 
of low level inflammatory stimuli from circulating sources. In order to test whether NF-
κB signalling is influenced by removal of Cezanne, inflammatory signalling was induced 
by intraperitoneal injection of bacterial LPS before expression of VCAM-1 was analysed 
by en face staining of the aortic arches of both wild-type and Otud7b–/– mice (Figure 4.7). 
Expression of VCAM-1 was found to co-localise with PECAM-1, indicating surface 
expression as expected. The results showed that was no significant difference in the 
expression levels of VCAM-1 between wild-type and knockout mice. These data 
recapitulate the in vitro results by demonstrating that Cezanne did not regulate NF-κB 
target gene expression under low shear stress. 
4.9 Endothelial proliferation in the murine aortic arch is not regulated by 
Cezanne. 
The other putative targets of Cezanne were in the non-canonical NF-κB and HIF 
pathways. These pathways are both known to regulate cellular proliferation by divergent 
mechanisms. Non-canonical NF-κB signalling has been shown to alter the expression of 
cell cycle genes, inhibiting expression of the antiproliferative p21 while also enhancing 
expression of Cyclin D1, which drives cell cycle progress (Schumm et al., 2006). HIF 
signalling, on the other hand, has been shown to drive expression of vascular endothelial 
growth factor (VEGF), leading to enhanced cell proliferation (Carmeliet et al., 1998; 
Semenza, 1996). Endothelial turnover is thought to play a crucial role in the development 
of atherosclerosis through elevation of proliferation at sites of low shear stress, where 
lesions develop (Akimoto et al., 2000; Choy et al., 2001; Davies et al., 1986). In order to 
determine whether Cezanne may be affecting either of these pathways in vivo, wild-type 
and Otud7b–/– mice were culled and aortic arches stained for the proliferation marker 
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Figure 4.7: Cezanne gene trap mutant mice do not have altered VCAM-1 expression in
response to LPS challenge. Ten week old Otud7b−/− or C57BL/6 mice were weighed and
administered an intraperitoneal injection of bacterial lipopolysaccharide at a dose of 4
mg/kg to induce systemic inflammation. The animals were monitored for six hours
before being culled. The vasculature of each animal was fixed by perfusion with 4%
formaldehyde and then aortic arches dissected and opened longitudinally. This tissue
was then stained with antibodies targeting VCAM-1, as well as PECAM-1 to label
endothelial junctions and TO-PRO-3 iodide as a nuclear counterstain. Aortic arches were
then mounted en face on cover slips and imaging carried out using confocal microscopy.
Quantification of VCAM-1 fluorescence was performed using ImageJ software, measuring
the fluorescent signal at junctions.
n=4; p<0.05, Two-way ANOVA with Tukey’s post test analysis.
C57BL/6 Otud7b-/-
0
500
1000
1500
M
ea
n 
flu
or
es
ce
nc
e 
in
te
ns
ity
inner curvature
outer curvature* *
n.s.
62 
 
 
Ki-67 by en face staining (Figure 4.8). Ki-67 localisation was found to be strongly 
nuclear, and the cells expressing this staining were counted as positive. All other nuclei 
labelled with TO-PRO-3 iodide were counted as negative. Analysis of the images by 
counting the percentage of positive nuclei showed that there were significantly more 
proliferating cells in the inner curvature in comparison to the outer curvature of the 
aortic arch. However, no difference in proliferation was detected between wild-type and 
Otud7b–/– samples. This lack of effect on proliferation suggests that non-canonical NF-
κB and HIF signalling are unlikely to be regulated by Cezanne in this context. 
4.10 Cezanne does not regulate the development of atherosclerotic lesions. 
The development of atherosclerosis in ECs exposed to low shear stress is a multifactorial 
process, and the outcome of a complex network of biochemical signalling (Hopkins, 
2013). To investigate whether Cezanne is responsible for the regulation of lesion 
development, an in vivo model of atherosclerosis was employed. A commonly used 
model is that of Ldlr–/– mice, these animals lack the low-density lipoprotein receptor 
which is normally responsible for uptake of LDL from the bloodstream into the liver. As 
a consequence, when these animals are fed a diet high in cholesterol, plasma cholesterol 
levels are enhanced due to lack of clearance and they develop atherosclerotic lesions in 
the major arteries (Ishibashi et al., 1994). To test the function of Cezanne in the 
development of atherosclerosis, Otud7b–/– mice were bred with Ldlr–/– mice to generate 
a double mutant Otud7b–/–Ldlr–/– strain. These mice were fed a high-fat Western diet 
and the size of atherosclerotic plaques measured compared to Ldlr–/– controls by staining 
for lipids with Oil Red O (Figure 4.9). The mean lesion area in Ldlr–/– animals was found 
to be approximately 0.55 mm2, or 1.9% of the total aortic area. Lesions were found to be 
localised predominantly to the inner curvature of the aortic arch, and at the major 
branches from the aorta. Some smaller regions of lipid were also detected in the 
descending aorta, likely localised to the intercostal artery branches, corresponding to 
haemodynamic changes. Analysis of Otud7b–/–Ldlr–/– animals showed no significant 
difference in either lesion size or percentage coverage of the lesions within the aorta. 
These data indicate that Cezanne does not regulate the development of atherosclerosis 
at sites of low shear stress. 
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Figure 4.8: Cezanne gene trap mutant mice do not have altered endothelial
proliferation. Ten week old Otud7b−/− or C57BL/6 mice were culled by pentobarbitone
overdose. The vasculature of each animal was fixed by perfusion with 4% formaldehyde
and then aortic arches dissected and opened longitudinally. This tissue was then stained
with antibodies targeting the proliferation marker Ki-67, as well as PECAM-1 to label
endothelial junctions and TO-PRO-3 iodide as a nuclear counterstain. Aortic arches were
then mounted en face on cover slips and imaging carried out using confocal microscopy.
Quantification of Ki-67 was performed using ImageJ software, counting positive nuclei
labelled with Ki-67 and total nuclei labelled with TO-PRO-3 iodide to calculate the
percentage of positive cells.
n=4; p<0.05, Two-way ANOVA with Tukey’s post test analysis.
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Figure 4.9: Cezanne gene trap mutant mice do not display altered atherosclerotic lesion
size. Eight week old female Ldlr−/− and Otud7b−/−Ldlr−/− mice were fed a Western diet for
six weeks in order to allow development of atherosclerotic lesions. Following the diet,
mice were sacrificed and perfusion fixed with 4% formaldehyde. The aortas were then
dissected and cleaned, ensuring the removal of any external fat. Each aorta was then
fixed for a further 24 hours before being stained with Oil Red O to identify lipids.
Following staining, each aorta was cut longitudinally and pinned en face in paraffin wax
for imaging, using a digital camera attached to a dissection microscope. The percentage
of lesion coverage was quantified by measuring the area of lesion coverage and the total
aortic area with ImageJ.
n=9; unpaired t-test.
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4.11 Conclusions 
Cezanne activity is responsible for inhibiting RelA phosphorylation specifically in ECs 
under low, but not high shear stress in vitro. This modification does not appear to affect 
expression of canonical NF-κB target genes, as no difference in expression was detected 
between silenced or control samples, with or without TNFα stimulation. The expression 
of the non-canonical NF-κB subunit p100/p52 and HIF-1α were both elevated under low 
shear stress, however depletion of Cezanne had no effect on processing of p100 to p52 or 
stability of HIF-1α. Further studies in vivo confirmed these observations. No difference 
in the canonical NF-κB target gene VCAM-1 was seen between wild-type and Otud7b–/– 
mice, indicating that NF-κB activity was unchanged. In addition, analysis of endothelial 
proliferation by Ki-67 immunofluorescence staining revealed similar levels of 
proliferation between both groups, suggesting that non-canonical NF-κB and HIF 
signalling were not affected by loss of Cezanne. Furthermore, a comparison between 
Otud7b–/–Ldlr–/– and Ldlr–/– mice fed a Western diet for six weeks revealed no difference 
between the two groups in atherosclerotic lesion size as determined by Oil Red O 
staining, indicating that pathways regulating the development of atherosclerosis were 
not affected by loss of Cezanne. Thus, although Cezanne regulated RelA phosphorylation 
in ECs exposed to low shear stress, the physiological significance of this is uncertain.  
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4.12 Discussion 
Several studies to date have been primarily concerned with identifying the function of 
Cezanne in regulating downstream cellular events. However, these studies have involved 
a variety of techniques, cell types and signalling pathways, summarised in Table 4.1, 
which complicates the interpretation of the findings as a whole. The experiments in the 
previous chapter have shown Cezanne expression to be significantly elevated in ECs 
exposed to low shear stress in comparison to high shear stress. In addition, NF-κB and 
hypoxic signalling pathways are known to be important in the regulation of 
cardiovascular health and the development of atherosclerosis (Gao et al., 2012; Van der 
Heiden et al., 2010). Therefore, the aim of this chapter was to investigate whether NF-
κB or HIF-1α was regulated by Cezanne in ECs exposed to low shear stress. 
4.12.1 Cezanne function in canonical NF-κB signalling 
The most striking difference observed in Cezanne depleted cells was the effect on the 
canonical NF-κB pathway. In ECs exposed to shear stress in vitro, loss of Cezanne by 
siRNA was sufficient to significantly induce phosphorylation of the NF-κB subunit RelA 
at the serine 536 residue specifically in cells exposed to low shear stress, while cells under 
high shear stress did not show any effect of knockdown on this pathway. However, given 
the lack of a significant difference in phosphorylated RelA between cells exposed to high 
and low shear stress (where Cezanne expression is also significantly different) this 
conclusion is not certain. It is plausible that the effects of Cezanne depletion on 
phosphorylated RelA under low shear stress are more pronounced than in high shear 
stress. Further experiments utilising a Cezanne knockout mouse model are justified in 
order to understand whether Cezanne plays a significant role in limiting RelA 
phosphorylation in vivo. 
Intriguingly, further experiments which tested mRNA expression of a variety of RelA 
target genes with divergent functions did not detect any alteration in gene expression in 
cells which were exposed to the same conditions or following additional exposure to the 
NF-κB stimulating cytokine TNFα. These data suggest that Cezanne is capable of 
negatively regulating activity of the canonical NF-κB pathway through inhibition of RelA 
phosphorylation, but this does not result in an alteration in gene expression resulting 
from the pathway.  
Previous research has identified an induction of inflammatory gene expression upon 
Cezanne depletion in ECs. Stimulation with TNFα following transfection with Cezanne 
siRNA showed an increase in IL-8 expression compared to scrambled control siRNA 
(Enesa et al., 2008a). Additionally, silencing of Cezanne was sufficient to enhance 
expression of VCAM-1, ICAM-1 and E-selectin in ECs exposed to a period of hypoxia 
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followed by reoxygenation – a stimulus which can activate NF-κB (Natarajan et al., 
2002). Notably, increased phosphorylation of RelA at serine 536 was also detected in 
these experiments (Luong et al., 2013). Importantly, however, in each of these studies 
Cezanne function was observed in activated cells, where its expression was elevated in 
comparison to unstimulated controls. There was no reported effect on inflammatory 
gene expression in the absence of TNFα or hypoxia and reoxygenation. In the 
experiments presented in this chapter, Cezanne expression under flow may be lower than 
in the other studies with stimulated cells. This could mean that Cezanne expression 
under shear is insufficient to provide an inhibitory effect on NF-κB target genes. A 
comparison of Cezanne expression between the conditions studied here and in previous 
research may shed light on the discrepancy in Cezanne function seen between the 
studies. 
Additionally, low shear stress activates NF-κB via a different mechanism compared to 
TNFR and this may not be responsive to Cezanne activity. Indeed, there is some evidence 
to suggest that Ras-GTPase signalling can induce NF-κB nuclear localisation 
independent of IκBα degradation in ECs exposed to shear stress (Ganguli et al., 2005). 
As the reported function of Cezanne in the canonical NF-κB pathway is to deubiquitinate 
RIP1 or TRAF6 linked polyubiquitin chains in TNFR mediated signalling, Cezanne may 
not be capable of inhibiting NF-κB signalling resulting from changes in shear stress, and 
explain why silencing of its expression did not have any effect in this context. Further 
experiments could focus on using different stimuli which may be more similar to an 
atherogenic environment, for example a lower dose of TNFα may be sensitive to Cezanne 
inhibition in ECs exposed to shear stress. Alternatively, other inflammatory molecules 
found in atherosclerotic plaques could be used, such as IL-1 or ox-LDL. Utilisation of a 
less overwhelming stimulating factor may reveal more subtle regulation of the NF-κB 
pathway by Cezanne, while also being relevant to atherosclerosis. 
4.12.2 Does RelA phosphorylation influence transcriptional activity? 
An important question is what is the significance of limiting RelA phosphorylation at 
serine 536 if Cezanne does not regulate the expression of NF-κB target genes. 
Phosphorylation at this residue is controlled by several upstream kinases, including 
IKKα (Sakurai et al., 2003), IKKβ (Jeong et al., 2005) and ribosomal S6 kinase 1 (RSK1) 
(Bohuslav et al., 2004). Several studies have investigated the function of serine 536 
phosphorylation on RelA and NF-κB activity, however there is some disagreement within 
the literature as to its role. Depending on the method used to modify phosphorylation of 
this residue and in which cell type, there are very different conclusions. In general, two 
broad theories for the function of this phosphorylation have been suggested. The first is 
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that it alters the kinetics of nuclear NF-κB; serine 536 phosphorylation in the Saos-2 
osteosarcoma cell line has been shown to reduce the affinity of the RelA protein for IκB, 
thereby allowing nuclear import independent of classical IκB degradation (Bohuslav et 
al., 2004). In addition, a study published in Nature in 2005 utilised overexpression of a 
mutated version of RelA with serine 536 replaced with an alanine residue to block 
phosphorylation at this site, finding that this greatly reduced LPS induced turnover of 
the protein in human macrophages, maintaining nuclear RelA expression and DNA 
binding activity at later time points (Lawrence et al., 2005). 
The second theory is that the serine 536 phosphorylation event is responsible for altering 
the target gene specificity of the RelA protein. For example, transcription of ICAM-1, but 
not IL-8, was blocked by a phosphomimetic RelA via a mechanism involving altered 
heterodimer association and thus promoter specificity (Sasaki et al., 2005). Further 
research using a competitive peptide for IKKα in vivo to limit serine 536 phosphorylation 
in mouse livers once again found that the modification only affected transcriptional 
activation of certain genes, for instance TNFα and IL-1β but not MCP-1 (Moles et al., 
2013). Taken together, these studies suggest that phosphorylation of RelA at serine 536 
may result in an alteration of the consensus sequence for RelA potentially via a shift to 
homodimerisation. 
Either of these mechanisms may explain why Cezanne was found to alter 
phosphorylation of RelA, but have no discernible effect on NF-κB target genes. Due to 
the design of the experiments presented in this chapter, the expression of the target genes 
was only analysed at a single time point. If phosphorylation alters RelA nuclear 
translocation kinetics, it is conceivable that Cezanne controls nuclear entry or 
transcriptional activity of RelA at different time points, which were not studied. 
Moreover, the genes that were tested following Cezanne silencing were only a subset of 
all the genes known to be regulated by NF-κB signalling, and did not include certain 
genes which have been found to be altered by phosphorylation, including TNFα and IL-
1β. If RelA phosphorylation in this context resulted in an alteration of gene specificity, 
perhaps the genes that are regulated were not studied. A broader approach such as RNA 
sequencing, chromatin immunoprecipitation (ChIP)-sequencing or microarray analysis 
may reveal unstudied genes which are specifically targeted by serine 536 phosphorylated 
RelA and thus Cezanne. 
4.12.3 Cezanne function in non-canonical NF-κB signalling 
Processing of p100 to p52 in the non-canonical NF-κB pathway was also investigated 
following depletion of Cezanne in ECs exposed to shear stress. Non-canonical NF-κB 
signalling is not well studied in the context of atherosclerosis (see Chapter 5), however 
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the role of the pathway in regulating proliferation (Ishikawa et al., 1997; Schumm et al., 
2006) and apoptosis (Burkitt et al., 2015; Saxon et al., 2016) is of interest as these 
pathways are known to be dysregulated in ECs at sites of atherosclerosis (Akimoto et al., 
2000; Choy et al., 2001). Western blot analysis revealed that although both p100 and 
p52 expression was elevated under low shear stress, there was no difference in processing 
in cells transfected with Cezanne siRNA compared to controls, both with and without 
stimulation of the pathway. 
The function of Cezanne reported by Hu et al. is to inhibit p100 processing to p52 through 
inhibition of TRAF3 degradation by removal of lysine-48 linked polyubiquitin chains. 
However, there are several important differences in methodology which may explain the 
discrepancy in the results. The first major difference is in the cell types chosen to study; 
the published work utilised primary B cells and embryonic fibroblasts isolated from both 
wild-type and Otud7b–/– mice. B cells in particular have very high levels of non-canonical 
NF-κB gene expression (biogps.org), and the pathway is intimately linked to the 
development and maturation of this cell type (Cildir et al., 2016). In ECs, while 
appreciable expression of p100 and p52 were detected, levels of these and other 
molecules in the pathway are lower than in B cells. Thus, it is possible that TRAF3 
stability is being reduced as a result of Cezanne silencing but levels of NIK are insufficient 
to increase in processing to p52. Analysis of these molecules may allow a greater 
understanding of Cezanne function in this context. In addition, the most striking 
differences seen in the work by Hu et al. are in the nuclear expression of p52 and RelB in 
Otud7b–/– cells, perhaps Cezanne regulates p52 nuclear localisation, an event that was 
not studied during this PhD. Alternatively, it could be a cell-type specific effect; Cezanne 
function in B cells and MEFs could differ from that in ECs, or exposure to shear stress 
could alter the function of either Cezanne or non-canonical NF-κB pathway components. 
Another important distinction between the two studies is the difference between using 
primary cells from knockout mice in comparison to siRNA mediated knockdown. While 
the efficiency of knockdown was very good, there was still a proportion of residual 
Cezanne expression which may have been sufficient to still carry out its function. 
4.12.4 Cezanne function in HIF signalling 
The final in vitro experiments to investigate Cezanne function involved testing the 
expression of HIF-1α. Cezanne has been shown to stabilise both HIF-1α (Bremm et al., 
2014) and HIF-2α (Moniz et al., 2015) levels via direct and indirect mechanisms 
respectively. As endothelial HIF-1α has been shown to be upregulated in low shear stress 
and promote the development of atherosclerosis (Akhtar et al., 2015), determining 
whether Cezanne was involved in its expression was of great interest. Upon analysis, 
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HIF-1α expression was elevated in ECs exposed to low shear stress both in the presence 
and absence of DMOG, however levels were not found to differ significantly between 
Cezanne knockdown and control samples. 
There are some key points which may explain the lack of functional effect in comparison 
to the observations of Bremm et. al. Firstly, the authors suggest a mechanism whereby 
Cezanne removes lysine-11 linked polyubiquitin from HIF-1α, resulting in the inhibition 
of a non-proteasomal degradation pathway. A role for chaperone mediated autophagy 
was suggested but not studied in depth. It is feasible that the mechanism by which 
Cezanne regulates HIF-1α stability is cell-type specific. Indeed, in contrast to the HeLa 
and MEF cell lines which displayed a decrease of HIF-1α following Cezanne silencing, 
two renal cell carcinoma cell lines did not show an effect. Analysis of the ubiquitination 
state of HIF-1α in ECs exposed to shear stress may explain why Cezanne did not alter 
HIF-1α stability in this cell type. Secondly, HIF-1α expression in ECs has previously been 
shown to be regulated in an oxygen-independent fashion, enhanced in cells overlying 
atherosclerotic lesions, in partially ligated carotid arteries (Akhtar et al., 2015) and as a 
result of NF-κB activity (Tirziu et al., 2012). Our data shows that HIF-1α is expressed 
more highly in ECs exposed to low shear stress in normoxic conditions, indicating a novel 
mechanism of HIF-1α induction. It is feasible that Cezanne regulates HIF-1α specifically 
in hypoxia and not in the context of low shear stress under normoxia. 
A potential pathway which was not investigated here was the role that Cezanne may play 
in regulation of HIF-2α. Cezanne promotes HIF-2α expression via binding to and 
stabilising the transcription factor E2F1, which targets HIF-2α (Moniz et al., 2015). 
Interestingly, this effect was observed in the 786-O renal cell line which lacks VHL and 
so expresses HIF-2α in normoxia, indicating that the mechanism is not dependent on 
hypoxia. It would be interesting to test the expression of HIF-2α and E2F1 in ECs 
exposed to low shear stress with depletion of Cezanne expression to see whether in this 
context their expression levels are reduced. 
4.12.5 Cezanne function in vivo 
The experiments carried out using the Cezanne gene trap mutation on either normal 
C57BL/6 or atheroprone Ldlr–/– backgrounds aimed to investigate the same pathways as 
the in vitro experiments, however technical limitations resulting from analysis of ECs 
from a small area within the aortic arch meant that analyses were limited to 
quantification of expression by en face staining. Firstly, VCAM-1 expression was used as 
a surrogate for NF-κB activity. Following LPS challenge, there was no difference in levels 
of the adhesion molecule between wild-type or knockout samples, mimicking the 
observations in vitro. Similar to exposure to TNFα in cell culture, it is possible that the 
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LPS challenge was a harsh inflammatory stimulus and therefore any increase in 
inflammatory activity generated from loss of Cezanne would be masked. Expression of 
VCAM-1 in unstimulated aortas was not studied as pilot experiments revealed that 
VCAM-1 was not detected by en face staining without the addition of LPS. 
Assessment of proliferation was undertaken as both HIF and non-canonical NF-κB 
signalling have been linked to regulation of the cell cycle. Staining of the proliferative 
protein Ki-67 showed that while there was significantly more proliferation in cells from 
the inner curvature of the aortic arch compared the outer curvature, no difference in 
proliferation was seen between the wild-type and knockout mice. A limitation in using 
Ki-67 is its expression across the cell cycle; maximal activation of the Ki-67 promoter 
occurs in G2 and M phase (Zambon, 2011). Quantification relying on Ki-67 excludes 
actively proliferating cells in G1 phase which may potentially be regulated by Cezanne. 
Furthermore, if Cezanne does affect the cell cycle in these mice, it may cause an alteration 
in checkpoint progression and thus accurate measurement of each phase of the cell cycle 
may reveal more information about any changes. 
The final in vivo experiment utilised a cross of the atheroprone Ldlr–/– line with the 
Otud7b–/– line to generate double knockout Otud7b–/–Ldlr–/– mice. Mice on this 
background develop atherosclerotic lesions when fed a Western diet. Analysis of lesion 
size between Otud7b–/–Ldlr–/– and Ldlr–/– mice following six weeks of atherogenic diet 
revealed that there was no significant difference between the two groups. Given that 
Otud7b–/– mice had no discernible difference in inflammation or proliferation at the 
atheroprone inner curvature of the aortic arch, it stands to reason that there would also 
be no effect on lesion development, however there are some limitations in the study 
which mean that a role for Cezanne in regulating atherosclerosis cannot be ruled out. 
Firstly, lesion size was assessed after only six weeks of Western diet. However, lesions in 
Ldlr–/– animals fed this diet continue to grow for at least twelve months (Ma et al., 2012) 
and so potentially at a later time point some effect of Cezanne deletion would be seen. 
Lesion size is not the sole factor in determining the severity of atherosclerosis; in human 
disease, a major cause of mortality associated with atherosclerosis is the occurrence of 
myocardial infarction or stroke as a result of plaque rupture. Several factors regarding 
the composition of a plaque – including collagen content, macrophage and smooth 
muscle infiltration, lipid core size and calcification – have been shown to be predictors 
of cardiovascular events (Hellings et al., 2010). Many of these features become present 
at later stages in plaque progression, and determining whether Cezanne plays a role in 
these events is necessary to fully understand its role in the pathogenicity of 
atherosclerosis. 
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Linking this work to previous in vivo studies of Cezanne function is complicated both by 
the scarcity of data and the pathways investigated. Three published papers have 
investigated the functional consequence of Cezanne mutation, but none have looked at 
the regulation of atherogenic signalling in ECs from low shear stress atheroprone sites. 
Luong et al. (2013) identified a role for Cezanne in inhibiting renal inflammation and 
injury in response to ischaemia reperfusion. The in vivo part of the work used whole 
kidney lysates to investigate expression of VCAM-1 and E-selectin in both wild-type and 
mutant mice. While expression of both adhesion molecules was elevated in Cezanne 
mutant mice following ischaemia/reperfusion injury, interestingly the expression in 
uninjured kidneys was unaffected. This may have also been the case in the experiments 
presented here; perhaps with an appropriate stimulus a function of Cezanne would have 
become apparent. The other two studies were both carried out in the lab of Shao-Cong 
Sun, and look at the function of Cezanne in B and T lymphocytes. In B lymphocytes 
isolated from Otud7b–/– mice, no difference in canonical NF-κB signalling was seen in 
response to TNFα, LPS or IL-1β. However, an increase in non-canonical NF-κB DNA 
binding activity as well as elevated proliferation was seen in splenic B cells from the 
Cezanne mutants when stimulated with CD40 or BAFF (Hu et al., 2013). Intriguingly, 
their later work showed that Otud7b–/– T cells had increased expression of IκBα with less 
phosphorylation in response to ligation of CD3 and CD28, indicating lower canonical 
NF-κB activity (Hu et al., 2016). The discrepancy between these two studies further lends 
weight to the idea that the function of Cezanne could be cell-type or context specific. 
Recent unpublished data has suggested that complete removal of the Otud7b gene in 
mice results in embryonic lethality; which may mean that the gene trap mutants utilised 
in this and other studies are not true representations of Cezanne loss. Perhaps a small 
amount of functional protein is sufficient for activity, generated via a cryptic splice site 
or other mechanism. To combat this, future experiments using these animals could use 
tissue specific or inducible knockouts to reduce lethality. Tissue specificity could also 
help to dissect the function of Cezanne in the endothelium further. It is possible that loss 
of Cezanne in other cell types involved in atherosclerosis (monocytes, macrophages, 
VSMCs) may mask any EC specific effects. Using either bone marrow transplants to 
ensure leukocyte genotype does not affect vascular cells, or a EC specific knockout model 
may help clarify these factors. 
There are several other explanations for the lack of downstream functional effect seen 
with depletion of Cezanne in vitro or in vivo. For example, other genes or proteins may 
be able to compensate for the loss of Cezanne. Several other deubiquitinases are known 
to be involved in the negative regulation of NF-κB, notably A20 (Wertz et al., 2004) and 
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CYLD (Trompouki et al., 2003). Perhaps these or other NF-κB inhibitors become more 
active following Cezanne depletion and result in no net change in NF-κB activity. In 
addition, Cezanne-2 (OTUD7A) may play a role in compensating for loss of Cezanne. 
Cezanne-2 is another ovarian tumour domain deubiquitinase with close sequence 
similarity to Cezanne in the OTU domain. It has been shown to also interact with TRAF6 
and inhibit ICAM-1 expression (Xu et al., 2014). Further research is required to identify 
if these other genes are compensating for loss of Cezanne, as the prospect of a family of 
genes coordinating to inhibit NF-κB signalling would provide great mechanistic insight 
into the function of the pathway. 
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4.12.6 Summary 
In summary, the primary function of Cezanne which was identified in these experiments 
appeared to be in the negative regulation of RelA phosphorylation at the serine 536 
residue. This modification has been previously identified as controlling NF-κB activity, 
but the exact mechanism is still unclear. Surprisingly, in these experiments, additional 
phosphorylation of RelA in Cezanne knockdown samples did not appear to affect mRNA 
expression of several NF-κB target genes tested, which may reflect the complexity of NF-
κB regulation. Further research should employ a broader approach, utilising microarray 
or RNA sequencing technology to elucidate if specific target genes are being regulated by 
a change in DNA binding specificity of the NF-κB complex. 
Two other molecular events were also measured in vitro; processing of p100 to p52 in 
the non-canonical NF-κB pathway and stability of HIF-1α. Each of these events have 
been previously reported to be regulated by Cezanne, but not in ECs. Neither were found 
to be affected by Cezanne silencing in the context of ECs exposed to shear stress. This 
may have been due to cell-type specific differences in Cezanne function. 
The in vivo experiments utilising Cezanne gene-trap mutant mice gave similar results to 
the in vitro experiments. Published work has identified Cezanne’s function in vivo as 
regulating canonical and non-canonical NF-κB signalling. However, no difference in 
these pathways were detected in ECs. The size of atherosclerotic lesions was also not 
significantly altered by the absence of Cezanne in these animals, although the 
composition of plaques was not analysed. It is plausible that Cezanne deletion led to 
activation of compensatory mechanisms, for example induction of other OTU 
deubiquitinases. 
Cellular signalling events tend to form complex networks with multiple levels of 
regulation. Cezanne was not responsible for regulating canonical NF-κB gene expression, 
p100 processing or HIF signalling in the experiments carried out as part of this PhD. 
However, a role in regulating RelA phosphorylation under shear stress was discovered 
and further research is required to discover the importance of this modification in the 
vascular endothelium. 
 	
73 
 
 
5. Non-canonical NF-κB drives EC proliferation under 
low shear stress 
5.1 Introduction 
The NF-κB pathway is a key regulator of cellular inflammation, and plays a critical role 
in the progression of many inflammatory diseases, including atherosclerosis. NF-κB 
signalling can be broadly split into two pathways, defined by the subunit combinations 
and upstream signalling pathways leading to nuclear localisation. The canonical NF-κB 
pathway has been predominantly studied in vascular disease, finding that RelA (Gareus 
et al., 2008) and c-Rel (Djuric et al., 2012) subunits promote the development of 
atherosclerotic lesions. In contrast, very little is known about the role that the non-
canonical NF-κB pathway may play in controlling atherosclerosis. 
Non-canonical NF-κB signalling results in the processing of the precursor p100 subunit 
to p52 and subsequent nuclear localisation of the p52:RelB heterodimer. While there is 
some degree of cross-talk between canonical and non-canonical NF-κB (Oeckinghaus et 
al., 2011), activation of p100 processing is primarily potentiated by a distinct pathway 
involving post-translational control of NIK. This kinase is constitutively expressed, and 
is responsible for phosphorylating p100 via IKKα, allowing processing. Prior to 
stimulation, NIK is marked for proteasomal degradation by the addition of ubiquitin by 
TRAF3 (Skaug et al., 2009). Activation of the pathway by ligation of members of the 
TNFR superfamily, in particular CD40, LTβR and BAFFR, results in TRAF3 recruitment 
to the cell-surface receptor and its subsequent degradation (Vallabhapurapu et al., 
2008), thus allowing NIK accumulation and p52 generation. 
The non-canonical NF-κB pathway has primarily been studied in B cells, where it plays 
a major role in regulating development and maturation (Claudio et al., 2002; Hahn et 
al., 2016; Jellusova et al., 2013). In B cell cancers, such as diffuse large B cell lymphoma 
and some types of leukaemia, non-canonical NF-κB signalling can be oncogenic (De 
Donatis et al., 2015; Park et al., 2006; Vallabhapurapu et al., 2015). 
There is some evidence to suggest that this pathway may be important in atherosclerosis 
too. Firstly, expression of NFKB2 (the gene encoding p100) was identified as being 
upregulated at the inner curvature of the porcine aortic arch in a microarray study 
(Passerini et al., 2004), and phosphorylated RelB was found to be increased at the same 
site in mice (Jhaveri et al., 2012). In addition, TRAF3 has been found to be elevated in 
ECs following exposure to high shear stress, and in vivo overlying areas of plaques 
corresponding to higher shear stress (Urbich et al., 2001). Lastly, CD40 signalling has 
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been shown to be increased at sites prone to atherosclerosis. ApoE mutant mice also 
lacking the CD40 gene were found to have significantly less lesion coverage, with a 
decreased macrophage content and increased collagenisation (Lutgens et al., 1999). 
Furthermore, delivery of CD40L-containing microparticles to ECs stimulated 
proliferation in vitro and neovessel formation in vivo (Leroyer et al., 2008). 
The expression of canonical NF-κB subunits are increased at sites of atherosclerosis, as 
a result of the haemodynamic conditions, however whether non-canonical NF-κB activity 
is regulated by shear stress has not been tested. Increased endothelial turnover has been 
associated with areas of atherosclerosis and exposure to low shear stress (Chaudhury et 
al., 2010; Dardik et al., 2005; Davies et al., 1986). As non-canonical NF-κB signalling can 
control endothelial proliferation in lymphatic vessels (Vondenhoff et al., 2009) it may 
function to carry out this role in ECs and therefore play a critical role in regulating the 
development of disease. 
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5.2 Hypothesis and aims 
Hypothesis: The expression and activity of the non-canonical NF-κB pathway in ECs is 
regulated by shear stress and responsible for modulating endothelial phenotype at sites 
prone to atherosclerosis.  
Aim 1: Determine the expression pattern and activity of non-canonical NF-κB pathway 
components in ECs exposed to shear stress. 
Aim 2: Determine the function of this pathway in ECs exposed to shear stress. 
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5.3 Non-canonical NF-κB subunits are expressed at the inner curvature 
of the porcine aortic arch 
The expression of NFKB2 – the gene encoding the p100 subunit of NF-κB – has been 
highlighted in a microarray study as a gene potentially induced in ECs at the atheroprone 
region of the porcine aortic arch (Passerini et al., 2004), while phosphorylated RelB was 
found at the same region in mice (Jhaveri et al., 2012). To validate the expression 
changes of p100 and its binding partner RelB (RELB gene), ECs were isolated from the 
inner and outer curvatures of the porcine aortic arch and qPCR carried out for these 
genes on cDNA isolated from these regions. (Figure 5.1). Porcine aortas obtained from a 
local abattoir were cleaned and regions of the inner and outer curvatures of the aortic 
arch dissected. ECs were scraped from these sections and total RNA isolated and 
converted to cDNA by reverse transcription. Assessment of endothelial purity was 
carried out by determining the ratio of PECAM-1 to α-smooth muscle actin by qPCR 
(Figure 5.1a). The expression of NFKB2 and RELB were also measured by qPCR (Figure 
5.1b), using the expression of the housekeeper β2 microglobulin (B2M) to normalise 
cDNA quantity. The expression of both NFKB2 and RELB were found to be significantly 
increased in ECs from the inner curvature of the aortic arch compared to the outer 
curvature, with approximately a four-fold increase in expression of each gene. This 
confirms the expression change found in the previous microarray study (Passerini et al., 
2004), and also shows that RELB expression is similarly regulated. The underlying 
mechanism resulting in this expression change is not known, nor whether an alteration 
in mRNA expression causes a similar change in protein expression or non-canonical NF-
κB activity. 
5.4 Components of the non-canonical NF-κB signalling pathway are 
downregulated under high shear stress. 
The differential expression of p100 and RelB between the two sites of the porcine aortic 
arch (Figure 5.1) may be due to the shear stress patterns exerted on ECs. To investigate 
whether shear stress can affect the expression of non-canonical NF-κB subunits, human 
ECs were exposed to different shear stress patterns in vitro using both the ibidi® and 
orbital shaker systems. HUVECs were exposed to shear stress for 72 hours using these 
systems before lysis and protein isolation. The expression of p100/p52 and RelB were 
determined using Western blotting, using the housekeeper PDHX for normalisation. The 
expression of p100, p52 and RelB were found to be significantly reduced by high shear 
stress in the orbital shaker system, compared to cells under low shear stress (Figure 5.2); 
the expression levels of cells under either condition was not significantly different to 
static cells. The expression of these proteins was also found to be significantly lower in 
Figure 5.1: The expression of NFKB2 and RELBmRNA was elevated in ECs from the inner
curvature of the porcine aortic arch. Porcine aortas were obtained from a local abattoir.
The aortas were then dissected and cleaned, before a scalpel was used to isolate a 1 cm2
section from both low and high shear stress sites as previously determined by
computational fluid dynamics. These sections were incubated endothelial side down in
collagenase to free ECs, which were then scraped into PBS and pelleted. RNA was then
isolated from these cell pellets using a commercial kit. The RNA was then converted to
cDNA by reverse transcription and gene expression tested by qPCR. (a) The expression of
the EC marker PECAM-1 and the VSMC marker α smooth muscle actin (SMA) were
determined in samples from each condition, normalised to the housekeeping gene β-2
microglobulin (B2M) to ensure EC purity. Samples with a ratio lower than 3:1 PECAM-1 to
α-SMA were rejected. (b) The expression of non-canonical NF-κB subunits NFKB2 and
RELB were measured in both samples, normalised to B2M.
n=4; p<0.05; paired t-test
The data from (a) were gathered by Dr. Ismael Gauci and used with permission.
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Figure 5.2: Expression of non-canonical NF-κB subunits were decreased in ECs exposed
to high shear stress. HUVECs were seeded into six-well plates and exposed to shear
stress for 72 hours using the orbital shaker system, or left static for the same period.
Cells were then scraped from the centre (low shear stress) and periphery (high shear
stress) of orbited wells, and from the entire well of static. Lysates were then generated
and expression of p100/p52 and RelB determined by Western blotting, normalising to
the housekeeper PDHX.
n=4; p<0.05; one-way ANOVA with Tukey’s post test analysis.
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cells exposed to high shear stress compared to low shear stress in the ibidi® system 
(Figure 5.3). In combination, these data confirm that shear stress alone is not sufficient 
to alter the expression of components of the non-canonical signalling pathway, but that 
low shear stress resulted in enhanced expression compared to high shear stress. 
5.5 Exposure to low shear stress results in an increase in p100 processing. 
While expression of components of the non-canonical NF-κB pathway was found to be 
decreased under high shear stress, the proportion of active p52 was relatively low. To test 
whether the change in expression resulted in an alteration in the processing of p100 to 
active p52 in response to stimulus, the non-canonical NF-κB pathway was stimulated by 
the addition of CD40L. HUVECs were seeded onto six-well plates and exposed to shear 
stress using the orbital shaker system for 72 hours. CD40L was added to samples for the 
final 2 hours of orbiting before cells were lysed and protein samples isolated from each 
condition. Levels of p100 and p52 were quantified by Western blotting, normalised to 
the housekeeper PDHX (Figure 5.4). The processing of p100 to p52 was found to be 
strongly induced by the addition of CD40L in cells exposed to low shear stress (compare 
lanes 1 and 3). Levels of p52 were significantly increased by CD40L stimulation in these 
conditions, and p100 tended to decrease. While not statistically significant, p52 
expression was also found to increase in cells exposed to high shear stress, but notably 
the level following stimulation was less than 50% of the expression in low shear stress 
(compare lanes 3 and 4). Thus, it was concluded that p100 processing to p52 in response 
to CD40L is elevated under low compared to high shear stress. 
5.6 Non-canonical NF-κB signalling promotes endothelial proliferation 
under low shear stress 
A higher level of expression and increased capacity for activation under low shear stress 
indicated that the non-canonical NF-κB pathway may play a role in regulating the 
phenotype of ECs exposed to this mechanical environment. Non-canonical NF-κB has 
been previously reported to regulate B cell and lymphoid proliferation (Sun, 2011), and 
CD40L stimulation has been shown to induce proliferation in ECs (Leroyer et al., 2008). 
In addition, EC proliferation is regulated by shear stress, with unidirectional high shear 
stress inhibiting proliferation (Akimoto et al., 2000). In order to understand the role 
non-canonical NF-κB signalling may play in controlling endothelial proliferation, small 
interfering RNA was used to deplete NFKB2 mRNA, then EC proliferation was measured 
following the application of low or high shear stress using the orbital shaker system 
(Figure 5.5). A subset of cells from each condition were collected for Western blotting to 
confirm knockdown (Figure 5.5a). The remainder of the samples were fixed in 
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Figure 5.3: Expression of non-canonical NF-κB subunits were decreased in ECs exposed
to high shear stress in the ibidi system. HUVECs were seeded into chamber slides, and
once adherent, exposed to low (±4 dyn/cm2) or high (13 dyn/cm2) shear stress for 72
hours using the ibidi® system. Cells were then lysed and the expression of p100, p52 and
RelB determined by Western blotting, normalising to the housekeeper PDHX.
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Figure 5.4: Processing of p100 in response to CD40L is increased in endothelial cells
exposed to low shear stress. HUVECs were exposed to shear stress for 72 hours using
the orbital shaker system. CD40L (100 ng/ml) was added to a proportion of the wells for
the final 2 hours of shear stress, with the remaining wells left untreated. Following
treatment, cells were scraped from both shear stress regions of each condition and lysed
separately. Protein concentration was determined using a BCA assay and samples
normalised accordingly. The expression of p100 and p52 were determined by Western
blotting, normalising to the housekeeper PDHX. Densitometry was carried out using
ImageJ software. Data are presented as mean ± SD.
n=3; *p<0.05; Two-way ANOVA with Tukey’s post test analysis.
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Figure 5.5: Non-canonical NF-κB subunits promote EC proliferation under low shear
stress. HUVECs were transfected with NFKB2 siRNA or a scrambled siRNA control using
electroporation, then seeded onto six-well plates. Following adherence, cells were
exposed to shear stress for 72 hours using the orbital shaker system. (a) After exposure
to shear stress, cells were scraped from the centre (low shear stress) and periphery (high
shear stress) of each well and lysed. Expression of p100/p52 was determined to confirm
knockdown, as well as the proliferation marker Ki-67. The housekeeper PDHX was used
for normalisation. (b) Following exposure to shear stress, cells were washed with PBS,
fixed with 4% formaldehyde, permeabilised using 0.1% Triton-X100 and blocked with 5%
BSA. Samples were stained for the proliferation marker PCNA and the nuclear stain DAPI.
n=3; *p<0.05; (a) paired t test, carried out on raw data; (b) Two-way ANOVA.
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formaldehyde for further immunofluorescence staining for proliferating cell nuclear 
antigen (PCNA) (Figure 5.5b). As previously reported, EC proliferation was significantly 
elevated in cells under low shear stress (Figure 5.5b, compare 1 and 2)). Knockdown of 
NFKB2 resulted in a significant decrease in proliferating cells from the low shear stress 
site (compare 1 and 3), but had no effect on cells under high shear stress (compare 2 and 
4). 
5.7 Nfkb2–/– mice display reduced endothelial proliferation at the inner 
curvature of the aortic arch 
To determine whether the effect on endothelial proliferation seen with knockdown of 
non-canonical NF-κB in vitro was an accurate assessment of the role of this pathway in 
vivo, studies were carried out using aortas from Nfkb2–/– mice. Aortic arches from 10-
week old female Nfkb2–/– mice and C57BL/6J wild-type controls were dissected and EC 
proliferation assessed by immunofluorescence staining for Ki-67 in cells from the inner 
and outer curvatures of the arch, exposed to low and high shear stress respectively 
(Figure 5.6). Imaging with confocal microscopy revealed that EC proliferation in the 
aortic arch in C57BL/6J animals was significantly higher at the inner curvature in 
comparison to the outer curvature, with almost no detectable proliferating cells in the 
latter region (Figure 5.6, compare 1 and 2). In the Nfkb2–/– animals, the percentage of 
proliferating cells as identified by Ki-67 was significantly lower than in the wild-type 
control group (compare 1 and 3), while there was no significant difference in proliferation 
at the outer curvature (compare 2 and 4). Thus, it was concluded that Nfkb2 expression 
is required for EC proliferation at low shear stress regions of arteries. 
5.8 ICAM-1 expression at the inner curvature of the aortic arch is 
unchanged between wild-type and Nfkb2–/– mice. 
Previous studies found that CD40 signalling can alter multiple cellular processes in ECs. 
In addition to its role in promoting proliferation, stimulation with CD40L also promotes 
an inflammatory response, with activation of p38, Akt and NF-κB and upregulation of 
MCP-1, ICAM-1 and other inflammatory cytokine and adhesion molecule expression 
(Chakrabarti et al., 2007; Henn et al., 1998). As the non-canonical NF-κB pathway can 
be activated by exposure to CD40L, it is possible that inflammation is also being 
promoted by its activity. To determine whether p100/p52 depletion was regulating 
inflammatory signalling in addition to proliferation in cells exposed to low shear stress, 
expression of ICAM-1 was measured by immunofluorescence staining in aortic arches 
from both wild-type and Nfkb2–/– mice in a pilot study (Figure 5.7). Analysis of 
fluorescence intensity by en face confocal microscopy showed that ICAM-1 was strongly 
Figure 5.6: Nfkb2–/– mice display less EC proliferation at the low shear stress site of the
aortic arch. Ten week old female Nfkb2–/– and matched C57BL/6J control mice were
culled by intraperitoneal injection of pentobarbitone. The vasculature was then perfusion
fixed with 4% formaldehyde and aortic arches dissected and opened longitudinally.
These tissue samples were stained for Ki-67 to mark proliferating cells, as well as PECAM-
1 as an EC marker and TO-PRO-3 to label nuclei. Sections were mounted on cover slips en
face and imaged using confocal microscopy. Proliferation was quantified using ImageJ
software to count the number of Ki-67 positive cells compared to the total number of
cells per field and expressed as a percentage.
n=7; *p<0.05; ***p; 0.005; Two-way ANOVA.
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Figure 5.7: Nfkb2–/– aortic arches do not show altered ICAM-1 expression. Ten week old
female Nfkb2–/– and matched C57BL/6J control mice were culled by intraperitoneal
injection of pentobarbitone. The vasculature was then perfusion fixed with 4%
formaldehyde and aortic arches dissected and opened longitudinally. These tissue
samples were stained for ICAM-1, as well as PECAM-1 as an EC marker and TO-PRO-3 to
label nuclei. Sections were mounted on cover slips en face and imaged using confocal
microscopy.
Images are from a single experiment.
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expressed on EC junctions at the inner curvature of the aortic arch in both wild-type and 
Nfkb2–/– animals, fitting with previous work (Iiyama et al., 1999), and indicating that 
there was an upregulation of inflammation at this site. Preliminary analysis suggests 
ICAM-1 expression was not altered, however, between the aortic arches of the wild-type 
and Nfkb2–/– mice. This observation suggests that p100/p52 does not function to 
regulate endothelial inflammation at sites of low shear stress. 
5.9 The expression of p21 is negatively regulated by p100/p52 under low 
shear stress. 
With both in vitro and in vivo results indicating that non-canonical NF-κB signalling 
plays an important role in the negative regulation of EC proliferation specifically at sites 
of low shear stress, a crucial further issue is to determine the mechanism or pathway 
involved in this regulation. Both p52 and RelB have been previously implicated in 
controlling the expression of several genes which are important in regulating cell-cycle 
progression (Burkitt et al., 2015; Ramachandiran et al., 2015; Rocha et al., 2003; 
Schumm et al., 2006), however which, if any, genes are being controlled in ECs is 
unclear.  
To assess this, NFKB2 or RELB were silenced in HUVECs by transfection with siRNA. 
The ECs were then plated onto six-well plates and exposed to shear stress using the 
orbital shaker system, before isolation of RNA. A list of putative genes which may affect 
proliferation were chosen based on their regulation by non-canonical NF-κB in the 
literature (Burkitt et al., 2015; Ramachandiran et al., 2015; Rocha et al., 2003; Schumm 
et al., 2006), in addition to several inflammatory genes which were also tested. The 
mRNA expression of these genes was tested by qPCR in samples from cells exposed to 
low shear stress and transfected with either scrambled, NFKB2 or RELB siRNA (Figure 
5.8). The results show that the expression of only one gene in the panel, p21, was affected 
by silencing of a non-canonical NF-κB subunit. The expression of p21 was found to be 
significantly elevated in cells exposed to low shear stress following silencing of NFKB2, 
and showed a trend towards elevation following RELB silencing. 
To further investigate this phenomenon, p21 protein expression was also tested by 
Western blotting in lysates from sheared HUVECs transfected with NFKB2 siRNA 
(Figure 5.9). The expression of p21 was also found to be significantly increased in cells 
transfected with NFKB2 siRNA in comparison to scrambled siRNA control samples. This 
observation further verifies the result from the qPCR and shows that p21 expression at 
both mRNA and protein level is inhibited by p52 in cells exposed to low shear stress. As 
p21 is a negative regulator of proliferation, through its inhibition of cyclin-dependent 
Figure 5.8: Silencing of NFKB2 results in enhanced p21 expression in cells exposed to
low shear stress. HUVECs were transfected with NFKB2, RELB or scrambled control siRNA
by electroporation before being seeded onto six well plates. Once adherent, cells were
exposed to shear stress for 72 hours using the orbital shaker system. Next, cells were
scraped from the centre of each well (low shear stress), RNA isolated using a commercial
kit and converted to cDNA by reverse transcription. The expression of a panel of putative
non-canonical NF-κB target genes were tested by qPCR, normalising to the housekeeping
gene HPRT.
n=3; *p<0.05; One-way ANOVA.
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Figure 5.9: Silencing of NFKB2 enhances p21 protein expression in ECs exposed to low
shear stress. Gene silencing was carried out in HUVECs by electroporation, transfecting
with either NFKB2 siRNA or non-targeting scrambled control siRNA. Transfected cells
were plated into six-well plates, allowed to adhere, then exposed to shear stress for 72
hours using the orbital shaker system. Next, cells from the low shear stress region at the
centre of each well were isolated and lysed. The expression of p21 was tested in these
samples by Western blotting, normalising to the expression of the housekeeper PDHX.
Densitometry analysis was performed using Image Studio Digits software.
n=5; p<0.05; paired t-test. Statistical analysis was carried out prior to normalisation.
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kinases this suggests that elevated expression of non-canonical NF-κB subunits in cells 
exposed to low shear stress results in an enhancement of proliferation through inhibition 
of p21 expression. This is potentially a major pathway which controls the difference in 
EC proliferation between sites of the vasculature protected from and prone to 
atherosclerosis, and may have a role in regulating atherogenesis. 
5.10 Cezanne expression in Nfkb2—/— mice 
An important experiment that was not carried out during the course of this PhD was 
testing Cezanne expression in either cells transfected with NFKB2 siRNA or in the aortas 
of Nfkb2–/– mice. An unanswered question about the upregulation of Cezanne expression 
by low shear stress is the mechanism behind it. Future work should include investigation 
that the effect of non-canonical NF-κB loss has on Cezanne. 
5.11 Conclusions 
The experiments described in this chapter provide an insight into the role of the non-
canonical branch of NF-κB signalling in regulating endothelial responses to the 
haemodynamic environment they inhabit. The expression of the non-canonical NF-κB 
subunits p100/p52 and RelB were found to be enhanced by exposure to low shear stress 
both in vitro in HUVECs exposed to shear stress in two complimentary systems, and in 
vivo in ECs isolated from the aortic arch of healthy pigs. The mechanism of expression 
change was not investigated in detail but likely involved downregulation by high shear 
stress, as static and low shear stress samples possessed similar quantities. 
The expression of these subunits was responsible for promoting EC proliferation. 
Silencing of the subunits in vitro revealed a significant decrease in Ki-67 and PCNA 
positivity specifically in ECs exposed to low shear stress. Analysis of aortic arches from 
Nfkb2–/– mice showed a similar result. There were significantly fewer Ki-67 positive cells 
at the inner curvature when compared to the same region in wild-type mice. 
A potential mechanism was identified, involving p52 inhibition of p21 expression. 
Silencing of NFKB2 resulted in a significant increase in both mRNA and protein 
expression of p21 in cells exposed to low shear stress. As a cyclin-dependent kinase 
inhibitor, p21 is responsible for stalling the cell-cycle and preventing proliferation. Its 
expression is known to be elevated in ECs exposed to high shear stress, and this 
inhibition by non-canonical NF-κB under low shear stress may be a mechanism for this 
difference, resulting in enhanced EC proliferation at atheroprone sites and potentially 
regulating the development of atherosclerosis.  
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5.12 Discussion 
NF-κB signalling is known to play an important role in the development of 
atherosclerosis. Studies have primarily focused on the canonical pathway, which is 
upregulated at sites of low shear stress and drives expression of inflammatory cytokines 
and adhesion molecules, leading to monocyte recruitment and the development of 
atherosclerosis. The data presented in this chapter demonstrate that the non-canonical 
NF-κB pathway is also important in regulating endothelial phenotype by promoting EC 
proliferation specifically at sites of low shear stress, which may be important in 
mediating the development of atherosclerosis. 
5.12.1 The expression of non-canonical NF-κB subunits were regulated by shear 
stress. 
Previous studies have suggested that the expression of the non-canonical NF-κB subunits 
p100 and RelB are enhanced at regions of atherosclerosis. Passerini et al. (2004) carried 
out a microarray on porcine ECs from different regions of the aortic arch, with the 
NFKB2 gene (p100 subunit) on the list of genes more highly expressed at the inner 
curvature of the aorta. Phosphorylated RelB has also been noted to be increased at the 
same site in mice (Jhaveri et al., 2012).  
The experiments presented in this chapter confirm these observations, and suggest that 
the presence of low shear stress at the inner curvature is responsible for the differences. 
Expression analysis of NFKB2 and RELB mRNA from ECs scraped from the inner and 
outer curvatures of the porcine aortic arch revealed a significant difference in expression 
between the two regions, with approximately four times more expression in cells from 
the inner curvature than the outer. This difference was likely caused by a decrease in 
expression at sites of high shear stress, as further in vitro studies compared expression 
in ECs exposed to low or high shear stress compared to static cells. This showed that 
there was no difference in protein expression of p100, p52 or RelB between static and 
low shear stress, but a significant decrease in high shear stress conditions. 
This expression pattern is similar to that of both NFKB1 (p105/p50) and RELA (Hajra et 
al., 2000; Passerini et al., 2004), suggesting that there could be a common mechanism 
controlling the induction of canonical and non-canonical components. RelA 
upregulation under low shear stress has been found to be controlled by the activity of 
JNK (Cuhlmann et al., 2011), and indeed there is some evidence that RelB expression is 
also affected by this pathway. Pharmacological inhibition of JNK was found to ablate 
induction of RELB transcription in response to a cytomegalovirus protein (Wang and 
Sonenshein, 2005). Thus, JNK may control expression of both canonical and non-
82 
 
 
canonical NF-κB. Another potential explanation is that expression of the non-canonical 
NF-κB subunits are regulated by canonical NF-κB transcriptional activity. The promoter 
regions of both NFKB2 and RELB contain κB binding sites (Liptay et al., 1994; Wang and 
Sonenshein, 2005), and their transcription has been found to be responsive to various 
canonical NF-κB activating factors including TNFα, LPS and IL-1β (Bren et al., 2001; de 
Wit et al., 1998). Induction of non-canonical NF-κB subunit expression via canonical NF-
κB activity would explain the localisation to sites of low shear stress while also providing 
useful information on how inflammatory signalling in ECs may be responsible for other 
phenotypic changes. 
5.12.2 CD40L mediated processing of p100 to p52 was more rapid in cells 
exposed to low shear stress 
Exposure of sheared HUVECs to CD40L was carried out to test whether p100 processing 
could occur in this context. Stimulation for 2 hours revealed a significant increase in p52 
generation in cells exposed to low shear stress. This may have been due simply to the 
elevated expression of p100 seen in these cells allowing more p52 to be generated, 
however another mechanism may have been involved. TRAF3 has been shown to be 
dampened in ECs exposed to low shear stress in previous studies (Urbich et al., 2001). It 
was found to inhibit CD40L signalling by blocking AP-1 DNA binding, but expression of 
p100 was not tested. In principle, decreased TRAF3 expression under low shear stress 
may result in a higher basal expression of NIK due to reduced proteasomal degradation 
(Figure 1.7). Upon stimulation with CD40L, as TRAF3 is degraded, enhanced NIK 
expression under low shear stress may allow these cells to begin p100 processing more 
rapidly. Antibody specificity issues prohibited the analysis of TRAF3 expression here, but 
if its expression was enhanced under high shear stress it may indicate a mechanism of 
negative regulation of non-canonical NF-κB at these sites. 
CD40 signalling has been implicated in lesion development for some time; CD40L 
knockout mice have been found to have significantly decreased lesion size (Lutgens et 
al., 1999). The function of CD40 signalling has been identified as being involved in 
inflammatory responses. CD40L activation of ECs has been shown to induce expression 
of several inflammatory genes including IL-8, E-selectin and ICAM-1 (Henn et al., 1998; 
Urbich et al., 2001). Interestingly, in the present study, ICAM-1 expression was 
unchanged at the inner curvature of Nfkb2–/– mice compared to wild-type controls, 
suggesting that non-canonical NF-κB is not involved in this process. My data offer an 
alternative mechanism since non-canonical NF-κB drives excessive EC proliferation at 
atheroprone sites. Thus, CD40L may promote atherosclerosis by activating p52-
dependent proliferation. Consistent with this, VEGF – an important regulator of EC 
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proliferation – can be induced by CD40L (Dormond et al., 2008; Leroyer et al., 2008; 
Melter et al., 2000).  
5.12.3 Non-canonical NF-κB promotes EC proliferation under low shear stress 
The application of low shear stress to ECs generates endothelial dysfunction, 
characterised by elevated inflammation, apoptosis and proliferation. The increase in 
both proliferation and apoptosis leads to higher EC turnover in cells exposed to these 
haemodynamics (Davies et al., 1986). This creates a disparity in EC turnover between 
sites prone to and protected from atherosclerosis and may be an important factor in 
regulating the development of disease. 
In this study, EC proliferation was also found to be elevated in cells exposed to low shear 
stress at the inner curvature of the aortic arch in vivo, as measured by 
immunofluorescence staining for Ki-67. Analysis of ECs exposed to shear stress in vitro 
using the orbital shaker system recapitulated this difference in proliferation, with a 
significantly higher percentage of cells from the centre of each well displaying positive 
staining for PCNA, as well as showing an increase in Ki-67 expression by Western 
blotting. Examination of Nfkb2–/– mice or HUVECs transfected with NFKB2 siRNA 
revealed a significant reduction in these markers specifically at the inner curvature of the 
aortic arch in vivo and cells exposed to low shear stress in vitro.  
In the orbital shaker system, both the percentage of positive PCNA cells and total Ki-67 
expression under low shear stress were reduced by NFKB2 silencing to the levels seen in 
cells exposed to high shear stress. This suggests that p52 may play an important role in 
regulating the switch in proliferation phenotype between cells exposed to different 
physiological shear stress patterns. Ki-67 staining in vivo was not decreased to the same 
extent in Nfkb2–/– aortic arches, which may be due to the influence of signalling from 
other cell types or stimuli present in vivo which may also alter endothelial proliferation. 
The effect of NFKB2 silencing on the two markers in vitro may provide additional 
information about the mechanism by which proliferation is being reduced. Both Ki-67 
and PCNA are expressed specifically by actively proliferating cells, but each display 
maximal expression at different stages of the cell cycle (Figure 5.10). The similar 
reduction in both PCNA and Ki-67 suggests that non-canonical NF-κB signalling acts to 
promote proliferation either independently of cell cycle regulation or at a cell cycle 
checkpoint prior to S phase entry. 
In order to investigate the mechanism by which non-canonical NF-κB could be 
enhancing proliferation, the expression of several genes was tested by qPCR in ECs 
exposed to low shear stress following silencing of either NFKB2 or RELB. These genes 
Figure 5.10: Expression of Ki-67 and PCNA proliferation markers over the cell cycle. A
schematic of the cell cycle showing the relative lengths of each phase along with the
peak expression two markers of proliferation. Ki-67 peaks during G2 and M phase, while
PCNA is increased in late G1 and S phase.
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were chosen due to their previous association with non-canonical NF-κB signalling in the 
literature (Burkitt et al., 2015; Ramachandiran et al., 2015; Rocha et al., 2003; Schumm 
et al., 2006), and do not represent an exhaustive list of proliferation genes. Nevertheless, 
these data showed a significant increase in the expression of p21, a negative regulator of 
proliferation, upon silencing of NFKB2. A second negative regulator, REDD1, trended 
towards an increase, but was not statistically significant. Western blotting for p21 in 
knockdown samples confirmed this observation, with a significant increase in p21 
protein following silencing of NFKB2. REDD1 levels were not tested due to issues with 
antibody specificity. 
While non-canonical NF-κB signalling has not been previously studied in the context of 
endothelial dysfunction, several published papers provide further evidence which 
combined lend support to the conclusion that p100/p52 can drive proliferation by 
negatively regulating p21 expression in cells exposed to low shear stress. Firstly, p21 
expression is known to be regulated by shear stress in ECs. Exposure of HUVECs to 
unidirectional high shear stress leads to a gradual increase in p21 protein expression over 
a period of hours, resulting in a suppression of proliferation (Akimoto et al., 2000). 
The anti-proliferative protein p21 is a cyclin-dependent kinase (CDK) inhibitor, 
responsible for suppressing proliferation by inhibiting several CDKs at various points in 
the cell-cycle and thus stalling checkpoint progression. In particular p21 has been shown 
to inhibit G1 to S phase progression, maintain cells in the quiescent G0 phase, and act 
alongside p53 to promote senescence (Dutto et al., 2014). This is consistent with the 
functional effect seen in vitro; loss of PCNA positivity and Ki-67 expression can be 
explained by ECs being blocked in either G0 or G1 phase, or being senescent upon p21 
induction. Enhanced EC proliferation under low shear stress coincides with a shift from 
G0/G1 to G2/M phase cells (Guo et al., 2007), supporting the idea that loss of p21 at these 
sites is causative of this change. Thus, enhanced non-canonical NF-κB signalling may be 
a key factor in dampening p21 expression under low shear stress, leading to elevated 
proliferation. 
Additionally, non-canonical NF-κB signalling has been shown to be an inducer of 
proliferation in other contexts. Knockdown of NFKB2 or MAP3K14 (NIK) resulted in 
reduced cell number and increased senescence in melanoma cells (De Donatis et al., 
2015), while silencing of RelB reduced embryonic stem cell proliferation and 
differentiation (Yang et al., 2010). Moreover, exposure of HUVECs to microparticles 
containing CD40L isolated from human carotid endarterectomy samples stimulated EC 
proliferation in a CD40-dependent manner (Leroyer et al., 2008), suggesting that non-
canonical NF-κB signalling could play a role. The role of non-canonical NF-κB subunits 
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in the regulation of p21 has also been previously studied. While in complex with HDAC1 
and p53, p52 has been shown to bind to the p21 promoter, repressing its expression 
(Schumm et al., 2006). Additionally, RELB silencing has been shown to induce p21 
protein expression in fibroblasts, though interestingly in that study, NFKB2 silencing 
had no effect on p21 protein, and neither knockdown altered mRNA expression (Iannetti 
et al., 2014).  
Studies which have investigated mechanisms of p21 regulation by shear stress have also 
found mechanisms involving the same molecules, although these run opposed by 
implicating p53 as an initiator of p21 transcription under high shear stress through 
HDAC1 or HDAC3-mediated deacetylation and activation (Zeng et al., 2003, 2006). 
Investigation of the role of HDACs in the putative non-canonical NF-κB regulation of p21 
is important to understand the pathway. The conflicting roles for these proteins may 
suggest a context dependent regulation of p21 expression depending on potential p53 
activity. Interestingly, p53 expression has also been shown to be differentially regulated 
within the aortic arch, with higher expression at the inner curvature. Levels of expression 
were found to be heterogeneous between cells exposed to shear stress in vitro but 
strongly correlated with p21 expression, lending evidence to the suggestion that they may 
act within the same pathway (Warboys et al., 2011). 
5.12.4 Implications for atherogenesis 
Non-canonical NF-κB signalling has been shown here to be an important regulator of EC 
proliferation specifically in cells exposed to low shear stress. As the development of 
atherosclerosis is also predominantly localised to regions of the vasculature exposed to 
this haemodynamic environment, speculation about the role of this pathway can be put 
forward.  
Some studies have found a correlation between altered low shear stress proliferation and 
the development of atherosclerosis, although its effect is unclear. Schober et al. (2014) 
identified a micro-RNA (miR-126-5p) responsible for repressing the anti-proliferative 
protein Dlk1 (delta-like 1 homolog), which was downregulated by low shear stress 
resulting in a net increase in proliferation at sites prone to atherosclerosis. Deletion of 
this micro-RNA in mice was found to impede EC repair in response to denudation, as 
well as lead to increased lesion size in Mir126–/–Apoe–/– double knockout animals. The 
authors conclude that EC proliferation at sites of low shear stress protects from 
atherogenesis by maintaining a pool of replicative cells which can replace dead or injured 
cells quickly. In contrast, we have observed an opposing role; analysis of endothelial 
specific Gata4 or Twist1 knockout mice revealed a loss of proliferation at the inner 
curvature of the aortic arch, and a decrease in lesion size (Mahmoud et al., 2016). This 
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suggests that proliferation at low shear stress is pathogenic, and is supported by in vitro 
data showing loss of proliferation by overexpression of p21 in ECs exposed to low shear 
stress corresponded with a significant reduction in monocyte adhesion (Obikane et al., 
2010) and that excessive proliferation increases endothelial permeability to LDL (Cancel 
and Tarbell, 2011). These studies do not directly investigate the effect of proliferation on 
the development of atherosclerosis, instead proliferation is correlated with protection or 
disease. Thus, the role of non-canonical NF-κB regulated proliferation in atherogenesis 
is as yet unclear. Further study could focus on determining whether the induction of 
proliferation conferred by non-canonical NF-κB signalling in ECs exposed to low shear 
stress results in an increase or decrease in lesion size or an alteration in plaque 
composition. 
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5.12.5 Summary 
In summary, the expression of NF-κB subunits p100, p52 and RelB, which are known to 
be involved in the non-canonical pathway of NF-κB activation, are regulated by exposure 
to different shear stress environments. Expression both in vivo and in vitro is decreased 
by exposure to high shear stress, and activity was also found to follow the same pattern. 
This may be due to the role of JNK or TRAF3 activity, although this was untested. 
Silencing of NFKB2 in HUVECs exposed to shear stress and analysis of the aortic arches 
of Nfkb2–/– mice revealed that EC proliferation was significantly reduced specifically in 
cells exposed to low shear stress. An upregulation of the antiproliferative genes p21 and 
REDD1 following silencing of NFKB2 or RELB suggests this is the mechanism for this 
reduction in proliferation, and as p21 is known to be increased at atheroprotected sites 
of the vasculature this suggests that non-canonical NF-κB signalling may play an 
important role in controlling the difference in EC proliferation between sites exposed to 
low and high shear stress. EC proliferation has been identified as being altered as a 
consequence of gene knockout in other studies which involve changes in atherosclerotic 
lesion size, thus non-canonical NF-κB signalling may be an important signalling 
mechanism which can control atherogenesis by modulating the proliferation of ECs. 
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6. General discussion 
The research carried out during this PhD has focused on the role of NF-κB signalling in 
controlling EC phenotype and gene expression in the context of atherosclerosis. I have 
investigated the contribution that biomechanical forces have on regulating both 
canonical and non-canonical NF-κB and how these pathways can regulate EC gene 
expression to alter the development of atherosclerosis. The two main projects are 
discussed here. 
6.1 Investigation into the regulation and function of Cezanne in vascular 
endothelium. 
Prior to the completion of this PhD, the function of the deubiquitinase Cezanne had not 
been studied in the context of atherosclerosis. It was known to be a negative regulator of 
both canonical (Enesa et al., 2008a; Luong et al., 2013) and non-canonical (Hu et al., 
2013) NF-κB signalling, in ECs and B cells respectively, as well as an enhancer of HIF-1α 
and HIF-2α (Bremm et al., 2014; Moniz et al., 2015). Its expression had also been found 
to be elevated by treatment with several NF-κB activating molecules, (Enesa et al., 
2008a; Hu et al., 2013), by exposure to hypoxia (Luong et al., 2013) and in ECs exposed 
to high shear stress both in vivo (Passerini et al., 2004) and in culture (Enesa et al., 
2008a). However, whether these factors were important for controlling Cezanne 
expression in vivo at sites prone to or protected from atherosclerosis was not known, nor 
was the function of Cezanne in controlling NF-κB in EC dysfunction and atherogenesis. 
This study tested the hypotheses that Cezanne expression was differentially regulated in 
ECs from regions of the vasculature with a predilection to atherosclerosis development, 
that this regulation was as a result of the differences in shear stress, cytokines or oxygen 
availability experienced by these cells, and that the function of Cezanne was to inhibit 
both branches of NF-κB signalling, thus resulting in a dampening of atherosclerotic 
lesion development at the regions in which it was expressed. 
The expression of Cezanne in ECs was determined in vivo at sites prone to and protected 
from atherosclerosis, as well as in vitro following the application of shear stress 
combined with NF-κB-activating stimuli or hypoxia. Cezanne function was probed by 
investigating NF-κB activity and target gene expression in vitro in cells depleted of 
Cezanne by gene silencing. Its role in vivo was also investigated, using Cezanne knockout 
mice to investigate adhesion molecule expression and EC phenotype, and double 
knockout mice also lacking the LDL receptor were used as a model for atherosclerosis 
development to probe Cezanne contribution to disease. 
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The main conclusions were that Cezanne expression was elevated in ECs from 
atheroprone regions of the vasculature as a result of the effects of low shear stress. 
Exposure to low shear stress in vitro enhanced Cezanne expression, but the addition of 
NF-κB-activating molecules or hypoxia did not further increase Cezanne expression 
indicating that low shear stress is the primary regulator of its elevation. Its function in 
vitro was found to be inhibition of NF-κB activity, measured by phosphorylation at serine 
536 of RelA, although interestingly this did not alter gene expression of several NF-κB 
target genes. Processing of p100 to p52, or HIF stability was also found to be unaffected. 
In Cezanne knockout mice, the expression of the NF-κB target gene VCAM-1 was also not 
changed from wild-type, and neither was EC proliferation. Analysis of lesion size in 
Otud7b–/–Ldlr–/– mice fed a high-fat diet for six weeks, revealed no difference in 
comparison to Ldlr–/– controls. Thus, it was concluded that Cezanne is not responsible 
for controlling the development of atherosclerosis. 
These conclusions point to a model (Figure 6.1) where low shear stress activates 
expression of RelA in ECs, leading to inflammation and thus atherosclerosis, but in 
addition the expression of Cezanne is also enhanced. Cezanne acts to suppress 
phosphorylation of RelA at serine 536, which does not alter the expression of adhesion 
molecules or inflammatory cytokines important in atherogenesis, but may alter other 
cellular pathways which have not been identified. 
6.2 Discovery of the role of non-canonical NF-κB in ECs exposed to shear 
stress 
While testing the role of Cezanne in regulating p100 processing to p52 in ECs exposed to 
shear stress, an interesting additional finding was that the expression of non-canonical 
NF-κB subunits p100, p52 and RelB were also strongly induced by exposure to low shear 
stress in vitro. Surprisingly, when searching the literature, the expression of NFKB2 had 
been identified as being expressed at an atheroprone site in an in vivo microarray study 
(Passerini et al., 2004), but no further research had been done to identify the regulation 
by shear stress, nor the function of this pathway in the endothelium. 
The primary focus of most non-canonical NF-κB research is in B cell development, 
lymphoid organogenesis and cancer where it can regulate cellular proliferation (Sun, 
2011), while studies in other cell types remain limited. However, activation of the 
pathway by processing of p100 to p52 is known to be under the regulation of cytokines 
such as CD40L, which are important in atherogenesis (Lutgens et al., 1999). The 
hypothesis to be tested was that non-canonical NF-κB components were elevated in 
Figure 6.1: A model for the regulation and function of Cezanne in atherosclerosis. Low
shear stress results in the induction of RelA expression, which enhances transcription of
inflammatory cytokines and adhesion molecules and drives the initiation of
atherosclerosis. Cezanne is also induced by low shear stress, and inhibits the
phosphorylation of RelA at serine 536. This phosphorylation does not alter NF-κB
activation of inflammatory genes but may have another role which has not been
discovered.
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expression by low shear stress, and this was responsible for enhancing EC proliferation 
at these sites. 
This was tested by measuring the expression of NFKB2 and RELB in vivo at sites of low 
and high shear stress, as well as in ECs exposed to shear stress in vitro. Silencing of 
NFKB2 in vitro was found to specifically reduce proliferation in ECs exposed to low shear 
stress, and this was recapitulated in vivo in the aortic arches of Nfkb2–/– mice. Analysis 
of putative non-canonical NF-κB target genes by qPCR in ECs depleted of NFKB2 or 
RELB revealed enhanced p21 expression when NFKB2 was silenced. 
p21 is a CDK inhibitor responsible for stalling the cell cycle and preventing proliferation 
(Dutto et al., 2014). Thus, these conclusions suggest a model (Figure 6.2) where 
enhanced EC proliferation at sites of low shear stress is as a result of p21 loss, mediated 
by inhibition of transcription by p52 and/or RelB. This conclusion is supported by 
previous research observing that p21 expression is enhanced under high shear stress in 
ECs (Akimoto et al., 2000; Zeng et al., 2003, 2006), by evidence that CD40 ligation can 
induce EC proliferation (Dormond et al., 2008; Melter et al., 2000) and observations 
that p52 can act to repress p21 expression in complex with HDACs and p53 (Schumm et 
al., 2006). These findings shed new light on the importance of non-canonical NF-κB 
signalling in EC dysfunction, and suggests the pathway is important in regulating the 
initiation of atherosclerosis, as aberrant proliferation has been associated with disease 
previously (Cancel and Tarbell, 2011; Mahmoud et al., 2016; Obikane et al., 2010). 
6.3 NF-κB signalling regulates many cellular functions in ECs exposed to 
shear stress. 
ECs play a critical role in regulating the initiation of atherogenesis and further lesion 
development. At regions of the vasculature prone to atherosclerosis, EC sensing of low 
magnitude oscillating shear stress leads to dysfunction of these cells. Inflammatory 
activity is enhanced, with elevated expression of secreted chemokines and cell-surface 
adhesion molecules which collaborate to attract circulating monocytes and other 
leukocytes to the vessel wall and promote their transmigration into the subendothelial 
space where they can begin to take up LDL from the bloodstream (Warboys et al., 2011). 
Furthermore, this process is enhanced by increased proliferation and apoptosis of ECs 
at sites of low shear; cells undergoing mitosis or apoptosis increase the permeability of 
the endothelial monolayer and allow further transport of leukocytes and LDL, 
exacerbating disease (Cancel and Tarbell, 2011; Weinbaum et al., 1985). 
Previous work has demonstrated that NF-κB signalling is a central regulator of many of 
these events. Upon exposure to the haemodynamics found at sites prone to 
Figure 6.2: A diagram explaining the mechanism by which non-canonical NF-κB induces
EC proliferation at sites of low shear stress. Low shear stress promotes expression of
non-canonical NF-κB subunits p100 and RelB. Processing of the inactive p100 subunit to
active p52 proceeds basally, and is enhanced by low shear stress and stimulation with
CD40L. Active p52 is capable of inhibiting the transcription of p21, by a mechanism which
may involve HDACs or p53. Lower p21 expression at low shear stress sites leads to
enhanced proliferation by removing a negative regulator of cell cycle progression. This
increased proliferation may be responsible for positively or negatively regulating the
development of atherosclerosis.
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atherosclerosis, expression of the NF-κB subunit RelA is enhanced, priming cells here 
for an inflammatory response (Cuhlmann et al., 2011; Hajra et al., 2000). Transcriptional 
targets of NF-κB in ECs include the secreted cytokines MCP-1 and IL-8, as well as 
adhesion molecules VCAM-1, ICAM-1 and E-selectin (Van der Heiden et al., 2010). 
Expression of these targets are all enhanced under low shear stress. Furthermore, there 
is evidence to suggest that NF-κB signalling can also be involved in cytoprotective activity 
by suppressing apoptosis. Transcription of antiapoptotic genes such as GADD45β is 
controlled by NF-κB signalling (Partridge et al., 2007; De Smaele et al., 2001), and 
inhibition of NF-κB has also been shown to increase apoptosis in response to vascular 
endothelial growth inhibitor (Grimaldo et al., 2009).  
The experiments presented in this thesis do not show a role for Cezanne in regulating 
these pathways, nor on atherosclerotic lesion size. However, unpublished data recently 
generated by the lab has uncovered a novel mechanism by which Cezanne can regulate 
EC proliferation via NF-κB and HIF-1α. While, silencing of Cezanne did not confer an 
effect on HIF stability (Figure 4.6), overexpression of a dominant negative mutant 
Cezanne (possessing a cysteine to serine substitution within its active site (Enesa et al., 
2008a)) in ECs resulted in a marked reduction in HIF-1α protein levels. NF-κB activity 
was found to be responsible for low shear stress induction of HIF, which consequently 
led to increased proliferation and inflammation (Feng S, Bowden N, Fragiadaki M and 
Evans PC, unpublished). It is likely that the discrepancy between the dominant negative 
Cezanne and silencing is due to residual levels of Cezanne protein following siRNA 
treatment that can still function to stabilise HIF, whereas the dominant negative Cezanne 
resulted in a complete abolition of function. This mechanism links canonical NF-κB 
signalling to EC proliferation at low shear stress sites and further underlines the 
importance of the pathway in EC dysfunction (Figure 6.3). 
These functions of NF-κB are associated with the canonical pathway, primarily involving 
the action of RelA. In this thesis, I have identified an additional role for NF-κB in the 
regulation of EC dysfunction. Upregulation of non-canonical NF-κB at sites of low shear 
stress was responsible for enhanced proliferation in these regions. This finding sheds 
light on the importance of understanding the additional role of the previously unstudied 
non-canonical pathway in the initiation of atherosclerosis. Non-canonical NF-κB has 
also been attributed to enhanced apoptosis (Burkitt et al., 2015; Saxon et al., 2016) and 
cellular senescence (De Donatis et al., 2015; Iannetti et al., 2014), which may also 
contribute to EC dysfunction, but were not tested in this study.  
Combined, both branches of NF-κB signalling influence a broad range of endothelial 
processes involved in the initiation of atherosclerosis. This thesis contributes knowledge 
Figure 6.3: A diagram explaining how canonical and non-canonical NF-κB signalling can
combine to enhance EC proliferation at sites of low shear stress. Non-canonical NF-κB
signalling can contribute to EC proliferation by downregulating the CDK inhibitor p21 at
sites of low shear. In addition, HIF-1α expression is driven by canonical NF-κB signalling at
sites of low shear stress and stabilised by Cezanne. This pathway drives proliferation by
inducing glycolysis genes.
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of the function of non-canonical NF-κB into this regulatory network, while also raising 
questions about the unknown role of Cezanne and phosphorylated RelA in regulating 
cellular mechanisms other than inflammatory gene expression in ECs. 
6.4 Future work 
In order to possess a full picture of the roles of Cezanne and non-canonical NF-κB 
signalling in EC dysfunction and atherosclerosis, further experiments are required to test 
additional hypotheses which have been raised by the stated conclusions. 
6.4.1 The function of Cezanne-dependent inhibition of RelA phosphorylation. 
Perhaps the most difficult conclusion to explain was Cezanne inhibition of RelA 
phosphorylation conferring no discernible effect on NF-κB target gene expression as 
measured by qPCR. However, limitations in the study design meant that only a limited 
number of genes were tested, and at a single time-point after 72 hours of exposure to 
shear stress. Phosphorylation of serine 536 of RelA has been implicated in having several 
effects on NF-κB activity, including altering the dynamics of nuclear import, reducing 
the time spent bound to DNA and altering its target genes (Bohuslav et al., 2004; 
Lawrence et al., 2005; Moles et al., 2013; Sasaki et al., 2005). Thus, full elucidation of 
the role of Cezanne in regulating canonical NF-κB signalling in low shear stress may 
require more detailed analysis of NF-κB kinetics. Time-lapse microscopy in conjunction 
with fluorescently tagged RelA has previously been employed to study NF-κB nuclear 
oscillations (Nelson et al., 2004). Utilising this technique to study the effect of Cezanne 
silencing and shear stress on RelA transport may reveal differences in the dynamics of 
NF-κB that could inform its function. 
In addition, unbiased screening approaches could be utilised to determine whether the 
expression of genes which were not included in the study were altered by Cezanne 
silencing or phosphorylation of RelA. Microarray or RNA sequencing analysis of 
transcripts from Cezanne depleted ECs in culture may be used for this, or RNA from the 
carotid arteries of Otud7b–/– mice after undergoing partial carotid ligation (Ni et al., 
2010). This approach will allow the discovery of novel targets and avoid the technical 
limitations of primer design for specific targets. 
6.4.2 The role of Cezanne in the development of atherosclerosis. 
From the lack of difference in atherosclerotic lesion size seen between Otud7b–/–Ldlr–/– 
and Ldlr–/– animals, I concluded that Cezanne did not function to alter the development 
of plaques. However, there are some reasons why this may not be the complete story, and 
further experiments could be used to clarify the results. Firstly, this study used a 
relatively short period of high-fat diet feeding at only six weeks. This served to test 
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whether Cezanne regulates early atherogenesis, but the effect of enhanced RelA 
phosphorylation may not be seen until later in plaque development. Maintaining these 
animals on a high-fat diet for longer periods may show an effect on later stages of lesion 
development. Secondly, lesion size as measured in flat tissue was the only metric used to 
assess the function of Cezanne in regulating the severity of atherosclerosis. Many genes 
are known to influence the development of atherosclerosis by altering plaque 
composition and not necessarily absolute lesion coverage. Histological analysis of the 
difference in lesion composition between Otud7b–/–Ldlr–/– and Ldlr–/– animals may 
reveal a previously undetected effect of Cezanne loss on atherosclerosis. 
6.4.3 Investigating the molecular mechanism behind p52 mediated p21 
inhibition. 
While previous studies have also shown inhibition of p21 by non-canonical NF-κB, it is 
not clear whether these mechanisms are at play in ECs exposed to shear stress. Elevated 
p21 under high shear stress has been found to occur as a result of HDACs and p53 
promoting transcription (Zeng et al., 2003, 2006), but transcriptional repression of p21 
has also been seen with these molecules in combination with p52 (Schumm et al., 2006). 
Immunoprecipitation studies would help to understand whether this inhibition was as a 
result of direct DNA binding, and which other molecules were involved. ChIP could be 
used with cells exposed to shear stress and silencing of HDACs or p53 to test whether 
p52 binds directly to the p21 promoter and if this binding is dependent on these 
molecules. Moreover, if ChIP-sequencing was utilized, many novel DNA binding sites of 
p52/RelB could be elucidated and help to inform further research into the function of 
non-canonical NF-κB, perhaps in apoptosis or inflammation 
6.4.4 Determining the function of non-canonical NF-κB in atherosclerosis. 
An unanswered question about non-canonical NF-κB signalling in ECs is what role does 
the pathway play in regulating the development of atherosclerosis. Enhanced 
proliferation at low shear stress has been associated with both increased and decreased 
lesion development (Cancel and Tarbell, 2011; Mahmoud et al., 2016; Schober et al., 
2014), which may be due to differences in the mechanism controlling the change in 
proliferation. Aside from enhancing proliferation, non-canonical NF-κB signalling may 
also regulate other pathways involved in atherogenesis. To test the effects of the pathway 
on the lesion development, Nfkb2–/– mice could be crossed with Ldlr–/– or Apoe–/– mice, 
generating double knockouts. Alternatively, recent advances have resulted in the 
development of an adenoviral vector expressing a gain of function mutant of proprotein 
convertase subtilisin/kexin type 9 (PCSK9) which can be used to infect mice and confer 
susceptibility to atherosclerosis by directing LDLR for degradation (Bjørklund et al., 
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2014). Feeding a high-fat diet to these animals and measuring plaque development and 
composition will provide valuable information about the role of the non-canonical NF-
κB pathway. 
6.4.5 Modulation of non-canonical NF-κB activity as a potential therapeutic 
strategy. 
Upon determining the positive or negative effects that non-canonical NF-κB has on the 
development of atherosclerosis, the pathway may be an appropriate target for clinical 
intervention in the prevention of disease. If protective, treatment strategy may involve 
stimulation of p100 processing by a natural ligand. CD40L and LT-β have been shown to 
have inflammatory effects on ECs (Chakrabarti et al., 2007; Gene et al., 2008), so may 
not be suitable, however other non-canonical NF-κB stimuli may not confer the same 
response. If the non-canonical NF-κB pathway drives atherogenesis, then chemical 
inhibition of the pathway could be employed. SN52 is a small peptide inhibitor of 
p52/RelB nuclear import, through competitive binding of the nuclear import proteins 
(Xu et al., 2008). This could be employed to specifically block non-canonical NF-κB 
signalling and alleviate its effects. As NF-κB signalling is crucial in the normal function 
of immune cells, off-target effects could be minimised by targeting delivery to ECs at sites 
of low shear stress (Chung et al., 2016). 
6.5 Closing remarks. 
Signalling to and from NF-κB involves a large network of interacting members, with 
multiple levels of complexity. From the variety of cell surface receptors, signals are 
channelled into two main branches of signalling, which can initiate the transcription of 
numerous target genes depending on context. From the experiments in this thesis and 
previous work, it is clear that NF-κB signalling plays a key role in the alteration of many 
aspects of endothelial cell physiology which can promote the development of 
atherosclerosis, although there are still many important unanswered questions about the 
function of the pathway which can hopefully be addressed in the coming years. 
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Target	gene Sequence
Non-targeting	“scrambled”	
control
UGGUUUACAUGUCGACUAA
UGGUUUACAUGUUGUGUGA
UGGUUUACAUGUUUUCUGA
UGGUUUACAUGUUUUCCUA
OTUD7B CCGAUUGGCCAGUGUAAUU
CCGAGUGGCUGAUUCCUAU
GCAUCUAGGUACCAAUGGA
UAACGGAGGGAGCAAGUAU
NFKB2 CGAACAGCCUUGCAUCUAG
GUAGACACGUACCGACAGA
AGACGAGUGUGGUGAGCUU
GAUCUGCGCCGUUUCUGUG
RELB CUGCGGAUUUGCCGAAUUA
GCACAGAUGAAUUGGAGAU
CCAUUGAGCGGAAGAUUCA
GCCCGUCUAUGACAAGAAA
Appendix 7.3: List of siRNA molecules used.
Gene Sense sequence Antisense	sequence
OTUD7B	(Cezanne) GAGTTGAGAAGGAAGCGTT CACTCCTTCTGCCATTCATC 
VCAM-1 CATTGACTTGCAGCACCACA AGATGTGGTCCCCTCATTCG
ICAM-1 CACAAGCCACGCCTCCCTGAACCTA TGTGGGCCTTTGTGTTTTGATGCTA
E-selectin GCTCTGCAGCTCGGACAT GAAAGTCCAGCTACCAAGGGAAT
SOD2 CATCAGCGGTAGCACCAGCA GCGTGGTGCTTGCTGTGGTG
BCL2 GCTGCACCTGACGCCCTTCA CCGTACAGTTCCACAAAGGC
GADD45B TGGAGGAGCTTTTGGTGGC AAGTGGATTTGCAGGGCGAT
CCND1 ATGAACTACCTGGACCGCTT TTCAATGAAATCGTGCGGGG
CCNG2 GAAAGCTTGCAACTGCCGAC CAAATTGAGAAGGCACAAGGCT
REDD1 GTTCATCAGCAAACGCCCTG GACACCCCATCCAGGTAAGC
p21 GATGTCCGTCAGAACCCATG TTAGGGCTTCCTCTTGGAGA
GADD45A GCTGGTGACGAATCCACAT ATCCATGTAGCGACTTTCCC
IL-8 TGCCAAGGAGTGCTAAAG CTCCACAACCCTCTGCAC
p53 GCCCCCAGGGAGCACTA GGGAGAGGAGCTGGTGTTG
HPRT TTGGTCAGGCAGTATAATCC GGGCATATCCTACAACAAAC
MCP1 GCAGAAGTGGGTTCAGGATT TGGGTTGTGGAGTGAGTGTT 
eNOS TGAAGCACCTGGAGAATGAG TTGACCATCTCCTGATGGAA 
(Sus scrofa)	NFKB2 CTGAAGCCGGTTATCTCCCA ATAAACCTCATCTCCACCCCG
(Sus scrofa)	RELB GACAGCTACGGAGTGGACAAG CGTCGTTTGCTCTCGATGC
(Sus scrofa)	B2M GGTTCAGGTTTACTCACGCCAC CTTAACTATCTTGGGCTATTCG
NFKB2 GCCGAAAGACCTATCCCACT TTAGTCACATGCAGGACACCC
RELB ATTGACCCCTACAACGCTGG AAGTGGATTTGCAGGGCGAT
Appendix 7.4: List of primers used.
Antibody Company Use Concentration
Cezanne ProteinTech WB 1/3000
EF 5 μg/ml
Cezanne	(C	terminal) Human	Protein Atlas WB 1/1000
RelA Santa	Cruz	Biotechnology WB 1/5000
IF 1/1000
pSer536-RelA Cell Signaling WB 1/1000
p100/p52 Millipore WB 1/3000
RelB Cell	Signaling WB 1/1000
PDHX Santa	Cruz	Biotechnology WB 1/6000
PCNA Abcam IF 1/500
VE-cadherin BD	Pharmingen IF 1/500
VCAM-1 Abcam EF 5	μg/ml
ICAM-1 ProteinTech EF 5	μg/ml
Ki-67 Abcam WB 1/1000
EF 5	μg/ml
Goat	anti-rabbit	Alexa
Fluor	488
Life	Technologies IF variable
Goat	anti-rabbit	Alexa-
Fluor 568
Life	Technologies IF variable
Goat anti-rat	Alexa	Fluor	
568
Life	Technologies IF variable
Goat	anti-rabbit	horse	
radish	peroxidase
Dako WB variable
Goat	anti-mouse	horse	
radish	peroxidase
Dako WB variable
Appendix 7.5: Antibodies used. 
WB = Western blotting; 
IF = immunofluorescence staining; 
EF = en face immunofluorescence staining.
Reagent Volume	(ml)
Distilled	H2O 180
1	M	Tris-HCl (pH	8.5) 10
10%	Tween-20 10
0.5	M	EDTA	(pH	8.0) 0.4
Appendix 7.6: Composition of ear-clip lysis buffer.
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Ingredient Percentage	(w/w)
Sucrose 33.94
Anhydrous milk	fat 20.00
Casein 19.50
Maltodextrin 10.00
Corn	starch 5.00
Cellulose 5.00
Corn oil 1.00
Calcium	carbonate 0.40
L-cysteine 0.30
Choline	bitartrate 0.20
Cholesterol 0.15
Antioxidant 0.01
AIN-76A-MX 3.50
AIN-76A-VX 1.00
Appendix 7.8: Composition of Western diet.
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